
<html lang="en"     class="pb-page"  data-request-id="f1593828-44b0-4400-bad3-51b102e9ca1d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm8002262;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2008.51.issue-13;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure−Activity Relationships of the Cycloalkanol Ethylamine Scaffold: Discovery of Selective Norepinephrine Reuptake Inhibitors" /></meta><meta name="dc.Creator" content="Paige E.  Mahaney" /></meta><meta name="dc.Creator" content="Lori K.  Gavrin" /></meta><meta name="dc.Creator" content="Eugene J.  Trybulski" /></meta><meta name="dc.Creator" content="Gary P.  Stack" /></meta><meta name="dc.Creator" content="An T.  Vu" /></meta><meta name="dc.Creator" content="Stephen T.  Cohn" /></meta><meta name="dc.Creator" content="Fei  Ye" /></meta><meta name="dc.Creator" content="Justin K.  Belardi" /></meta><meta name="dc.Creator" content="Arthur A.  Santilli" /></meta><meta name="dc.Creator" content="Joseph P.  Sabatucci" /></meta><meta name="dc.Creator" content="Jennifer  Leiter" /></meta><meta name="dc.Creator" content="Grace H.  Johnston" /></meta><meta name="dc.Creator" content="Jenifer A.  Bray" /></meta><meta name="dc.Creator" content="Kevin D.  Burroughs" /></meta><meta name="dc.Creator" content="Scott A.  Cosmi" /></meta><meta name="dc.Creator" content="Liza  Leventhal" /></meta><meta name="dc.Creator" content="Elizabeth J.  Koury" /></meta><meta name="dc.Creator" content="Yingru  Zhang" /></meta><meta name="dc.Creator" content="Cheryl A.  Mugford" /></meta><meta name="dc.Creator" content="Douglas M.  Ho" /></meta><meta name="dc.Creator" content="Sharon J.  Rosenzweig-Lipson" /></meta><meta name="dc.Creator" content="Brian  Platt" /></meta><meta name="dc.Creator" content="Valerie A.  Smith" /></meta><meta name="dc.Creator" content="Darlene C.  Deecher" /></meta><meta name="dc.Description" content="Further exploration of the cycloalkanol ethylamine scaffold, of which venlafaxine (1) is a member, was undertaken to develop novel and selective norepinephrine reuptake inhibitors (NRIs) for evalua..." /></meta><meta name="Description" content="Further exploration of the cycloalkanol ethylamine scaffold, of which venlafaxine (1) is a member, was undertaken to develop novel and selective norepinephrine reuptake inhibitors (NRIs) for evalua..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 17, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm8002262" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm8002262" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm8002262" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm8002262" /></link>
        
    
    

<title>Structure−Activity Relationships of the Cycloalkanol Ethylamine Scaffold: Discovery of Selective Norepinephrine Reuptake Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm8002262" /></meta><meta property="og:title" content="Structure−Activity Relationships of the Cycloalkanol Ethylamine Scaffold: Discovery of Selective Norepinephrine Reuptake Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0010.jpeg" /></meta><meta property="og:description" content=" Further exploration of the cycloalkanol ethylamine scaffold, of which venlafaxine (1) is a member, was undertaken to develop novel and selective norepinephrine reuptake inhibitors (NRIs) for evaluation in a variety of predictive animal models. These efforts led to the discovery of a piperazine-containing analogue, 17g (WY-46824), that exhibited potent norepinephrine reuptake inhibition, excellent selectivity over the serotonin transporter, but no selectivity over the dopamine transporter. Synthesis and testing of a series of cyclohexanol ethylpiperazines identified (S)-(−)-17i (WAY-256805), a potent norepinephrine reuptake inhibitor (IC50 = 82 nM, Ki = 50 nM) that exhibited excellent selectivity over both the serotonin and dopamine transporters and was efficacious in animal models of depression, pain, and thermoregulatory dysfunction." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm8002262"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm8002262">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm8002262&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm8002262&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm8002262&amp;href=/doi/10.1021/jm8002262" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 4038-4049</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm701618q" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm8001857" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure−Activity Relationships of the Cycloalkanol Ethylamine Scaffold: Discovery of Selective Norepinephrine Reuptake Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paige+E.++Mahaney">Paige E. Mahaney</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lori+K.++Gavrin">Lori K. Gavrin</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eugene+J.++Trybulski">Eugene J. Trybulski</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary+P.++Stack">Gary P. Stack</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=An+T.++Vu">An T. Vu</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+T.++Cohn">Stephen T. Cohn</a></span><span class="author-xref-symbol "><sup>§</sup></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fei++Ye">Fei Ye</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Justin+K.++Belardi">Justin K. Belardi</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arthur+A.++Santilli">Arthur A. Santilli</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+P.++Sabatucci">Joseph P. Sabatucci</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer++Leiter">Jennifer Leiter</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Grace+H.++Johnston">Grace H. Johnston</a></span><span class="author-xref-symbol "><sup>†</sup></span><span class="author-xref-symbol "><sup>£</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jenifer+A.++Bray">Jenifer A. Bray</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+D.++Burroughs">Kevin D. Burroughs</a></span><span class="author-xref-symbol "><sup>†</sup></span><span class="author-xref-symbol "><sup>£</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott+A.++Cosmi">Scott A. Cosmi</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Liza++Leventhal">Liza Leventhal</a></span><span class="author-xref-symbol "><sup>#</sup></span><span class="author-xref-symbol "><sup>×</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth+J.++Koury">Elizabeth J. Koury</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yingru++Zhang">Yingru Zhang</a></span><span class="author-xref-symbol "><sup>§</sup></span><span class="author-xref-symbol "><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheryl+A.++Mugford">Cheryl A. Mugford</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+M.++Ho">Douglas M. Ho</a></span><span class="author-xref-symbol "><sup>▽</sup></span><span class="author-xref-symbol "><sup>△</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sharon+J.++Rosenzweig-Lipson">Sharon J. Rosenzweig-Lipson</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Platt">Brian Platt</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valerie+A.++Smith">Valerie A. Smith</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Darlene+C.++Deecher">Darlene C. Deecher</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: 484-865-0627. Fax: 484-865-9399. E-mail: <a href="/cdn-cgi/l/email-protection#1f727e777e717a6f5f68667a6b77317c7072"><span class="__cf_email__" data-cfemail="2a474b424b444f5a6a5d534f5e4204494547">[email protected]</span></a></div><div class="corresp-fn" id="afn1">§Chemical and Screening Sciences, Wyeth Research, PA.</div><div class="corresp-fn" id="afn2">⊥Chemical and Screening Sciences, Wyeth Research, NJ.</div><div class="corresp-fn" id="afn3">‡Current address: Encysive Pharmaceuticals Inc., Houston, TX 77030.</div><div class="corresp-fn" id="afn4">†Women’s Health and Musculoskeletal Biology, Wyeth Research, PA.</div><div class="corresp-fn" id="afn5">£Current address: Neotropix, Inc., Malvern, PA 19355.</div><div class="corresp-fn" id="afn6">#Department of Neuroscience, Wyeth Research, NJ.</div><div class="corresp-fn" id="afn7">×Current address: EnVivo Pharmaceuticals, Watertown, MA 02472.</div><div class="corresp-fn" id="afn8">∞Current address: Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543.</div><div class="corresp-fn" id="afn9">∥Drug Safety and Metabolism, Wyeth Research, PA.</div><div class="corresp-fn" id="afn10">▽Current address: Department of Chemistry, Harvard University, Cambridge, MA 02138.</div><div class="corresp-fn" id="afn11">△Department of Chemistry, Princeton University.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm8002262&amp;href=/doi/10.1021%2Fjm8002262" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 4038–4049</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 17, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 March 2008</li><li><span class="item_label"><b>Published</b> online</span>17 June 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 July 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm8002262" title="DOI URL">https://doi.org/10.1021/jm8002262</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4038%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPaige%2BE.%2BMahaney%252C%2BLori%2BK.%2BGavrin%252C%2BEugene%2BJ.%2BTrybulski%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D13%26contentID%3Djm8002262%26title%3DStructure%25E2%2588%2592Activity%2BRelationships%2Bof%2Bthe%2BCycloalkanol%2BEthylamine%2BScaffold%253A%2BDiscovery%2Bof%2BSelective%2BNorepinephrine%2BReuptake%2BInhibitors%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4049%26publicationDate%3DJuly%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm8002262"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1462</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm8002262" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure−Activity Relationships of the Cycloalkanol Ethylamine Scaffold: Discovery of Selective Norepinephrine Reuptake Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Paige&quot;,&quot;last_name&quot;:&quot;E. Mahaney&quot;},{&quot;first_name&quot;:&quot;Lori&quot;,&quot;last_name&quot;:&quot;K. Gavrin&quot;},{&quot;first_name&quot;:&quot;Eugene&quot;,&quot;last_name&quot;:&quot;J. Trybulski&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;P. Stack&quot;},{&quot;first_name&quot;:&quot;An&quot;,&quot;last_name&quot;:&quot;T. Vu&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;T. Cohn&quot;},{&quot;first_name&quot;:&quot;Fei&quot;,&quot;last_name&quot;:&quot;Ye&quot;},{&quot;first_name&quot;:&quot;Justin&quot;,&quot;last_name&quot;:&quot;K. Belardi&quot;},{&quot;first_name&quot;:&quot;Arthur&quot;,&quot;last_name&quot;:&quot;A. Santilli&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;P. Sabatucci&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;Leiter&quot;},{&quot;first_name&quot;:&quot;Grace&quot;,&quot;last_name&quot;:&quot;H. Johnston&quot;},{&quot;first_name&quot;:&quot;Jenifer&quot;,&quot;last_name&quot;:&quot;A. Bray&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;D. Burroughs&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;A. Cosmi&quot;},{&quot;first_name&quot;:&quot;Liza&quot;,&quot;last_name&quot;:&quot;Leventhal&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;J. Koury&quot;},{&quot;first_name&quot;:&quot;Yingru&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Cheryl&quot;,&quot;last_name&quot;:&quot;A. Mugford&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;M. Ho&quot;},{&quot;first_name&quot;:&quot;Sharon&quot;,&quot;last_name&quot;:&quot;J. Rosenzweig-Lipson&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Platt&quot;},{&quot;first_name&quot;:&quot;Valerie&quot;,&quot;last_name&quot;:&quot;A. Smith&quot;},{&quot;first_name&quot;:&quot;Darlene&quot;,&quot;last_name&quot;:&quot;C. Deecher&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;4038-4049&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm8002262&quot;},&quot;abstract&quot;:&quot;Further exploration of the cycloalkanol ethylamine scaffold, of which venlafaxine (1) is a member, was undertaken to develop novel and selective norepinephrine reuptake inhibitors (NRIs) for evaluation in a variety of predictive animal models. These efforts led to the discovery of a piperazine-containing analogue, 17g (WY-46824), that exhibited potent norepinephrine reuptake inhibition, excellent selectivity over the serotonin transporter, but no selectivity over the dopamine transporter. Synthesis and testing of a series of cyclohexanol ethylpiperazines identified (S)-(−)-17i (WAY-256805), a potent norepinephrine reuptake inhibitor (IC50 = 82 nM, Ki = 50 nM) that exhibited excellent selectivity over both the serotonin and dopamine transporters and was efficacious in animal models of depression, pain, and thermoregulatory dysfunction.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8002262&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8002262" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8002262&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8002262" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8002262&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8002262" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm8002262&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8002262&amp;href=/doi/10.1021/jm8002262" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm8002262" /></input><a href="/doi/pdf/10.1021/jm8002262" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (199 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm8002262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm8002262%26sid%3Dliteratum%253Aachs%26pmid%3D18557608%26genre%3Darticle%26aulast%3DMahaney%26date%3D2008%26atitle%3DStructure%25E2%2588%2592Activity%2BRelationships%2Bof%2Bthe%2BCycloalkanol%2BEthylamine%2BScaffold%253A%2BDiscovery%2Bof%2BSelective%2BNorepinephrine%2BReuptake%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D13%26spage%3D4038%26epage%3D4049%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8002262&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Further exploration of the cycloalkanol ethylamine scaffold, of which venlafaxine (<b>1</b>) is a member, was undertaken to develop novel and selective norepinephrine reuptake inhibitors (NRIs) for evaluation in a variety of predictive animal models. These efforts led to the discovery of a piperazine-containing analogue, <b>17g</b> (WY-46824), that exhibited potent norepinephrine reuptake inhibition, excellent selectivity over the serotonin transporter, but no selectivity over the dopamine transporter. Synthesis and testing of a series of cyclohexanol ethylpiperazines identified (<i>S</i>)-(−)-<b>17i</b> (WAY-256805), a potent norepinephrine reuptake inhibitor (IC<sub>50</sub> = 82 nM, <i>K</i><sub>i</sub> = 50 nM) that exhibited excellent selectivity over both the serotonin and dopamine transporters and was efficacious in animal models of depression, pain, and thermoregulatory dysfunction.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24062" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24062" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Norepinephrine (NE<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>), <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations; NRI, norepinephrine reuptake inhibitor; NE, norepinephrine; NET, norephinephrine transporter; 5-HT, serotonin; MDD, major depressive disorder; SUI, stress urinary incontinence; ADHD, attention hyperactivity disorder; SNRI, serotonin and norepinephrine reuptake inhibitor; SAR, structure−activity relationship; hNET, human norepinephrine transporter; hSERT, human serotonin transporter; cpm, counts per minute; MDCK, Madin−Darby canine kidney; hDAT, human dopamine transporter; BOP, benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate; THF, tetrahydrofuran; SSRI, selective serotonin reuptake inhibitor; SRI, serotonin reuptake inhibitor; ip, intraperitoneal; sc, subcutaneous; po, oral; AUC, area under the curve; <i>C</i><sub>max</sub>, maximum concentration; OVX, ovariectomized; TST, tail-skin temperature.</p></div> a major neurotransmitter, is released from noradrenergic neurons during synaptic transmission. Noradrenergic neurons project from the locus coeruleus to stimulate stress responses<a onclick="showRef(event, 'cit1c cit1d'); return false;" href="javascript:void(0);" class="ref cit1c cit1d">(1c, 1d)</a> and arousal<a onclick="showRef(event, 'cit1a cit1b'); return false;" href="javascript:void(0);" class="ref cit1a cit1b">(1a, 1b)</a> and to regulate the sympathetic nervous system.<a onclick="showRef(event, 'cit1d cit1e'); return false;" href="javascript:void(0);" class="ref cit1d cit1e">(1d, 1e)</a> These neurons modulate nearly all areas of the brain including the hippocampus, which is involved in memory and learning,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> the prefrontal cortex, which is involved in drive and motivation,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and the hypothalamus, which is involved in temperature regulation and sleep.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> NRIs enhance the transmission of NE by increasing its synaptic availability through blockage of its reuptake by the norepinephrine transporter (NET), making NRIs potential treatments for a wide range of disorders. Compounds that block both NE and serotonin (5-HT) reuptake, such as venlafaxine (<b>1</b>), duloxetine (<b>2</b>), and milnacipran (<b>3</b>), Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, have been approved in the U.S. and in Europe for indications including major depressive disorder (MDD) and pain disorders such as diabetic neuropathy. In addition, compounds with this profile have been reported to exhibit efficacy for other ailments such as stress urinary incontinence (SUI),<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> attention deficit hyperactivity disorder (ADHD),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and fibromyalgia.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Drugs that selectively inhibit norepinephrine reuptake, including reboxetine (<b>4</b>) and nisoxetine (<b>5</b>), are marketed for the treatment of MDD; more recently, atomoxetine (<b>6</b>) was approved for the treatment of ADHD. Interestingly, although atomoxetine has little affinity for the dopamine transporter (DAT), it has been shown to selectively increase extracellular dopamine levels in the prefrontal cortex without a concomitant increase in either the nucleus accumbens or striatum.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Reboxetine and atomoxetine have also been reported to show efficacy for chronic pain disorders such as fibromyalgia<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and low back pain.<a onclick="showRef(event, 'cit9a'); return false;" href="javascript:void(0);" class="ref cit9a">(9a)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of marketed SSRIs, SNRIs, and NRIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8002262&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Background</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50855" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50855" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Venlafaxine (<b>1</b>), a member of the cycloalkanol ethylamine scaffold, was the first dual-acting serotonin and norepinephrine reuptake inhibitor (SNRI) to be approved for the treatment of MDD and continues to be widely prescribed. A drug discovery program was initiated to re-examine the structure−activity relationship (SAR) within the cycloalkanol ethylamine scaffold to identify novel and selective NRIs for in vivo evaluation in a panel of predictive animal models. Our initial strategy involved screening libraries of in-house compounds that were originally prepared for the historical MDD program. This approach entailed retesting compounds using a cell line expressing the human norepinephrine transporter (hNET), since uptake inhibition of NE and 5-HT was previously evaluated in rat brain cortical synaptosomes as reported in the original cycloalkanol ethylamine paper.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> According to a new paradigm, compounds were screened in vitro in MDCK-Net6 cells that were stably transfected with hNET. These cells were then treated with the test compound followed by [<sup>3</sup>H]NE to initiate NE uptake. Once the cells were washed and lysed, uptake of [<sup>3</sup>H]NE was measured by collection of counts per minute (cpm) data. Serotonin uptake into JAR cells that were stably transfected with the human serotonin transporter (hSERT) was similarly measured. Binding affinity for hNET was determined using a competition radioligand-binding assay in whole MDCK cells with [<sup>3</sup>H]nisoxetine as the radioligand. Previous studies with cycloalkanol ethylamine analogues revealed a significant reduction in binding affinity using purified membranes versus whole cells.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In addition, values from the whole cell assay more closely correlated to inhibition of NE uptake.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Affinity for hNET was compared to affinity for the human dopamine transporter (hDAT) measured using purified CHO membranes expressing recombinant hDAT. The cocaine analogue, [<sup>3</sup>H]-3β-(4-fluorophenyl)tropane-2β-carboxylic acid methyl ester<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> (<b>18</b>, [<sup>3</sup>H]WIN35,428) was used as the radioligand. Target in vitro profiles for drug candidates included an IC<sub>50</sub> value of less than 100 nM in the hNET uptake assay and selectivity over hSERT and hDAT of greater than 100-fold.</div><div class="NLM_p">A set of original cyclohexanol ethyl <i>N,N′</i>-dimethylamines, chosen to examine the effect of aromatic ring substitution on selectivity and potency, was characterized for activity at the human monoamine transporters (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Good agreement was observed between the previously reported SAR established in rat cortical synaptosomes<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and that determined in cells transfected with the human transporters; however, the absolute IC<sub>50</sub> values differed for some compounds. In general, increasing the electron-withdrawing nature of the aromatic ring provided more potent inhibitors of NE uptake and improved the selectivity for NET over SERT. For example, substitution with a <i>p</i>-methoxy group (compound <b>1</b>) provided the weakest NRI (535 nM) and was 17-fold more potent at inhibiting 5-HT uptake. The <i>m</i>-chloro analogue (<b>9</b>) had an intermediate IC<sub>50</sub> value of 149 nM in the NE uptake assay and exhibited 2.4-fold selectivity over SERT, while the strongest electron-withdrawing <i>m</i>-trifluoromethyl analogue (<b>11</b>) was the most potent inhibitor of NE uptake, with an IC<sub>50</sub> value of 32 nM, and exhibited the best selectivity over 5-HT uptake, nearly 17-fold. All compounds tested exhibited only weak binding to hDAT.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Characterization of Cyclohexanol Ethyl <i>N,N′</i>-dimethylamine Analogues at the Human Norepinephrine, Serotonin, and Dopamine Transporters<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0002.gif" alt="" id="_i6" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">compd</th><th align="center" valign="bottom">R<sub>1</sub></th><th align="center" valign="bottom">R<sub>2</sub></th><th align="center" valign="bottom">R<sub>3</sub></th><th align="center" valign="bottom">hNET binding,<a class="ref internalNav" href="#tbl1-fn2" aria-label="b">b</a><i>K</i><sub>i</sub> (StDev), nM</th><th align="center" valign="bottom">hNET uptake,<a class="ref internalNav" href="#tbl1-fn3" aria-label="c">c</a> IC<sub>50</sub>(StDev) [rNET uptake],<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> nM</th><th align="center" valign="bottom">hSERT uptake,<a class="ref internalNav" href="#tbl1-fn4" aria-label="d">d</a> IC<sub>50</sub> (StDev) [rSERT uptake],<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> nM</th><th align="center" valign="bottom" char=".">ratio of (hSERT uptake IC<sub>50</sub>, nM)/(hNET uptake IC<sub>50</sub>, nM)<a class="ref internalNav" href="#tbl1-fn5" aria-label="e">e</a></th><th align="center" valign="bottom">hDAT binding inhibition<a class="ref internalNav" href="#tbl1-fn6" aria-label="f">f</a> (StDev), %</th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b></td><td align="left">OCH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">385 (103)</td><td align="left">535 (64) [640]</td><td align="left">31 (4) [210]</td><td align="char" char=".">0.05</td><td align="left">45<a class="ref internalNav" href="#tbl1-fn8" aria-label="h">h</a> (2)</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="left">H</td><td align="left">OCH<sub>3</sub></td><td align="left">H</td><td align="left">316 (108)</td><td align="left">208 (16) [620]</td><td align="left">88 (34) [190]</td><td align="char" char=".">0.42</td><td align="left">9<a class="ref internalNav" href="#tbl1-fn7" aria-label="g">g</a></td></tr><tr valign="top"><td align="left"><b>8</b></td><td align="left">Cl</td><td align="left">H</td><td align="left">H</td><td align="left">249 (121)</td><td align="left">120 (1) [300]</td><td align="left">123 (88) [180]</td><td align="char" char=".">1.0</td><td align="left">23<a class="ref internalNav" href="#tbl1-fn7" aria-label="g">g</a></td></tr><tr valign="top"><td align="left"><b>9</b></td><td align="left">H</td><td align="left">Cl</td><td align="left">H</td><td align="left">149 (40)</td><td align="left">121 (45) [160]</td><td align="left">292 (115) [320]</td><td align="char" char=".">2.4</td><td align="left">28<a class="ref internalNav" href="#tbl1-fn7" aria-label="g">g</a></td></tr><tr valign="top"><td align="left"><b>10</b></td><td align="left">H</td><td align="left">H</td><td align="left">Cl</td><td align="left">125 (49)</td><td align="left">205 (119) [NR]</td><td align="left">177 (127) [NR]</td><td align="char" char=".">0.86</td><td align="left">13<a class="ref internalNav" href="#tbl1-fn7" aria-label="g">g</a></td></tr><tr valign="top"><td align="left"><b>11</b></td><td align="left">H</td><td align="left">CF<sub>3</sub></td><td align="left">H</td><td align="left">21 (12)</td><td align="left">32 (7) [360]</td><td align="left">534 (62) [1440]</td><td align="char" char=".">16.7</td><td align="left">15<a class="ref internalNav" href="#tbl1-fn7" aria-label="g">g</a></td></tr><tr valign="top"><td align="left">(<i>R</i>)-(−)-<b>9</b></td><td align="left">H</td><td align="left">Cl</td><td align="left">H</td><td align="left">41 (18)</td><td align="left">46 (13)</td><td align="left">405 (99)</td><td align="char" char=".">8.8</td><td align="left">17<a class="ref internalNav" href="#tbl1-fn7" aria-label="g">g</a></td></tr><tr valign="top"><td align="left">(<i>S</i>)-(+)-<b>9</b></td><td align="left">H</td><td align="left">Cl</td><td align="left">H</td><td align="left">339 (100)</td><td align="left">303 (46)</td><td align="left">155 (78)</td><td align="char" char=".">0.51</td><td align="left">0<a class="ref internalNav" href="#tbl1-fn7" aria-label="g">g</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Data are the average of at least two independent experiments, each run in triplicate. NR means the data were not previously reported.</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">Inhibition of [<sup>3</sup>H]nisoxetine binding to MDCK-Net6 cells stably transfected with hNET. Desipramine (<i>K</i><sub>i</sub> = 2.1 ± 0.6 nM) was used as a standard. <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [L]/<i>K</i><sub>D</sub>), where [L] equals concentration of radioligand added.</p></div><div class="footnote" id="tbl1-fn3"><sup>c</sup><p class="last">Inhibition of NE uptake in MDCK-Net6 cells stably transfected with hNET. Desipramine (IC<sub>50</sub> = 3.4 ± 1.6 nM) was used as a standard.</p></div><div class="footnote" id="tbl1-fn4"><sup>d</sup><p class="last">Inhibition of 5-HT uptake in JAR cells stably transfected with hSERT. Fluoxetine (IC<sub>50</sub> = 9.4 ± 3.1 nM) was used as a standard.</p></div><div class="footnote" id="tbl1-fn5"><sup>e</sup><p class="last">Unitless value as a ratio in which higher numbers represent relatively greater NET selectivity. A value of 1 represents no selectivity.</p></div><div class="footnote" id="tbl1-fn6"><sup>f</sup><p class="last">Inhibition of radioligand <b>18</b> binding to membranes from CHO cells expressing recombinant hDAT. Mazindol (22.1 ± 6.5 nM) was used as a standard.</p></div><div class="footnote" id="tbl1-fn7"><sup>g</sup><p class="last">Percent inhibition measured at a concentration of 1000 nM.</p></div><div class="footnote" id="tbl1-fn8"><sup>h</sup><p class="last">Percent inhibition measured at a concentration of 10 000 nM.</p></div></div></div><div class="NLM_p">The effect of stereochemistry on selectivity and potency of the series was examined by separating compound <b>9</b> into its enantiomers using chiral HPLC. Assignment of the stereochemistry was based upon analogy to (<i>S</i>)-(+)-venlafaxine, which was unequivocally established previously via single-crystal X-ray diffraction.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The <i>R-</i>enantiomer of <b>9</b> exhibited an increase in both potency for hNET and selectivity over hSERT when compared to its racemate, while the <i>S-</i>enantiomer was both less potent and selective versus the racemate. Interestingly, hSERT had a potency preference for the <i>S</i>-enantiomer, which was opposite to that observed for hNET.</div><div class="NLM_p last">Since variation of aromatic substitution in the cyclohexanol ethyl <i>N,N′</i>-dimethylamine series did not provide compounds that met selectivity criteria for hNET over hSERT, additional examples within the cycloalkanol ethylamine scaffold with varied amine moieties were screened. These efforts led to the identification of a piperazine-containing analogue, <b>17g</b> (WY-46824), <img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0003.gif" alt="" id="_i7" /></img> as a potent NRI (IC<sub>50</sub> = 58 nM, hNET <i>K</i><sub>i</sub> = 46 nM) that exhibited nearly 300-fold selectivity over hSERT. Unfortunately, this compound had high affinity for hDAT (<i>K</i><sub>i</sub> = 53 nM), which was an undesired target for the purposes of this program. Therefore, new piperazine-containing analogues were synthesized with the goal of eliminating affinity for hDAT while maintaining the potency for hNET and selectivity over hSERT that was exhibited by the lead compound (<b>17g</b>).</div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36643" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36643" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A parallel synthesis approach for the generation of new analogues in the cyclohexanol ethylpiperazine scaffold was evaluated. The published synthetic route<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> was not deemed suitable for parallel synthesis because of a tendency toward retroaldol and low isolable yields obtained when the aldol reaction was conducted on the starting phenylacetic amide. Consequently, an improved synthesis that was amenable to a parallel approach was developed (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Performing the aldol reaction on the dianion of the starting phenylacetic acid at −78 °C prevented the occurrence of the reverse aldol reaction and gave the desired product in high yield. In contrast, quenching the aldol product at 0 °C, instead of maintaining a temperature of −78 °C, resulted in the isolation of a significant amount of starting material, presumably due to the retroaldol mechanism. Amine coupling to aldol product <b>14</b> to form amide <b>15</b> could be accomplished with a variety of conventional agents; however, benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate (BOP reagent) was selected because of its ease of handling and good yields obtained in parallel reactions. Reduction of the amide with borane−THF complex at elevated temperatures followed by in situ deprotection with hydrochloric acid afforded cycloalkanol amine analogues <b>16</b>, which could be N-methylated with an aqueous solution of formaldehyde in formic acid to afford <i>N</i>-methylpiperazine analogues <b>17</b>. Amines <b>16</b> and <b>17</b> were converted to dihydrochloride salts using methanolic hydrochloric acid prior to in vitro characterization.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0004.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Cycloalkanol Ethylamine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8002262&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) LDA (2.5 equiv), THF, −78 °C to room temp, then cyclohexanone, −78 °C (83−99%); (b) BOP reagent, 1-Boc-piperazine, CH<sub>2</sub>Cl<sub>2</sub> (59−87%); (c) BH<sub>3</sub>−THF, reflux, then aqueous HCl (51−69%); (d) HCHO, HCO<sub>2</sub>H, H<sub>2</sub>O, then HCl/MeOH (58−79%).</p></p></figure><div class="NLM_p">The enantiomers of compounds <b>16g</b>, <b>17g</b>, <b>16i</b>, and <b>17i</b> were prepared in >99.5% optical purity via separation of the Boc-protected amide intermediates <b>15g</b> and <b>15i</b> using chiral supercritical fluid chromatography. Attempts to separate the enantiomers of either <b>16g</b> or <b>17g</b> afforded products with significantly reduced optical purity. Assignment of the absolute configuration of (<i>R</i>)-(+)-<b>17g</b> was unequivocally established by a single-crystal X-ray analysis (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Assignment of the stereochemistry of <b>16g</b>, <b>16i</b>, and <b>17i</b> was based upon analogy.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. ORTEP view of 1-[(1<i>R</i>)-1-(3-chlorophenyl)-2-(4-methylpiperazin-1-yl)ethyl]cyclohexanol [(<i>R</i>)-(+)-<b>17g</b>].</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8002262&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vitro Characterization</h3><div class="NLM_p">The cyclohexanol ethylpiperazine analogues were characterized in vitro for their activity at the human monoamine transporters (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The effect of aromatic substitution on the SAR for reuptake inhibition at hNET in this series was similar to that seen within the <i>N,N′</i>-dimethylamine class. Again, the <i>p</i>-methoxy analogues (<b>16a</b> and <b>17a</b>) were the weakest inhibitors of NE uptake while the <i>m</i>-chloro (compounds <b>16g</b> and <b>17g</b>) and the <i>m</i>-trifluoromethyl analogues (<b>16j</b> and <b>17j</b>) were the most potent. Differing slightly, however, from the <i>N,N′</i>-dimethylamine SAR, in which the <i>m</i>-trifluoromethyl analogue <b>11</b> was preferred over the <i>m</i>-chloro analogue <b>9</b> for NRI potency and selectivity over hSERT, was the observation that within the cyclohexanol ethylpiperazines the <i>m</i>-chloro substituent (<b>16g</b>, <b>17g</b>) provided equivalent or improved potency and affinity at hNET versus the <i>m</i>-trifluoromethyl analogues (<b>16j</b>, <b>17j</b>). Interestingly, all analogues containing the <i>m</i>-chloro group also exhibited high affinity for hDAT while the trifluoromethyl analogues did not. To further explore this observation, the <i>m</i>-trifluoromethoxy analogues <b>16i</b> and <b>17i</b> were synthesized. These compounds also maintained good potency and affinity at hNET while possessing very little affinity for hDAT. In contrast, the <i>m</i>-methoxy analogue (compound <b>17b</b>) exhibited significantly reduced activity at all transporters.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Characterization of Cyclohexanol Ethylpiperazine Analogues at the Human Norepinephrine, Serotonin, and Dopamine Transporters<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0006.gif" alt="" id="_i13" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">compd</th><th align="center" valign="bottom">R<sub>1</sub></th><th align="center" valign="bottom">R<sub>2</sub></th><th align="center" valign="bottom">R<sub>3</sub></th><th align="center" valign="bottom">R<sub>4</sub></th><th align="center" valign="bottom">hNET binding,<a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a><i>K</i><sub>i</sub> (StDev), nM</th><th align="center" valign="bottom">hNET uptake,<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a> IC<sub>50</sub> (StDev), nM</th><th align="center" valign="bottom">hSERT uptake,<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a> IC<sub>50</sub> (StDev), nM</th><th align="center" valign="bottom">hDAT binding,<a class="ref internalNav" href="#tbl2-fn5" aria-label="e">e</a><i>K</i><sub>i</sub> (StDev), nM</th><th align="center" valign="bottom">hDAT binding inhibition at 1 µM<a class="ref internalNav" href="#tbl2-fn5" aria-label="e">e</a> (StDev), %</th></tr></thead><tbody><tr valign="top"><td align="left"><b>17a</b></td><td align="left">OCH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">CH<sub>3</sub></td><td align="left"> </td><td align="left">34% (18)<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a><sup>,</sup><a class="ref internalNav" href="#tbl2-fn7" aria-label="g">g</a></td><td align="left">11%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a> (13)</td><td align="left"> </td><td align="left">5</td></tr><tr valign="top"><td align="left"><b>16a</b></td><td align="left">OCH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">H</td><td align="left">519 (233)</td><td align="left">34% (1)<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a><sup>,</sup><a class="ref internalNav" href="#tbl2-fn7" aria-label="g">g</a></td><td align="left">24%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a> (8)</td><td align="left"> </td><td align="left">9</td></tr><tr valign="top"><td align="left"><b>17b</b></td><td align="left">H</td><td align="left">OCH<sub>3</sub></td><td align="left">H</td><td align="left">CH<sub>3</sub></td><td align="left">514 (339)</td><td align="left">600 (143)</td><td align="left">14%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a> (16)</td><td align="left"> </td><td align="left">4</td></tr><tr valign="top"><td align="left"><b>16b</b></td><td align="left">H</td><td align="left">OCH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">745 (248)</td><td align="left">870 (126)</td><td align="left">8%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a> (6)</td><td align="left"> </td><td align="left">2</td></tr><tr valign="top"><td align="left"><b>17c</b></td><td align="left">F</td><td align="left">H</td><td align="left">H</td><td align="left">CH<sub>3</sub></td><td align="left">1376 (738)</td><td align="left">1452 (73)</td><td align="left">13%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a> (4)</td><td align="left"> </td><td align="left">32</td></tr><tr valign="top"><td align="left"><b>16c</b></td><td align="left">F</td><td align="left">H</td><td align="left">H</td><td align="left">H</td><td align="left">1034 (394)</td><td align="left">1499 (242)</td><td align="left">29%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="left"> </td><td align="left">22</td></tr><tr valign="top"><td align="left"><b>17d</b></td><td align="left">H</td><td align="left">F</td><td align="left">H</td><td align="left">CH<sub>3</sub></td><td align="left">364 (167)</td><td align="left">240 (160)</td><td align="left">12%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="left"> </td><td align="left">29<a class="ref internalNav" href="#tbl2-fn7" aria-label="g">g</a></td></tr><tr valign="top"><td align="left"><b>16d</b></td><td align="left">H</td><td align="left">F</td><td align="left">H</td><td align="left">H</td><td align="left">368 (211)</td><td align="left">673 (66)</td><td align="left">12%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="left"> </td><td align="left">22</td></tr><tr valign="top"><td align="left"><b>17e</b></td><td align="left">H</td><td align="left">H</td><td align="left">F</td><td align="left">CH<sub>3</sub></td><td align="left">34%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a><sup>,</sup><a class="ref internalNav" href="#tbl2-fn7" aria-label="g">g</a></td><td align="left">19%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>16e</b></td><td align="left">H</td><td align="left">H</td><td align="left">F</td><td align="left">H</td><td align="left">38%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a><sup>,</sup><a class="ref internalNav" href="#tbl2-fn7" aria-label="g">g</a></td><td align="left">31%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a><sup>,</sup><a class="ref internalNav" href="#tbl2-fn7" aria-label="g">g</a></td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>17f</b></td><td align="left">Cl</td><td align="left">H</td><td align="left">H</td><td align="left">CH<sub>3</sub></td><td align="left">1220 (266)</td><td align="left">7%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="left">0%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="left"> </td><td align="left">26</td></tr><tr valign="top"><td align="left"><b>16f</b></td><td align="left">Cl</td><td align="left">H</td><td align="left">H</td><td align="left">H</td><td align="left">717 (95)</td><td align="left">29%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a><sup>,</sup><a class="ref internalNav" href="#tbl2-fn7" aria-label="g">g</a></td><td align="left">1525 (322)</td><td align="left"> </td><td align="left">35</td></tr><tr valign="top"><td align="left"><b>17g</b></td><td align="left">H</td><td align="left">Cl</td><td align="left">H</td><td align="left">CH<sub>3</sub></td><td align="left">46 (3)</td><td align="left">58 (10)</td><td align="left">18795 (4600)</td><td align="left">53 (18)</td><td align="left"> </td></tr><tr valign="top"><td align="left">(<i>R</i>)-(+)- <b>17g</b></td><td align="left">H</td><td align="left">Cl</td><td align="left">H</td><td align="left">CH<sub>3</sub></td><td align="left">187 (51)</td><td align="left">577 (103)</td><td align="left">0%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="left">235 (50)</td><td align="left"> </td></tr><tr valign="top"><td align="left">(<i>S</i>)-(−)- <b>17g</b></td><td align="left">H</td><td align="left">Cl</td><td align="left">H</td><td align="left">CH<sub>3</sub></td><td align="left">14 (8)</td><td align="left">29 (5)</td><td align="left">9%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="left">73 (35)</td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>16g</b></td><td align="left">H</td><td align="left">Cl</td><td align="left">H</td><td align="left">H</td><td align="left">18 (11)</td><td align="left">38 (14)</td><td align="left">4962 (423)</td><td align="left">45 (17)</td><td align="left"> </td></tr><tr valign="top"><td align="left">(<i>R</i>)-(−)- <b>16g</b></td><td align="left">H</td><td align="left">Cl</td><td align="left">H</td><td align="left">H</td><td align="left">214 (87)</td><td align="left">540 (26)</td><td align="left">6102 (749)</td><td align="left">340 (63)</td><td align="left"> </td></tr><tr valign="top"><td align="left">(<i>S</i>)-(+)- <b>16g</b></td><td align="left">H</td><td align="left">Cl</td><td align="left">H</td><td align="left">H</td><td align="left">17 (4)</td><td align="left">25 (7)</td><td align="left">2669 (175)</td><td align="left">135 (30)</td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>17h</b></td><td align="left">OCF<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">CH<sub>3</sub></td><td align="left">417 (131)</td><td align="left">575 (162)</td><td align="left">1214 (99)</td><td align="left"> </td><td align="left">13 (9)</td></tr><tr valign="top"><td align="left"><b>17i</b></td><td align="left">H</td><td align="left">OCF<sub>3</sub></td><td align="left">H</td><td align="left">CH<sub>3</sub></td><td align="left">91 (58)</td><td align="left">147 (87)</td><td align="left">12%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a> (14)</td><td align="left"> </td><td align="left">3% (11)</td></tr><tr valign="top"><td align="left">(<i>R</i>)-(+)- <b>17i</b></td><td align="left">H</td><td align="left">OCF<sub>3</sub></td><td align="left">H</td><td align="left">CH<sub>3</sub></td><td align="left">785 (488)</td><td align="left">3474 (313)</td><td align="left">4%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="left"> </td><td align="left">5 (7)</td></tr><tr valign="top"><td align="left">(<i>S</i>)-(−)- <b>17i</b></td><td align="left">H</td><td align="left">OCF<sub>3</sub></td><td align="left">H</td><td align="left">CH<sub>3</sub></td><td align="left">50 (8)</td><td align="left">82 (21)</td><td align="left">3%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="left"> </td><td align="left">6 (1)</td></tr><tr valign="top"><td align="left"><b>16i</b></td><td align="left">H</td><td align="left">OCF<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">140 (89)</td><td align="left">284 (93)</td><td align="left">3%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="left"> </td><td align="left">13 (5)</td></tr><tr valign="top"><td align="left">(<i>R</i>)-(−)- <b>16i</b></td><td align="left">H</td><td align="left">OCF<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">544 (232)</td><td align="left">1290 (110)</td><td align="left">11%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a> (15)</td><td align="left"> </td><td align="left">15 (6)</td></tr><tr valign="top"><td align="left">(<i>S</i>)-(+)- <b>16i</b></td><td align="left">H</td><td align="left">OCF<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">117 (41)</td><td align="left">140 (82)</td><td align="left">3%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="left"> </td><td align="left">13 (12)</td></tr><tr valign="top"><td align="left"><b>17j</b></td><td align="left">H</td><td align="left">CF<sub>3</sub></td><td align="left">H</td><td align="left">CH<sub>3</sub></td><td align="left">61 (10)</td><td align="left">92 (6)</td><td align="left">28%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a><sup>,</sup><a class="ref internalNav" href="#tbl2-fn7" aria-label="g">g</a></td><td align="left"> </td><td align="left">6</td></tr><tr valign="top"><td align="left"><b>16j</b></td><td align="left">H</td><td align="left">CF<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">58 (14)</td><td align="left">94 (17)</td><td align="left">13%<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="left"> </td><td align="left">4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Data are the average of at least three independent experiments, each run in triplicate.</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">Inhibition of [<sup>3</sup>H]nisoxetine binding to MDCK-Net6 cells stably transfected with hNET. Desipramine (<i>K</i><sub>i</sub> = 2.1 ± 0.6 nM) was used as a standard. <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [L]/<i>K</i><sub>D</sub>), where [L] equals concentration of radioligand added.</p></div><div class="footnote" id="tbl2-fn3"><sup>c</sup><p class="last">Inhibition of NE uptake in MDCK-Net6 cells stably transfected with hNET. Desipramine (IC<sub>50</sub> = 3.4 ± 1.6 nM) was used as a standard.</p></div><div class="footnote" id="tbl2-fn4"><sup>d</sup><p class="last">Inhibition of serotonin uptake in JAR cells stably transfected with human SERT. Fluoxetine (IC<sub>50</sub> = 9.4 ± 3.1 nM) was used as a standard.</p></div><div class="footnote" id="tbl2-fn5"><sup>e</sup><p class="last">Inhibition of radioligand <b>18</b> binding to membranes from CHO cells expressing recombinant hDAT. Mazindol (22.1 ± 6.5 nM) was used as a standard.</p></div><div class="footnote" id="tbl2-fn6"><sup>f</sup><p class="last">Percent inhibition measured at a concentration of 1000 nM.</p></div><div class="footnote" id="tbl2-fn7"><sup>g</sup><p class="last">Compound gave poor dose response; therefore, no IC<sub>50</sub> was obtained.</p></div></div></div><div class="NLM_p">N-Methylation of the piperazine ring had no significant impact in vitro on hNET potency and affinity. For example, a comparison of the two racemic <i>m</i>-trifluoromethoxy analogues revealed IC<sub>50</sub> values for NE uptake of 147 nM for <i>N</i>-methylpiperazine <b>17i</b> compared to 284 nM for the unsubstituted analogue (<b>16i</b>). Likewise, <i>m</i>-trifluoromethyl analogues <b>16j</b> and <b>17j</b> had essentially identical IC<sub>50</sub> values of 92 and 94 nM, respectively.</div><div class="NLM_p">While the effect of aromatic substitution on the SAR for reuptake inhibition at hNET in the cyclohexanol ethylpiperazine series was similar to that seen within the <i>N,N′</i>-dimethylamine class, a major difference was observed for 5-HT uptake inhibition. In general, the electronic nature of the aromatic ring had little effect because incorporation of a piperazine ring into the scaffold essentially eliminated 5-HT reuptake inhibitory activity. For example, the <i>N</i>-methylpiperazine analogue containing a <i>p</i>-methoxy substituent (<b>17a</b>), the most potent substituent for 5-HT uptake inhibition in the <i>N,N′</i>-dimethylamine series, exhibited only 11% inhibition of hSERT at 1 µM. Among the cyclohexanol ethylpiperazines that were synthesized, the most potent SRIs (compounds <b>16f</b> and <b>17h</b>) had IC<sub>50</sub> values of greater than 1 µM.</div><div class="NLM_p">The effect of stereochemistry on the selectivity and potency of this series was examined by testing the enantiomeric pairs of compounds <b>16g</b>, <b>17g</b>, <b>16i</b>, and <b>17i</b>. In all four examples, the <i>S</i>-enantiomer was the eutomer, exhibiting an increase in both functional potency and binding affinity at hNET compared to the corresponding racemate while the <i>R</i>-enantiomer was significantly less active. For example, in the NE uptake assay, (<i>S</i>)-(−)-<b>17g</b> had an IC<sub>50</sub> value of 29 nM (<i>K</i><sub>i</sub> value of 14 nM in the binding assay) while (<i>R</i>)-(+)-<b>17g</b> exhibited an IC<sub>50</sub> of 577 nM (<i>K</i><sub>i</sub> value of 187 nM in the binding assay). This is a striking reversal from the preferred stereochemistry seen in the cyclohexanol ethyl <i>N,N′</i>-dimethylamine series where the <i>R</i>-enantiomer was the eutomer. A future publication will examine this intriguing observation in detail. Unfortunately for the <i>m</i>-chloro derivatives, the preferred stereochemistry for both hDAT and hNET was the <i>S</i>-enantiomer; consequently, no additional selectivity for hNET over hDAT was achieved through resolution. However, among the <i>m</i>-trifluoromethoxy derivatives, (<i>S</i>)-(−)-<b>17i</b> (WAY-256805) was a potent NRI (IC<sub>50</sub> value of 82 nM, <i>K</i><sub>i</sub> value of 50 nM) that was highly selective over both hSERT and hDAT. This compound was selected for further evaluation.</div><div class="NLM_p last">The potential for cross-reactivity of (<i>S</i>)-(−)-<b>17i</b> with 5-HT and adrenergic receptors was assessed using either a calcium mobilization assay measured on a fluorometric imaging plate reader (FLIPR) testing for both agonists and antagonists or a competition radioligand-binding assay. (<i>S</i>)-(−)-<b>17i</b> exhibited IC<sub>50</sub> and EC<sub>50</sub> values of greater than 10 µM across all receptors. Test receptors included 5-HT<sub>1B</sub>, 5-HT<sub>1D</sub>, 5-HT<sub>2a</sub>, 5-HT<sub>2B,</sub> 5-HT<sub>6</sub>, 5-HT<sub>7</sub>, and adrenergic receptor 1α.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Characterization</h3><div class="NLM_p">The antidepressant-like effects of compound (<i>S</i>)-(−)-<b>17i</b> were assessed in the mouse tail-suspension model.<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> During testing, subsequent to compound administration, male mice were suspended upside down by their tails and movements of the animals during a 6 min test session were automatically recorded. These movements were classified into periods of agitation (i.e., efforts to regain footing) and immobility. A decrease in immobility time in this model has been reported to correspond with antidepressant-like activity.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, when administered via intraperitoneal injection (ip) (<i>S</i>)-(−)-<b>17i</b> significantly decreased immobility time, with a <i>p</i> value of <0.05 (ANOVA), at 17 and 30 mg/kg, 38% and 53%, respectively, in a dose-dependent manner indicating antidepressant activity. Desipramine, a classical tricyclic antidepressant with selectivity for NET, has been reported to reduce immobility time in this model 25% and 30% when administered ip at doses of 8 and 16 mg/kg, respectively.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0007.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of (<i>S</i>)-(−)-<b>17i</b> in the tail-suspension test in male mice. A vehicle of 2% Tween-80/0.5% methylcellulose in water was used for delivery of test compounds. Data represent group mean ± SEM for each dose (<i>N</i> = 10 per group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8002262&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The antinociceptive effects of (<i>S</i>)-(−)-<b>17i</b> were evaluated in a mouse <i>p</i>-phenylquinone model of acute visceral (abdominal) pain.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In this model, <i>p</i>-phenylquinone, administered via ip injection, acts as a localized irritant resulting in an abdominal constriction response (i.e., writhing) which can be quantified. The ability of a compound to reduce the number of abdominal constrictions predicts efficacy toward attenuating visceral pain. The role of NE, a major component of the endogenous descending pain inhibitory system from the rostral ventral medulla to the spinal cord,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> has been formerly characterized.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Our dose−response data for desipramine have been previously described in this model at doses between 1 and 30 mg/kg.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> shows the effect of (<i>S</i>)-(−)-<b>17i</b> compared to desipramine, after subcutaneous (sc) administration between 3 and 30 mg/kg. Compound (<i>S</i>)-(−)-<b>17i</b> significantly reduced the number of abdominal constrictions when compared to vehicle (<i>p</i> < 0.05, ANOVA) at 10 and 30 mg/kg with similar efficacy as desipramine at both doses. While efficacy was similar between the two compounds, not surprisingly, desipramine was more potent, exhibiting significant activity at doses down to 1 mg/kg,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> consistently reflecting the in vitro 25-fold difference in potency.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0008.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of (<i>S</i>)-(−)-<b>17i</b> in the mouse <i>p</i>-phenylquinone model of acute visceral (abdominal) pain. A vehicle of saline was used for dosing. Data are presented as percent blockade compared to vehicle (% blockade = [(mean vehicle) − (drug)/(mean vehicle)] × 100) ± SEM for each dose (<i>N</i> = 8 per group); ∗ signifies a <i>p</i> value of <0.05 vs saline vehicle (ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8002262&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">NE has been reported to stimulate areas of the hypothalamus that play an important role in temperature regulation.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In order to determine its effects on temperature homeostasis, compound (<i>S</i>)-(−)-<b>17i</b> was also evaluated in a telemetric rat model of ovariectomized (OVX)-induced thermoregulatory dysfunction.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Intact cycling rats exhibit a diurnal rhythm during which, over a 24 h period, their tail-skin temperature (TST) decreases during the dark (active) phase and remains elevated during the light (inactive) phase. Reduction in ovarian hormones as a result of ovariectomy causes the TST of OVX-rats to remain elevated during both the dark and light phases, and treatment with estrogen has been reported to restore the normal diurnal temperature pattern to that seen in an intact rat.<a onclick="showRef(event, 'cit19a'); return false;" href="javascript:void(0);" class="ref cit19a">(19a)</a> Results of the evaluation of both SSRIs and SNRIs in this model have been previously reported;<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> however, activity of a selective NRI has not been described. According to our published paradigm,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> test compounds, administered 30 min prior to the dark phase, were analyzed for their ability to reduce TST versus baseline (individual baselines are measured for vehicle-dosed rats 1 day prior to administration of compound). TST was measured with a temperature and physical activity transmitter implanted sc with the tip of the temperature probe tunneled 2.5 cm beyond the base of the tail. Results for (<i>S</i>)-(−)-<b>17i</b> administered at a dose of 30 mg/kg both ip and orally (po) are depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. Both routes of administration resulted in significant reductions of TST; however, ip administration achieved both a larger absolute reduction of TST and a longer duration of action when compared to po administration (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). To help understand this difference in activity, the female rat pharmacokinetic parameters were measured (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). A significant difference in both the maximum concentration (<i>C</i><sub>max</sub>) and the area under the curve (AUC) with (<i>S</i>)-(−)-<b>17i</b> in rats in the two routes of administration was observed. The <i>C</i><sub>max</sub> after ip administration was 8-fold higher than after po administration, while the AUC values differed by nearly 7-fold.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0009.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of ip and po administration of (<i>S</i>)-(−)-<b>17i</b> in a telemetric rat model of ovariectomized (OVX)-induced thermoregulatory dysfunction; ∗ signifies a <i>p</i> value of <0.05 vs 2% Tween-80 /0.5% methylcellulose in water vehicle. The onset of an effect was defined as the first half-hour interval of two consecutive significant (<i>p</i> < 0.05) half-hour intervals. The treatment effect was defined to have ended when there are two consecutive nonsignificant (<i>p</i> ≥ 0.05) half-hour intervals. Braces mark periods of significant effects. Error bars represent standard error of the mean of each data point.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8002262&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Summary of (<i>S</i>)-(−)-<b>17i</b> in a Telemetric Rat Model of OVX-Induced Thermoregulatory Dysfunction Dosed po and ip (30 mg/kg)</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">route of administration of (<i>S</i>)-(−)-<b>17i</b> (dose)</th><th align="center" valign="bottom" char=".">onset of activity vs baseline (<i>p</i> < 0.05), h</th><th align="center" valign="bottom" char=".">duration of action, h</th><th align="center" valign="bottom" char=".">mean reduction in TST from baseline, °C</th><th align="center" valign="bottom" char=".">maximum reduction in TST from baseline, °C</th></tr></thead><tbody><tr valign="top"><td align="left">po (30 mg/kg)</td><td align="char" char=".">1</td><td align="char" char=".">3</td><td align="char" char=".">−2.16</td><td align="char" char=".">−3.15</td></tr><tr valign="top"><td align="left">ip (30 mg/kg)</td><td align="char" char=".">0.5</td><td align="char" char=".">6.5</td><td align="char" char=".">−2.75</td><td align="char" char=".">−4.87</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Female Sprague−Dawley (SD) Rat Pharmacokinetic Parameters for Compound (<i>S</i>)-(−)-<b>17i</b> after ip and po Dosing<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">route of administration</th><th align="center" valign="bottom" char=".">dose, mg/kg</th><th align="center" valign="bottom"><i>C</i><sub>max</sub>, ng/mL</th><th align="center" valign="bottom"><i>t</i><sub>1/2</sub>, h</th><th align="center" valign="bottom">AUC<sub>0-inf</sub>, ng·h/mL</th></tr></thead><tbody><tr valign="top"><td align="left">ip<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></td><td align="char" char=".">30</td><td align="left">2686 (442)</td><td align="left">2.3 (0.5)</td><td align="left">6163 (362)</td></tr><tr valign="top"><td align="left">po<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></td><td align="char" char=".">30</td><td align="left">324 (131)</td><td align="left">1.6 (0)</td><td align="left">931 (310)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Numbers in parentheses are standard deviations of <i>n</i> = 3 animals.</p></div><div class="footnote" id="tbl4-fn2"><sup>b</sup><p class="last">Compound was dosed in 2% Tween-80/0.5% methylcellulose in water as the vehicle.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Summary</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32574" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32574" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Efforts to identify selective and potent NRIs from the cycloalkanol ethylamine scaffold, of which venlafaxine (<b>1</b>) is a member, provided a piperazine-containing class of compounds that is highly selective for hNET over hSERT. Replacement of the <i>m</i>-chloro group in the lead compound (<b>17g</b>) with a fluorine-containing electron-withdrawing group such as trifluoromethoxy or trifluoromethyl afforded potent NRIs with excellent selectivity over both hDAT and hSERT. Further investigation of the effect of (<i>S</i>)-(−)-<b>17i</b> in animals revealed it to be efficacious in models of depression, acute visceral pain, and thermoregulatory dysfunction.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36333" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36333" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Methods</h3><div class="NLM_p last">Solvents were purchased as anhydrous grade and were used without further purification. Melting points were measured on a Mel-Temp II (Laboratory Device, Inc.) melting point apparatus and are uncorrected. <sup>1</sup>H NMR spectra were recorded on a Varian INOVA 400 instrument, and chemical shifts are reported in δ values (parts per million, ppm) relative to an internal standard tetramethylsilane in CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub>. In all cases, NMR spectra of enantiomers were essentially identical to those of their corresponding racemates. Electrospray (ESI) mass spectra were recorded using a Waters Alliance-ZMD mass spectrometer. Electron impact ionization (EI, EE = 70 eV) mass spectra were recorded on a Finnigan Trace mass spectrometer. Combustion analyses were performed by Robertson Microlit. Analytical thin layer chromatography (TLC) was performed on precoated plates (silica gel, 60 F-254) and were visualized using UV light and/or staining with a phosphomolybdic acid solution in ethanol. Optical rotations of individual enantiomers were obtained on a JASCO P-1020 polarimeter using a 1.0 mL microcell and methanol as the solvent. In general, compound purity was assessed by <sup>1</sup>H NMR and either a LC/UV/MS method or an analytical HPLC method as described in <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>. Biological results were obtained on compounds of >97% chemical purity as determined by the above methods. The syntheses of <b>1</b> and <b>7</b>−<b>11</b> have been previously described.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 1-[(1<i>R</i>)-1-(3-Chlorophenyl)-2-(dimethylamino)ethyl]cyclohexanol [(<i>R</i>)-(−)-<b>9</b>]</h3><div class="NLM_p last">Racemic 1-(1-(3-chlorophenyl)-2-(dimethylamino)ethyl)cyclohexanol <b>9</b><a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> was dissolved in methanol at a concentration of approximately 40 mg/mL, and the resulting solution was injected onto the supercritical fluid chromatography (SFC) instrument with a volume of 1.0 mL per injection. The baseline resolved enantiomers were collected using a Berger MultiGram Prep SFC (Berger Instruments, Inc., Newark, DE) under the following conditions: Chiralpak AD-H SFC column (5 µm, 250 mm length × 20 mm i.d., Chiral Technologies, Inc., Exton, PA), 35 °C column temperature, 10% isopropanol with 0.2% DEA as CO<sub>2</sub> modifier, 50 mL/min flow rate, 100 bar outlet pressure, 220 nm UV detection. The chiral purity of each enantiomer was determined under the same SFC conditions using a Chiralcel OD column (10 µm, 250 mm length × 4.6 mm i.d.) at 2.0 mL/min flow rate on a Berger Analytical SFC instrument. The enantiomeric purity of 1-[(1<i>R</i>)-1-(3-chlorophenyl)-2-(dimethylamino)ethyl]cyclohexanol was determined to be >99.9% (with <0.1% of the undesired enantiomer) isolated as peak 2: retention time, 4.69 min; [α]<sub class="stack">D</sub><sup class="stack">25</sup> +8.8° (<i>c</i> 10 mg/mL, MeOH). HRMS: calcd for C<sub>16</sub>H<sub>24</sub>ClNO + H<sup>+</sup>, 282.161 92; found (ESI, [M + H]<sup>+</sup>), 282.1634.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 1-[(1<i>S</i>)-1-(3-Chlorophenyl)-2-(dimethylamino)ethyl]cyclohexanol [(<i>S</i>)-(+)-<b>9</b>]</h3><div class="NLM_p last">The enantiomeric purity was determined to be >99.9% (with <0.1% of the undesired enantiomer) isolated as peak 1: retention time, 3.91 min; [α]<sub class="stack">D</sub><sup class="stack">25</sup> −10.8° (<i>c</i> 10 mg/mL, MeOH). HRMS: calcd for C<sub>16</sub>H<sub>24</sub>ClNO + H<sup>+</sup>, 282.161 92; found (ESI, [M + H]<sup>+</sup>), 282.1628. Anal. (C<sub>16</sub>H<sub>24</sub>ClNO·HCl) C, H, N.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure for the Synthesis of Aldol Intermediates <b>14a</b>−<b>j</b></h3><div class="NLM_p last">A solution of diisopropylamine (7.87 mL, 56.2 mmol) in dry tetrahydrofuran (50 mL) under nitrogen was cooled to −78 °C and treated dropwise with a solution of <i>n</i>-butyllithium (2.5 M in hexanes, 22 mL, 55 mmol). The resulting solution was warmed to 0 °C and stirred for 15 min. The solution was recooled to −78 °C and treated, via cannula, with a solution of the appropriate phenylacetic acid (23.4 mmol) in tetrahydrofuran (20 mL). The mixture was then allowed to warm to 25 °C where it was stirred for 45 min and was then recooled to −78 °C. A solution of cyclohexanone (3.65 mL, 35.3 mmol) in tetrahydrofuran (10 mL) was then added via cannula, and the resulting mixture was stirred at −78 °C for 1.5 h. The reaction was then quenched by the addition of a saturated aqueous solution of ammonium chloride, and the tetrahydrofuran was removed in vacuo. The resulting residue was dissolved in a 2 N aqueous solution of sodium hydroxide (30 mL) and washed with ethyl acetate (1 × 30 mL). The aqueous layer was then acidified to pH 1 with the addition of a 2 N aqueous solution of hydrochloric acid. The product was extracted with ethyl acetate (3 × 30 mL), and the combined organic extracts were dried over magnesium sulfate and concentrated in vacuo to yield product (83−99%) that was used without further purification.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (1-Hydroxycyclohexyl)-4-methoxyphenylacetic Acid <b>14a</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.14−1.15 (m, 2H), 1.34−1.54 (m, 8H), 3.50 (s, 1H), 3.73 (s, 3H), 4.28 (bs, 1H), 6.85 (d, <i>J</i> = 8.8 Hz, 2H), 7.32 (d, <i>J</i> = 8.8 Hz, 2H), 12.35 (bs, 1H). HRMS: calcd for C<sub>15</sub>H<sub>20</sub>O<sub>4</sub> + NH<sub>4</sub><sup>+</sup>, 282.169 98; found (ESI-FT/MS, [M + NH<sub>4</sub>]<sup>1+</sup>), 282.1706.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (1-Hydroxycyclohexyl)-3-methoxyphenylacetic Acid <b>14b</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.00−1.10 (m, 1H), 1.12−1.21 (m, 1H), 1.31−1.55 (m, 8H), 3.54 (s, 1H), 3.73 (s, 3H), 4.32 (bs, 1H), 6.84 (dd, <i>J</i> = 2.1, 8.2 Hz, 1H), 6.96 (d, <i>J</i> = 7.8 Hz, 1H), 6.99 (d, <i>J</i> = 2.1 Hz, 1H), 7.20 (t, <i>J</i> = 7.9 Hz, 1H), 12.32 (bs, 1H). HRMS: calcd for C<sub>15</sub>H<sub>20</sub>O<sub>4</sub> + Na<sup>+</sup>, 287.1254; found (ESI-FT/MS, [M + Na]<sup>1+</sup>), 287.1256.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 4-Fluoro-(1-hydroxycyclohexyl)phenylacetic Acid <b>14c</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.05−1.10 (m, 2H), 1.33−1.57 (m, 8H), 3.59 (s, 1H), 4.31 (bs, 1H), 7.12 (dd, <i>J</i> = 2.1, 9.0 Hz, 2H), 7.45 (dd, <i>J</i> = 2.2, 8.8 Hz, 2H), 12.43 (bs, 1H). HRMS: calcd for C<sub>14</sub>H<sub>17</sub>FO<sub>3</sub> − H<sup>+</sup>, 251.10890; found (ESI, [M − H]<sup>−</sup>), 251.1077.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 3-Fluoro-(1-hydroxycyclohexyl)phenylacetic Acid <b>14d</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.06−1.21 (m, 2H), 1.34−1.60 (m, 8H), 3.62 (s, 1H), 4.37 (bs, 1H), 7.09 (dddd, <i>J</i> = 0.9, 2.6, 9.0, 9.0 Hz, 1H), 7.22 (d, <i>J</i> = 7.8 Hz, 2H), 7.27−7.36 (m, 2H), 12.50 (bs, 1H). HRMS: calcd for C<sub>14</sub>H<sub>17</sub>FO<sub>3</sub> − H<sup>+</sup>, 251.10890; found (ESI, [M − H]<sup>−</sup>), 251.1083.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-Fluoro-(1-hydroxycyclohexyl)phenylacetic Acid <b>14e</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3,</sub> 400 MHz) δ 1.15−1.28 (m, 2H), 1.35 (d, <i>J</i> = 13.5 Hz, 1H), 1.41−1.58 (m, 5H), 7.09 (ddd, <i>J</i> = 3.6, 10.3, 13.4 Hz, 1H), 1.86 (dd, <i>J</i> = 2.6, 14.4 Hz, 1H), 4.12 (s, 1H), 4.56 (bs, 1H), 7.04−7.13 (m, 2H), 7.25−7.30 (m, 1H), 7.61 (ddd, <i>J</i> = 1.5, 7.6, 7.6 Hz, 1H). HRMS: calcd for C<sub>14</sub>H<sub>17</sub>FO<sub>3</sub> − H<sup>+</sup>, 251.10890; found (ESI, [M − H]<sup>−</sup>), 251.1087. Anal. Calcd for C<sub>14</sub>H<sub>17</sub>FO<sub>3</sub>·0.5H<sub>2</sub>O: C, 64.35; H, 6.94; N, 0.00. Found: C, 64.40; H, 7.04; N, 0.00.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 4-Chloro-(1-hydroxycyclohexyl)phenylacetic Acid <b>14f</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.05−1.21 (m, 2H), 1.33−1.60 (m, 8H), 3.59 (s, 1H), 4.34 (bs, 1H), 7.36 (ddd, <i>J</i> = 2.6, 2.6, 9.1 Hz, 2H), 7.45 (ddd, <i>J</i> = 2.6, 2.6, 9.2 Hz, 2H), 12.47 (bs, 1H). HRMS: calcd for C<sub>14</sub>H<sub>17</sub>ClO<sub>3</sub> − H<sup>+</sup>, 267.07935; found (ESI, [M − H]<sup>−</sup>), 267.0792.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3-Chloro-(1-hydroxycyclohexyl)phenylacetic Acid <b>14g</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.06−1.23 (m, 2H), 1.33−1.56 (m, 8H), 3.61 (s, 1H), 4.37 (bs, 1H), 7.22−7.38 (m, 3H), 7.53 (s, 1H), 12.50 (bs, 1H). HRMS: calcd for C<sub>14</sub>H<sub>17</sub>ClO<sub>3</sub> + Na<sup>+</sup>, 291.075 84; found (ESI_FT, [M + Na]<sup>1+</sup>), 291.0748.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (1-Hydroxycyclohexyl)-(4-trifluoromethoxy)phenylacetic Acid <b>14h</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.06−1.21 (m, 2H), 1.35 (d, <i>J</i> = 10.4 Hz, 1H), 1.42−1.58 (m, 7H), 3.64 (s, 1H), 4.37 (bs, 1H), 7.29 (d, <i>J</i> = 8.5 Hz, 2H), 7.55 (d, <i>J</i> = 8.8 Hz, 2H), 12.51 (bs, 1H). HRMS: calcd for C<sub>15</sub>H<sub>17</sub>F<sub>3</sub>O<sub>4</sub> + H<sup>+</sup>, 319.115 17; found (ESI, [M + H]<sup>+</sup>), 319.1145. Anal. Calcd for C<sub>15</sub>H<sub>17</sub>F<sub>3</sub>O<sub>4</sub>·0.10H<sub>2</sub>O: C, 56.28; H, 5.41; N, 0.00. Found: C, 56.03; H, 4.99; N, 0.00.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (1-Hydroxycyclohexyl)-(3-trifluoromethoxy)phenylacetic Acid <b>14i</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.10−1.21 (m, 2H), 1.34−1.54 (m, 8H), 3.67 (s, 1H), 4.40 (bs, 1H), 7.27 (d, <i>J</i> = 3.6 Hz, 1H), 7.40−7.48 (m, 3H), 12.54 (bs, 1H). HRMS: calcd for C<sub>15</sub>H<sub>17</sub>F<sub>3</sub>O<sub>4</sub> + H<sup>+</sup>, 319.115 17; found (ESI, [M + H]<sup>+</sup>), 319.1158.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (1-Hydroxycyclohexyl)-(3-trifluoromethyl)phenylacetic Acid <b>14j</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.03−1.23 (m, 2H), 1.30−1.58 (m, 8H), 3.73 (s, 1H), 4.42 (bs, 1H), 7.53 (t, <i>J</i> = 7.8 Hz, 1H), 7.62 (dd, <i>J</i> = 0.7, 7.8 Hz, 1H), 7.72 (d, <i>J</i> = 7.7 Hz, 1H), 12.52 (bs, 1H). HRMS: calcd for C<sub>15</sub>H<sub>17</sub>F<sub>3</sub>O<sub>3</sub> + Na<sup>+</sup>, 325.102 20; found (ESI_FT, [M + Na]<sup>1+</sup>), 325.1024.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> General Procedure for the Coupling of Aldol Intermediates To Form boc-Protected Amides <b>15a</b>−<b>j</b></h3><div class="NLM_p last">A solution of aldol intermediate <b>14a</b>−<b>j</b> (2.00 mmol), benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate (1.42 g, 3.22 mmol), and <i>tert</i>-butyl 1-piperazinecarboxylate (0.60 g, 3.22 mmol) in methylene chloride (20 mL) was treated with triethylamine (0.84 mL, 6.0 mmol). The mixture was stirred at 25 °C for 16 h, after which time the solvent was removed in vacuo and the products (compounds <b>15a</b>−<b>j</b>) were purified via Biotage Horizon (FLASH 40 M, silica, gradient from 0% EtOAc/hexane to 30% EtOAc/hexane). This reaction gave a range of yields between 59% and 87%.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>tert</i>-Butyl 4-[(1-Hydroxycyclohexyl)(4-methoxyphenyl)acetyl]piperazine-1-carboxylate <b>15a</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.99−1.19 (m, 3H), 1.31 (s, 9H) 1.31−1.48 (m, 5H), 1.51−1.58 (m, 2H), 2.68−2.76 (m, 1H), 3.04−3.21 (m, 3H), 3.26−3.39 (m, 2H), 3.41−3.48 (m, 1H), 3.52−3.60 (m, 1H), 3.67 (s, 3H), 3.89 (s, 1H), 5.27 (s, 1H), 6.80 (d, <i>J</i> = 8.8 Hz, 2H), 7.25 (d, <i>J</i> = 8.7 Hz, 2H). HRMS: calcd for C<sub>23</sub>H<sub>33</sub>FN<sub>2</sub>O<sub>4</sub> + CH<sub>3</sub>CO<sub>2</sub>, 479.2557; found (ESI, [M + OAc]<sup>−</sup>), 479.2548.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>tert</i>-Butyl 4-[(1-Hydroxycyclohexyl)(3-methoxyphenyl)acetyl]piperazine-1-carboxylate <b>15b</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.01−1.20 (m, 3H), 1.37 (s, 9H) 1.37−1.53 (m, 5H), 1.54−1.66 (m, 2H), 2.78−2.85 (m, 1H), 3.11−3.28 (m, 3H), 3.31−3.44 (m, 2H), 3.50−3.57 (m, 1H), 3.61−3.70 (m, 1H), 3.72 (s, 3H), 3.99 (s, 1H), 5.36 (s, 1H), 6.84 (ddd, <i>J</i> = 1.9, 1.9, 7.6 Hz, 1H), 6.96−6.98 (m, 2H), 7.21 (t, <i>J</i> = 7.8 Hz, 1H). HRMS: calcd for C<sub>23</sub>H<sub>33</sub>FN<sub>2</sub>O<sub>4</sub> + CH<sub>3</sub>CO<sub>2</sub>, 479.2557; found (ESI, [M + OAc]<sup>−</sup>), 479.2578.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>tert</i>-Butyl 4-[(4-Fluorophenyl)(1-hydroxycyclohexyl)acetyl]piperazine-1-carboxylate <b>15c</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.95−1.02 (m, 1H), 1.05−1.14 (m, 2H), 1.37 (s, 9H) 1.37−1.65 (m, 7H), 2.80−2.88 (m, 1H), 3.16−3.28 (m, 3H), 3.33−3.44 (m, 2H), 3.50−3.58 (m, 1H), 3.61−3.70 (m, 1H), 4.06 (s, 1H), 5.28 (s, 1H), 7.13 (ddd, <i>J</i> = 2.0, 9.0, 9.0 Hz, 2H), 7.44 (dd, <i>J</i> = 5.6, 8.8 Hz, 2H). HRMS: calcd for C<sub>24</sub>H<sub>36</sub>N<sub>2</sub>O<sub>5</sub> + H<sup>+</sup>, 433.2697; found (ESI, [M + H]<sup>+</sup>), 433.2703.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>tert</i>-Butyl 4-[(3-Fluorophenyl)(1-hydroxycyclohexyl)acetyl]piperazine-1-carboxylate <b>15d</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.00−1.05 (m, 1H), 1.06−1.19 (m, 2H), 1.37 (s, 9H) 1.37−1.69 (m, 7H), 2.87−2.85 (m, 1H), 3.15−3.24 (m, 3H), 3.31−3.42 (m, 2H), 3.52−3.61 (m, 1H), 3.66−3.74 (m, 1H), 4.10 (s, 1H), 5.27 (s, 1H), 7.09 (dddd, <i>J</i> = 1.3, 2.6, 9.0, 9.0 Hz, 1H), 7.25 (dd, <i>J</i> = 1.3, 9.0 Hz, 2H), 7.35 (m, 1H). HRMS: calcd for C<sub>23</sub>H<sub>33</sub>FN<sub>2</sub>O<sub>4</sub> + H<sup>+</sup>, 421.2497; found (ESI, [M + H]<sup>+</sup>), 421.2500.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>tert</i>-Butyl 4-[(2-Fluorophenyl)(1-hydroxycyclohexyl)acetyl]piperazine-1-carboxylate <b>15e</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.11−1.14 (m, 3H), 1.33−1.63 (m, 6H), 1.37 (s, 9H), 1.68−1.74 (m, 1H), 2.73−2.80 (m, 1H), 3.10−3.18 (m, 1H), 3.21−3.30 (m, 2H), 3.41−3.59 (m, 4H), 4.21 (s, 1H), 5.18 (s, 1H), 7.15−7.23 (m, 2H), 7.34 (ddd, <i>J</i> = 1.0, 7.6, 7.6 Hz, 1H), 7.54 (ddd, <i>J</i> = 1.7, 7.8, 7.8 Hz, 1H). HRMS: calcd for C<sub>23</sub>H<sub>33</sub>FN<sub>2</sub>O<sub>4</sub> + H<sup>+</sup>, 421.2497; found (ESI, [M + H]<sup>+</sup>), 421.2509. Anal. (C<sub>23</sub>H<sub>33</sub>FN<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>tert</i>-Butyl 4-[(4-Chlorophenyl)(1-hydroxycyclohexyl)acetyl]piperazine-1-carboxylate <b>15f</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.97−1.03 (m, 1H), 1.05−1.15 (m, 2H), 1.37 (s, 9H) 1.37−1.66 (m, 7H), 2.81−2.90 (m, 1H), 3.12−3.28 (m, 3H), 3.35−3.42 (m, 2H), 3.50−3.58 (m, 1H), 3.61−3.70 (m, 1H), 4.07 (s, 1H), 5.26 (s, 1H), 7.37 (d, <i>J</i> = 8.6 Hz, 2H), 7.43 (d, <i>J</i> = 8.8 Hz, 2H). HRMS: calcd for C<sub>23</sub>H<sub>33</sub>ClN<sub>2</sub>O<sub>4</sub> + H<sup>+</sup>, 437.2202; found (ESI, [M + H]<sup>+</sup>), 437.2213.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>tert</i>-Butyl 4-[(3-Chlorophenyl)(1-hydroxycyclohexyl)acetyl]piperazine-1-carboxylate <b>15g</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.03−1.19 (m, 3H), 1.37 (s, 9H) 1.37−1.64 (m, 7H), 2.90−3.00 (m, 1H), 3.21−3.24 (m, 3H), 3.31−3.37 (m, 2H), 3.58−3.62 (m, 1H), 3.69−3.78 (m, 1H), 4.10 (s, 1H), 5.24 (s, 1H), 7.32−7.39 (m, 3H), 7.50 (s, 1H). HRMS: calcd for C<sub>23</sub>H<sub>33</sub>ClN<sub>2</sub>O<sub>4</sub> + H<sup>+</sup>, 437.2202; found (ESI, [M + H]<sup>+</sup>), 437.2187.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>tert</i>-Butyl 4-{(1-Hydroxycyclohexyl)[4-(trifluoromethoxy)phenyl]acetyl}piperazine-1-carboxylate <b>15h</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.95−1.02 (m, 1H), 1.09−1.18 (m, 2H), 1.37 (s, 9H), 1.37−1.68 (m, 7H), 2.85−2.92 (m, 1H), 3.14−3.24 (m, 3H), 3.30−3.40 (m, 2H), 3.55−3.62 (m, 1H), 3.65−3.72 (m, 1H), 4.13 (s, 1H), 5.25 (s, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 2H), 7.54 (d, <i>J</i> = 8.7 Hz, 2H); MS (ESI) <i>m</i>/<i>z</i> 487. Anal. Calcd for C<sub>24</sub>H<sub>33</sub>F<sub>3</sub>N<sub>2</sub>O<sub>5</sub>·0.40H<sub>2</sub>O: C, 58.38; H, 6.90; N, 5.67. Found: C, 57.91; H, 7.02; N, 6.27.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>tert</i>-Butyl 4-{(1-Hydroxycyclohexyl)[3-(trifluoromethoxy)phenyl]acetyl}piperazine-1-carboxylate <b>15i</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.96−1.04 (m, 1H), 1.10−1.19 (m, 2H), 1.37 (s, 9H), 1.38−1.69 (m, 7H), 2.72−2.80 (m, 1H), 3.10−3.30 (m, 3H), 3.39−3.54 (m, 3H), 3.62−3.70 (m, 1H), 4.16 (s, 1H), 5.24 (s, 1H), 7.27 (d, <i>J</i> = 3.2 Hz, 1H), 7.41−7.49 (m, 3H). HRMS: calcd for C<sub>24</sub>H<sub>33</sub>F<sub>3</sub>N<sub>2</sub>O<sub>5</sub> + H<sup>+</sup>, 487.2414; found (ESI, [M + H]<sup>+</sup>), 487.2406.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>tert</i>-Butyl 4-{(1-Hydroxycyclohexyl)[3-(trifluoromethyl)phenyl]acetyl}piperazine-1-carboxylate <b>15j</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.90−0.96 (m, 1H), 1.02−1.12 (m, 2H), 1.31 (s, 9H) 1.32−1.60 (m, 7H), 2.82−2.90 (m, 1H), 3.08−3.18 (m, 3H), 3.28−3.35 (m, 2H), 3.51−3.59 (m, 1H), 3.64−3.71 (m, 1H), 4.18 (s, 1H), 5.17 (s, 1H), 7.49 (t, <i>J</i> = 7.7 Hz, 1H), 7.57 (d, <i>J</i> = 7.7 Hz, 1H), 7.68 (d, <i>J</i> = 7.7 Hz, 1H), 7.75 (s, 1H). HRMS: calcd for C<sub>24</sub>H<sub>33</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub> + H<sup>+</sup>, 471.2426; found (ESI, [M + H]<sup>+</sup>), 471.2423.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> General Procedure for the Separation of Enantiomers To Form Amines (<i>R</i>)-(+)-<b>15g</b>, (<i>S</i>)-(−)-<b>15g</b>, (<i>R</i>)-(+)-<b>15i</b>, (<i>S</i>)-(−)-<b>15i</b></h3><div class="NLM_p last">Racemic boc-protected amides <b>15g</b> and <b>15i</b> were dissolved in methanol at a concentration of approximately 40 mg/mL, and the resulting solution was injected onto the supercritical fluid chromatography (SFC) instrument with a volume of 1.0 mL per injection. The baseline resolved enantiomers were collected using a Berger MultiGram Prep SFC (Berger Instruments, Inc., Newark, DE) under the following conditions: Chiralpak AD-H SFC column (5 µm, 250 mm length × 20 mm i.d., Chiral Technologies, Inc., Exton, PA), 35 °C column temperature, 40% methanol as CO<sub>2</sub> modifier for <b>15g</b> and 20% methanol as CO<sub>2</sub> modifier for <b>15i</b>, 50 mL/min flow rate, 100 bar outlet pressure, 220 nm UV detection. The chiral purity of each enantiomer was determined under the same SFC conditions using a Chiralpak AD-H column (10 µm, 250 mm length × 4.6 mm i.d.) at 2.0 mL/min flow rate on a Berger Analytical SFC instrument.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>tert</i>-Butyl 4-[(2<i>R</i>)-2-(3-Chlorophenyl)-2-(1-hydroxycyclohexyl)acetyl]piperazine- 1-carboxylate (<i>R</i>)-(+)-<b>15g</b></h3><div class="NLM_p last">The enantiomeric purity of was determined to be 99.5% (with 0.5% of the undesired enantiomer) isolated as peak 1: retention time, 2.82 min; [α]<sub class="stack">D</sub><sup class="stack">25</sup> +14° (<i>c</i> 6.2 mg/mL, EtOH). HRMS: calcd for C<sub>23</sub>H<sub>33</sub>ClN<sub>2</sub>O<sub>4</sub> + H<sup>+</sup>, 437.2202; found (ESI, [M + H]<sup>+</sup>), 437.2203.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>tert</i>-Butyl 4-[(2<i>S</i>)-2-(3-Chlorophenyl)-2-(1-hydroxycyclohexyl)acetyl]piperazine-1-carboxylate (<i>S</i>)-(−)-<b>15g</b></h3><div class="NLM_p last">The enantiomeric purity of was determined to be 99.6% (with 0.4% of the undesired enantiomer) isolated as peak 2: retention time, 3.84 min; [α]<sub class="stack">D</sub><sup class="stack">25</sup> −24° (<i>c</i> 4.6 mg/mL, EtOH). HRMS: calcd for C<sub>23</sub>H<sub>33</sub>ClN<sub>2</sub>O<sub>4</sub> + H<sup>+</sup>, 437.2202; found (ESI, [M + H]<sup>+</sup>), 437.2212.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>tert</i>-Butyl 4-[(2<i>R</i>)-2-(1-Hydroxycyclohexyl)-2-[3-(trifluoromethoxy)phenyl]acetyl]piperazine-1-carboxylate (<i>R</i>)-(+)-<b>15i</b></h3><div class="NLM_p last">The enantiomeric purity of was determined to be >99.9% (with <0.1% of the undesired enantiomer) isolated as peak 1: retention time, 3.0 min; [α]<sub class="stack">D</sub><sup class="stack">25</sup> +23° (<i>c</i> 11.6 mg/mL, EtOH). HRMS: calcd for C<sub>23</sub>H<sub>33</sub>ClN<sub>2</sub>O<sub>4</sub> + CH<sub>3</sub>CO<sub>2</sub>, 495.2262; found (ESI, [M + OAc]<sup>−</sup>), 495.2268.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>tert</i>-Butyl 4-[(2<i>S</i>)-2-(1-Hydroxycyclohexyl)-2-[3-(trifluoromethoxy)phenyl]acetyl]piperazine-1-carboxylate (<i>S</i>)-(−)-<b>15i</b></h3><div class="NLM_p last">The enantiomeric purity of was determined to be 99.8% (with 0.2% of the undesired enantiomer) isolated as peak 2: retention time, 3.58 min; [α]<sub class="stack">D</sub><sup class="stack">25</sup> −19° (<i>c</i> 11.2 mg/mL, MeOH). HRMS: calcd for C<sub>23</sub>H<sub>33</sub>ClN<sub>2</sub>O<sub>4</sub> + CH<sub>3</sub>CO<sub>2</sub>, 495.2262; found (ESI, [M + OAc]<sup>−</sup>), 495.2272.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> General Procedure for the Amide Reduction and Deprotection To Form Amines <b>16a</b>−<b>j</b></h3><div class="NLM_p last">A solution of boc-protected amide (<b>15a</b>−<b>j</b>) (0.46 mmol) in dry tetrahydrofuran (3 mL) under nitrogen was treated dropwise with a solution of borane (1.0 M in tetrahydrofuran, 1.60 mL, 1.60 mmol). The resulting solution was heated at 70 °C for 2 h, after which time the mixture was cooled in an ice bath and was treated dropwise with a 2 N aqueous solution of hydrochloric acid (1 mL). The mixture was again heated at 70 °C for 1 h and was then cooled and treated with methanol (1 mL). After the solvent was removed in vacuo, the resulting residue was dissolved in water (5 mL) and was washed with ethyl acetate (1 × 4 mL). The aqueous layer was basified with the addition of a 2 N aqueous solution of sodium hydroxide until pH 10 was attained. The product was extracted with ethyl acetate (4 × 5 mL) and the combined organic extracts were dried over magnesium sulfate and concentrated in vacuo to yield the amine as a colorless oil, which was used directly in the next step or converted to the HCl salt for pharmacological testing. The HCl salts were formed by dissolving the product in methanol (0.5 mL) and treating with a saturated methanolic solution of hydrochloric acid (0.5 mL) followed by diethyl ether. After crystallizing in the refrigerator for 16 h, the resulting solid was filtered, washed with diethyl ether, and dried in vacuo to afford the final products (<b>16a</b>−<b>k</b>) in a yield range between 51% and 69% as white solids.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-[1-(4-Methoxyphenyl)-2-piperazin-1-ylethyl]cyclohexanol Dihydrochloride <b>16a</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O<sub>,</sub> 400 MHz) δ 0.88−1.00 (m, 1H), 1.09 (d, <i>J</i> = 12.4 Hz, 1H), 1.14 (dd, <i>J</i> = 4.4, 10.9 Hz, 1H), 1.17−1.40 (m, 6H), 1.56 (d, <i>J</i> = 12.9 Hz, 1H), 2.95 (dd, <i>J</i> = 3.5, 11.3 Hz, 1H), 3.31−3.50 (m, 8H), 3.60 (dd, <i>J</i> = 3.5, 13.3 Hz, 1H), 3.66−3.72 (m, 1H), 3.68 (s, 3H), 6.88 (d, <i>J</i> = 9.0 Hz, 2H), 7.20 (d, <i>J</i> = 8.3 Hz, 2H). HRMS: calcd for C<sub>19</sub>H<sub>30</sub>N<sub>2</sub>O<sub>2</sub> + H<sup>+</sup>, 319.2380; found (ESI, [M + H]<sup>+</sup>), 319.2376. Anal. Calcd for C<sub>19</sub>H<sub>30</sub>N<sub>2</sub>O<sub>2</sub>·2HCl·1.2H<sub>2</sub>O: C, 55.26; H, 8.40; N, 6.78. Found: C, 55.48; H, 8.8; N, 6.67.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 1-[1-(3-Methoxyphenyl)-2-piperazin-1-ylethyl]cyclohexanol Dihydrochloride <b>16b</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O, 400 MHz) δ 0.90−0.99 (m, 1H), 1.10−1.12 (m, 1H), 1.17−1.37 (m, 7H), 1.59 (d, <i>J</i> = 12.2 Hz, 1H), 2.99 (d, <i>J</i> = 10.5 Hz, 1H), 3.18 (s, 1H), 3.32−3.42 (m, 7H), 3.64 (d, <i>J</i> = 13.3 Hz, 1H), 3.69 (s, 3H), 3.77 (t, <i>J</i> = 12.2 Hz, 1H), 6.84−6.90 (m, 3H), 7.24 (t, <i>J</i> = 7.8 Hz, 1H). Anal. Calcd for C<sub>19</sub>H<sub>30</sub>N<sub>2</sub>O<sub>2</sub>·2HCl·0.5H<sub>2</sub>O: C, 57.00; H, 8.31; N, 7.00. Found: C, 57.31; H, 8.64; N, 6.89.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 1-[1-(4-Fluorophenyl)-2-piperazin-1-ylethyl]cyclohexanol Dihydrochloride <b>16c</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.02−1.16 (m, 2H), 1.20−1.24 (m, 2H), 1.32−1.35 (m, 1H), 1.44−1.64 (m, 5H), 3.29−3.80 (m, 11H), 4.62 (s, 1H) 7.18 (d, <i>J</i> = 7.3 Hz, 2H), 7.39 (bs, 2H), 9.46 (bs, 2H), 10.60 (bs, 1H). HRMS: calcd for C<sub>18</sub>H<sub>27</sub>FN<sub>2</sub>O + H<sup>+</sup>, 307.2180; found (ESI, [M + H]<sup>+</sup>), 307.2166. Anal. Calcd for C<sub>18</sub>H<sub>27</sub>FN<sub>2</sub>O·2HCl·1.0H<sub>2</sub>O: C, 54.41; H, 7.86; N, 7.05. Found: C, 54.51; H, 7.88; N, 7.06.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 1-[1-(3-Fluorophenyl)-2-piperazin-1-ylethyl]cyclohexanol Dihydrochloride <b>16d</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O<sub>,</sub> 400 MHz) δ 0.89−1.00 (m, 1H), 1.08 (d, <i>J</i> = 12.2 Hz, 1H), 1.16 (dd, <i>J</i> = 4.5, 10.9 Hz, 1H), 1.20−1.37 (m, 6H), 1.60 (d, <i>J</i> = 13.2 Hz, 1H), 3.04 (dd, <i>J</i> = 3.1, 11.1 Hz, 1H), 3.21−3.55 (m, 8H), 3.65 (dd, <i>J</i> = 3.2, 13.5 Hz, 1H), 3.75 (t, <i>J</i> = 11.1 Hz, 1H), 7.98 (dd, <i>J</i> = 2.1, 8.3 Hz, 1H), 7.02 (t, <i>J</i> = 7.3 Hz, 1H), 7.07 (d, <i>J</i> = 7.7 Hz, 1H), 7.98 (ddd, <i>J</i> = 6.3, 8.1, 8.1 Hz, 1H). HRMS: calcd for C<sub>18</sub>H<sub>27</sub>FN<sub>2</sub>O + H<sup>+</sup>, 307.2180; found (ESI, [M + H]<sup>+</sup>), 307.2179. Anal. Calcd for C<sub>18</sub>H<sub>27</sub>FN<sub>2</sub>O·2HCl·1.3H<sub>2</sub>O: C, 53.68; H, 7.91; N, 6.96. Found: C, 53.97; H, 8.2; N, 7.02.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1-[1-(2-Fluorophenyl)-2-piperazin-1-ylethyl]cyclohexanol Dihydrochloride <b>16e</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O<sub>,</sub> 400 MHz) δ 0.88−0.98 (m, 1H), 1.16−1.47 (m, 8H), 1.64 (d, <i>J</i> = 12.9 Hz, 1H), 3.28−3.50 (m, 9H), 3.67 (dd, <i>J</i> = 3.2, 13.3 Hz, 1H), 3.70−3.80 (m, 1H), 7.05 (ddd, <i>J</i> = 1.2, 8.3, 8.3 Hz, 1H), 7.13 (t, <i>J</i> = 7.5 Hz, 1H), 7.13 (dddd, <i>J</i> = 1.7, 5.4, 7.3, 7.3 Hz, 1H), 7.30−7.36 (m, 1H). HRMS: calcd for C<sub>18</sub>H<sub>27</sub>FN<sub>2</sub>O + H<sup>+</sup>, 307.2180; found (ESI, [M + H]<sup>+</sup>), 307.2166. Anal. Calcd for C<sub>18</sub>H<sub>27</sub>FN<sub>2</sub>O·2.00HCl·1.0H<sub>2</sub>O: C, 54.41; H, 7.86; N, 7.04. Found: C, 54.52; H, 8.05; N, 6.80.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 1-[1-(4-Chlorophenyl)-2-piperazin-1-ylethyl]cyclohexanol Dihydrochloride <b>16f</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O<sub>,</sub> 400 MHz) δ 1.09−1.12 (m, 1H), 1.24 (d, <i>J</i> = 12.9 Hz, 1H), 1.30 (dd, <i>J</i> = 4.8, 10.9 Hz, 1H), 1.29−1.60 (m, 6H), 1.74 (d, <i>J</i> = 12.9 Hz, 1H), 3.14 (dd, <i>J</i> = 3.5, 10.9 Hz, 1H), 3.41−3.49 (m, 8H), 3.71 (dd, <i>J</i> = 3.5, 13.4 Hz, 1H), 3.77 (t, <i>J</i> = 13.4 Hz, 1H), 7.38 (d, <i>J</i> = 8.5 Hz, 2H), 7.45 (d, <i>J</i> = 8.7 Hz, 2H). HRMS: calcd for C<sub>18</sub>H<sub>27</sub>ClN<sub>2</sub>O + H<sup>+</sup>, 323.1885; found (ESI, [M + H]<sup>+</sup>), 323.1868. Anal. Calcd for C<sub>18</sub>H<sub>27</sub>ClN<sub>2</sub>O·2.00HCl·1.0H<sub>2</sub>O: C, 52.24; H, 7.56; N, 6.77. Found: C, 52.27; H, 8.0; N, 6.72.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 1-[1-(3-Chlorophenyl)-2-piperazin-1-ylethyl]cyclohexanol Dihydrochloride <b>16g</b></h3><div class="NLM_p last"><sup>1</sup>H NMR for free base (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.94−1.14 (m, 3H), 1.37−1.56 (m, 7H), 2.28 (bs, 2H), 2.33 (bs, 2H), 2.43 (dd, <i>J</i> = 6.2, 12.4 Hz, 1H), 2.59 (t, <i>J</i> = 4.7 Hz, 4 H), 2.93 (t, <i>J</i> = 6.4, 1 H), 3.01 (dd, <i>J</i> = 8.1, 12.4 Hz, 1H), 5.31 (s, 1H), 7.18 (d, <i>J</i> = 7.3 Hz, 1H), 7.22−7.29 (m, 3H); <sup>1</sup>H NMR for dihydrochloride salt (D<sub>2</sub>O, 400 MHz) δ 0.89−1.00 (m, 1H), 1.07 (d, <i>J</i> = 12.8 Hz, 1H), 1.15 (dd, <i>J</i> = 4.6, 11.0 Hz, 1H), 1.20−1.41 (m, 6H), 1.60 (d, <i>J</i> = 12.7 Hz, 1H), 3.00 (dd, <i>J</i> = 3.2, 11.1 Hz, 1H), 3.18−3.51 (m, 8H), 3.62 (dd, <i>J</i> = 3.2, 13.5 Hz, 1H), 3.71 (t, <i>J</i> = 11.1 Hz, 1H), 7.18 (d, <i>J</i> = 6.8 Hz, 1H), 7.23−7.32 (m, 3H). HRMS: calcd for C<sub>18</sub>H<sub>27</sub>ClN<sub>2</sub>O + H<sup>+</sup>, 323.1885; found (ESI, [M + H]<sup>+</sup>), 323.18831. Anal. Calcd for C<sub>18</sub>H<sub>27</sub>ClN<sub>2</sub>O·2.00HCl·1H<sub>2</sub>O: C, 52.24; H, 7.56; N, 6.77. Found: C, 52.00; H, 7.36; N, 6.78.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 1-[(1<i>R</i>)-1-(3-Chlorophenyl)-2-piperazin-1-ylethyl]cyclohexanol Dihydrochloride (<i>R</i>)-(−)-<b>16g</b></h3><div class="NLM_p last">[α]<sub class="stack">D</sub><sup class="stack">25</sup> −7° (<i>c</i> 5.1 mg/mL, MeOH). HRMS: calcd for C<sub>18</sub>H<sub>27</sub>ClN<sub>2</sub>O + H<sup>+</sup>, 323.1885; found (ESI, [M + H]<sup>+</sup>), 323.1873.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 1-[(1<i>S</i>)-1-(3-Chlorophenyl)-2-piperazin-1-ylethyl]cyclohexanol Dihydrochloride (<i>S</i>)-(+)-<b>16g</b></h3><div class="NLM_p last">[α]<sub class="stack">D</sub><sup class="stack">25</sup> +12.5° (<i>c</i> 4.5 mg/mL, MeOH). HRMS: calcd for C<sub>18</sub>H<sub>27</sub>ClN<sub>2</sub>O + H<sup>+</sup>, 323.1885; found (ESI, [M + H]<sup>+</sup>), 323.1867. Anal. Calcd for C<sub>18</sub>H<sub>27</sub>ClN<sub>2</sub>O·2.00 HCl·1.0 H<sub>2</sub>O: C, 52.24; H, 7.56; N, 6.77. Found: C, 52.23; H, 7.37; N, 6.65.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 1-{2-Piperazin-1-yl-1-[4-(trifluoromethoxy)phenyl]ethyl}cyclohexanol Dihydrochloride <b>16h</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ1.02 (t, <i>J</i> = 11.6 Hz, 2H), 1.15 (d, <i>J</i> = 13.6 Hz, 1H), 1.22 (t, <i>J</i> = 11.1 Hz, 1H), 1.31−1.36 (m, 1H), 1.45 (dd, <i>J</i> = 2.3, 12.2 Hz, 3H), 1.55 (t, <i>J</i> = 12.2 Hz, 1H), 1.67 (d, <i>J</i> = 13.0 Hz, 1H), 3.10−3.81 (m, 11H), 4.53 (bs, 1H), 7.33 (d, <i>J</i> = 8.1 Hz, 2H), 7.49 (d, <i>J</i> = 8.5 Hz, 2H), 9.70 (bs, 2H), 11.01 (bs, 1H). HRMS: calcd for C<sub>19</sub>H<sub>27</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> + H<sup>+</sup>, 373.2097; found (ESI, [M + H]<sup>+</sup>), 373.2086. Anal. Calcd for C<sub>19</sub>H<sub>27</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>·2.00HCl·2.10 H<sub>2</sub>O: C, 47.23; H, 6.93; N, 5.80. Found: C, 46.93; H, 6.80; N, 5.41.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 1-{2-Piperazin-1-yl-1-[3-(trifluoromethoxy)phenyl]ethyl}cyclohexanol Dihydrochloride <b>16i</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O, 400 MHz) δ 0.86−1.00 (m, 1H), 1.08 (d, <i>J</i> = 13.1 Hz, 1H), 1.14 (dd, <i>J</i> = 4.9, 10.9 Hz, 1H), 1.19−1.37 (m, 6H), 1.60 (d, <i>J</i> = 13.1 Hz, 1H), 3.06 (dd, <i>J</i> = 3.2, 11.0 Hz, 1H), 3.31−3.49 (m, 8H), 3.66 (dd, <i>J</i> = 3.0, 13.5 Hz, 1H), 3.75 (t, <i>J</i> = 13.3 Hz, 1H), 7.19−7.21 (m, 2H), 7.25 (d, <i>J</i> = 7.7 Hz, 1H), 7.36 (t, <i>J</i> = 7.9 Hz, 1H). HRMS: calcd for C<sub>19</sub>H<sub>27</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> + H<sup>+</sup>, 373.2097; found (ESI, [M + H]<sup>+</sup>), 373.2095. Anal. Calcd for C<sub>19</sub>H<sub>27</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>·2.00HCl·1.5H<sub>2</sub>O: C, 48.31; H, 6.83; N, 5.93. Found: C, 48.45; H, 6.79; N, 5.76.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 1-{(1<i>R</i>)-2-Piperazin-1-yl-1-[3-(trifluoromethoxy)phenyl]ethyl}cyclohexanol Dihydrochloride (<i>R</i>)-(−)-<b>16i</b></h3><div class="NLM_p last">[α]<sub class="stack">D</sub><sup class="stack">25</sup> −4.5° (<i>c</i> 10.2 mg/mL, MeOH). HRMS: calcd for C<sub>19</sub>H<sub>27</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> + H<sup>+</sup>, 373.2097; found (ESI, [M + H]<sup>+</sup>), 373.2102.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 1-{(1<i>S</i>)-2-Piperazin-1-yl-1-[3-(trifluoromethoxy)phenyl]ethyl}cyclohexanol Dihydrochloride (<i>S</i>)-(+)-<b>16i</b></h3><div class="NLM_p last">[α]<sub class="stack">D</sub><sup class="stack">25</sup> +2.2° (<i>c</i> 9.9 mg/mL, MeOH). HRMS: calcd for C<sub>19</sub>H<sub>27</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> + H<sup>+</sup>, 373.2097; found (ESI, [M + H]<sup>+</sup>), 373.2094.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 1-{2-Piperazin-1-yl-1-[3-(trifluoromethyl)phenyl]ethyl}cyclohexanol Dihydrochloride <b>16j</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O, 400 MHz) δ 0.89−1.00 (m, 1H), 1.05 (d, <i>J</i> = 11.5 Hz, 1H), 1.12−1.37 (m, 7H), 1.62 (d, <i>J</i> = 13.1 Hz, 1H), 3.10 (d, <i>J</i> = 10.6 Hz, 1H), 3.30−3.39 (m, 8H), 3.61−3.68 (m, 1H), 3.64 (dd, <i>J</i> = 3.0, 13.5 Hz, 1H), 3.77 (dd, <i>J</i> = 11.4, 13.2 Hz, 1H), 7.43−7.49 (m, 2H), 7.57−7.59 (m, 2H). HRMS: calcd for C<sub>19</sub>H<sub>27</sub>F<sub>3</sub>N<sub>2</sub>O + H<sup>+</sup>, 357.2148; found (ESI, [M + H]<sup>+</sup>), 357.2155.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> General Procedure for N-Methylation To Form <i>N</i>-Methylpiperazines <b>17a</b>−<b>j</b></h3><div class="NLM_p last">A solution of the appropriate amine (<b>16a</b>−<b>j</b>) (0.17 mmol) in formic acid (0.33 mL) at 50 °C was treated with an aqueous solution of formaldehyde (37% in water, 0.14 mL, 0.21 mmol). The mixture was heated at 70 °C for 1.5 h, after which time the mixture was poured into water (5 mL) and basified to pH 10 with the addition of a 2 N aqueous solution of sodium hydroxide. The product was then extracted with ethyl acetate (3 × 4 mL), and the combined organic extracts were dried over magnesium sulfate and concentrated to yield the methylamine as a colorless oil. The product was dissolved in methanol (0.5 mL), and the resulting solution was treated with a saturated methanolic solution of hydrochloric acid (0.5 mL) followed by diethyl ether (2 mL). The solution was stored in the refrigerator for 16 h. The resulting precipitate was filtered and washed with diethyl ether to afford the dihydrochloride salt (compounds <b>17a</b>−<b>j</b>) in a yield range of 58−79% as a white solid.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 1-[1-(4-Methoxyphenyl)-2-(4-methyl-1-piperazinyl)ethyl]cyclohexanol Dihydrochloride <b>17a</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O, 400 MHz) δ 0.99−1.08 (m, 1H), 1.19 (d, <i>J</i> = 12.9 Hz, 1H), 1.20−1.50 (m, 7H), 1.65 (d, <i>J</i> = 13.1 Hz, 1H), 2.88 (s, 3H), 3.04 (dd, <i>J</i> = 3.3, 11.0 Hz, 1H), 3.47 (bs, 8H), 3.70 (dd, <i>J</i> = 3.4, 12.9 Hz, 1H), 3.75−3.81 (m, 1H), 3.78 (s, 3H), 6.97 (d, <i>J</i> = 8.7 Hz, 2H), 7.29 (d, <i>J</i> = 8.3 Hz, 2H). Anal. (C<sub>20</sub>H<sub>32</sub>N<sub>2</sub>O<sub>2</sub>·2.00HCl) C, H, N.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1-[1-(3-Methoxyphenyl)-2-(4-methyl-1-piperazinyl)ethyl]cyclohexanol Dihydrochloride <b>17b</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O, 400 MHz) δ 1.01−1.10 (m, 1H), 1.20−1.22 (m, 1H), 1.25−1.53 (m, 7H), 1.69 (d, <i>J</i> = 12.5 Hz, 1H), 2.90 (s, 3H), 3.08 (dd, <i>J</i> = 2.8, 11.5 Hz, 1H), 3.30−3.52 (m, 8H), 3.74 (dd, <i>J</i> = 2.9, 12.1 Hz, 1H), 3.77−3.83 (m, 1H), 3.79 (s, 3H), 6.95−7.01 (m, 3H), 7.36 (t, <i>J</i> = 8.1 Hz, 1H). Anal. (C<sub>20</sub>H<sub>32</sub>N<sub>2</sub>O<sub>2</sub>·2.00HCl) C, H, N.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 1-[1-(4-Fluorophenyl)-2-(4-methylpiperazin-1-yl)ethyl]cyclohexanol Dihydrocholoride <b>17c</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O, 400 MHz) δ 1.09−1.19 (m, 1H), 1.24 (d, <i>J</i> = 13.2 Hz, 1H), 1.28−1.56 (m, 7H), 1.73 (d, <i>J</i> = 12.5 Hz, 1H), 2.87 (s, 3H), 3.10 (dd, <i>J</i> = 3.6, 10.9 Hz, 1H), 3.22−3.50 (m, 8H), 3.58 (dd, <i>J</i> = 3.5, 13.3 Hz, 1H), 3.65 (t, <i>J</i> = 13.2 Hz, 1H), 7.16 (t, <i>J</i> = 8.9 Hz, 2H), 7.39 (dd, <i>J</i> = 5.6, 8.5 Hz, 2H). HRMS: calcd for C<sub>19</sub>H<sub>29</sub>FN<sub>2</sub>O + H<sup>+</sup>, 321.2337; found (ESI, [M + H]<sup>+</sup>), 321.2332. Anal. (C<sub>19</sub>H<sub>29</sub>FN<sub>2</sub>O·2.00HCl) C, H, N.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 1-[1-(3-Fluorophenyl)-2-(4-methylpiperazin-1-yl)ethyl]cyclohexanol Dihydrocholoride <b>17d</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O, 400 MHz) δ 1.10−1.13 (m, 1H), 1.25 (d, <i>J</i> = 12.0 Hz, 1H), 1.30−1.56 (m, 7H), 1.74 (d, <i>J</i> = 12.5 Hz, 1H), 2.88 (s, 3H), 3.12 (dd, <i>J</i> = 3.4, 10.9 Hz, 1H), 3.22−3.50 (m, 8H), 3.57 (dd, <i>J</i> = 3.2, 13.2 Hz, 1H), 3.65 (t, <i>J</i> = 13.2 Hz, 1H), 7.10−7.16 (m, 1H), 7.20 (d, <i>J</i> = 7.6 Hz, 2H), 7.42 (q, <i>J</i> = 8.1 Hz, 1H). HRMS: calcd for C<sub>19</sub>H<sub>29</sub>FN<sub>2</sub>O + H<sup>+</sup>, 321.2337; found (ESI, [M + H]<sup>+</sup>), 321.2328. Anal. (C<sub>19</sub>H<sub>29</sub>FN<sub>2</sub>O·2.00HCl) C, H, N.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 1-[1-(2-Fluorophenyl)-2-(4-methylpiperazin-1-yl)ethyl]cyclohexanol Dihydrocholoride <b>17e</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O, 400 MHz) δ 1.03 (bs, 1H), 1.28−1.52 (m, 8H), 1.74 (d, <i>J</i> = 12.6 Hz, 1H), 2.89 (s, 3H), 3.47 (bs, 9H), 3.70−3.88 (m, 2H), 7.16 (t, <i>J</i> = 8.4 Hz, 1H), 7.23 (t, <i>J</i> = 7.5 Hz, 1H), 7.37 (q, <i>J</i> = 5.8 Hz, 1H), 7.46 (bs, 1H). HRMS: calcd for C<sub>19</sub>H<sub>29</sub>FN<sub>2</sub>O + H<sup>+</sup>, 321.2337; found (ESI, [M + H]<sup>+</sup>), 321.2326. Anal. Calcd for C<sub>19</sub>H<sub>29</sub>FN<sub>2</sub>O·2.00HCl·0.1H<sub>2</sub>O: C, 57.74; H, 7.95; N, 7.09. Found: C, 57.61; H, 7.43; N, 6.78.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 1-[1-(4-Chlorophenyl)-2-(4-methylpiperazin-1-yl)ethyl]cyclohexanol Dihydrocholoride <b>17f</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O, 400 MHz) δ 1.09−1.12 (m, 1H), 1.24 (d, <i>J</i> = 13.3 Hz, 1H), 1.28−1.56 (m, 7H), 1.73 (d, <i>J</i> = 12.5 Hz, 1H), 2.89 (s, 3H), 3.10 (dd, <i>J</i> = 3.5, 10.7 Hz, 1H), 3.22−3.55 (m, 8H), 3.60 (dd, <i>J</i> = 3.5, 13.4 Hz, 1H), 3.65 (t, <i>J</i> = 13.4 Hz, 1H), 7.37 (d, <i>J</i> = 8.4 Hz, 2H), 7.44 (d, <i>J</i> = 8.7 Hz, 1H). HRMS: calcd for C<sub>19</sub>H<sub>29</sub>ClN<sub>2</sub>O + H<sup>+</sup>, 337.2041; found (ESI, [M + H]<sup>+</sup>), 337.2060. Anal. Calcd for C<sub>19</sub>H<sub>29</sub>ClN<sub>2</sub>O·2.00HCl·0.3H<sub>2</sub>O: C, 54.96; H, 7.67; N, 6.75. Found: C, 55.26; H, 7.37; N, 6.68.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 1-[1-(3-Chlorophenyl)-2-(4-methylpiperazin-1-yl)ethyl]cyclohexanol Dihydrocholoride <b>17g</b></h3><div class="NLM_p last"><sup>1</sup>H NMR for free base (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.96−1.07 (m, 1H), 1.08−1.14 (m, 2H), 1.31−1.59 (m, 7H), 2.10 (s, 3H), 2.22 (bs, 4H), 2.38 (bs, 4H), 2.47 (dd, <i>J</i> = 6.8, 12.5 Hz, 1H), 2.90 (t, <i>J</i> = 7.0 Hz, 1 H), 3.04 (ddd, <i>J</i> = 7.5, 9.5, 12.6 Hz, 1 H), 5.12 (s, 1H), 7.18 (dd, <i>J</i> = 1.5, 7.2 Hz, 1H), 7.21−7.28 (m, 3H). HRMS: calcd for C<sub>19</sub>H<sub>29</sub>ClN<sub>2</sub>O + H<sup>+</sup>, 337.2041; found (ESI, [M + H]<sup>+</sup>), 337.2036. Anal. (C<sub>19</sub>H<sub>29</sub>ClN<sub>2</sub>O·2.00HCl) C, H, N.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 1-[(1<i>R</i>)-1-(3-Chlorophenyl)-2-(4-methylpiperazin-1-yl)ethyl]cyclohexanol Dihydrocholoride (<i>R</i>)-(+)-<b>17g</b></h3><div class="NLM_p last">The enantiomeric purity was determined to be >99.9% (with <0.1% of the undesired enantiomer): retention time, 2.49 min; [α]<sub class="stack">D</sub><sup class="stack">25</sup> +29° (<i>c</i> 9.9 mg/mL, MeOH). HRMS: calcd for C<sub>19</sub>H<sub>29</sub>ClN<sub>2</sub>O + H<sup>+</sup>, 337.204 12; found (ESI, [M + H]<sup>+</sup>), 337.2032. Anal. (C<sub>19</sub>H<sub>29</sub>ClN<sub>2</sub>O·2.00HCl) C, H, N.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 1-[(1<i>S</i>)-1-(3-Chlorophenyl)-2-(4-methylpiperazin-1-yl)ethyl]cyclohexanol Dihydrocholoride (<i>S</i>)-(−)-<b>17g</b></h3><div class="NLM_p last">The enantiomeric purity was determined to be >99.9% (with <0.1% of the undesired enantiomer): retention time, 3.58 min; [α]<sub class="stack">D</sub><sup class="stack">25</sup> −21.4° (<i>c</i> 10 mg/mL, MeOH). HRMS: calcd for C<sub>19</sub>H<sub>29</sub>ClN<sub>2</sub>O + H<sup>+</sup>, 337.2041; found (ESI, [M + H]<sup>+</sup>), 337.2032. Anal. Calcd for C<sub>19</sub>H<sub>29</sub>ClN<sub>2</sub>O·2.00HCl·0.2H<sub>2</sub>O: C, 55.20; H, 7.66; N, 6.78. Found: C, 55.24; H, 7.85; N, 6.67.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 1-{2-(4-Methylpiperazin-1-yl)-1-[4-(trifluoromethoxy)phenyl]ethyl}cyclohexanol Dihydrocholoride <b>17h</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O, 400 MHz) δ 1.00−1.09 (m, 1H), 1.20−1.50 (m, 7H), 1.68 (d, <i>J</i> = 12.9 Hz, 1H), 2.89 (s, 3H), 3.12 (dd, <i>J</i> = 2.8, 10.9 Hz, 1H), 3.47 (bs, 8H), 3.72 (d, <i>J</i> = 13.2 Hz, 1H), 3.80 (t, <i>J</i> = 11.1 Hz, 1H), 7.30 (d, <i>J</i> = 8.1 Hz, 2H), 7.42 (d, <i>J</i> = 8.3 Hz, 2H). HRMS: calcd for C<sub>20</sub>H<sub>29</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> + H<sup>+</sup>, 387.2254; found (ESI, [M + H]<sup>+</sup>), 387.2245.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 1-{2-(3-Methylpiperazin-1-yl)-1-[3-(trifluoromethoxy)phenyl]ethyl}cyclohexanol Dihydrocholoride <b>17i</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O, 400 MHz) δ 0.96−0.98 (m, 1H), 1.09−1.43 (m, 8H), 1.62 (d, <i>J</i> = 12.6 Hz, 1H), 2.81 (s, 3H), 3.06 (dd, <i>J</i> = 3.2, 10.9 Hz, 1H), 3.38 (bs, 8H), 3.64 (dd, <i>J</i> = 3.2, 13.5 Hz, 1H), 3.74 (dd, <i>J</i> = 11.0, 13.4 Hz, 2H), 7.21−7.28 (m, 3H), 7.38 (t, <i>J</i> = 8.5 Hz, 1H). HRMS: calcd for C<sub>20</sub>H<sub>29</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> + H<sup>+</sup>, 387.2254; found (ESI, [M + H]<sup>+</sup>), 387.2263.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 1-{(1<i>R</i>)-2-(4-Methylpiperazin-1-yl)-1-[3-(trifluoromethoxy)phenyl]ethyl}cyclohexanol Dihydrocholoride (<i>R</i>)-(+)-<b>17i</b></h3><div class="NLM_p last">The enantiomeric purity was determined to be >99.8% (with 0.2% of the undesired enantiomer): retention time, 9.52 min; [α]<sub class="stack">D</sub><sup class="stack">25</sup> +20.6° (<i>c</i> 10.8 mg/mL, MeOH). HRMS: calcd for C<sub>20</sub>H<sub>29</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> + H<sup>+</sup>, 387.2254; found (ESI, [M + H]<sup>+</sup>), 387.2269. Anal. (C<sub>20</sub>H<sub>29</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>·2.00HCl) C, H, N.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 1-{(1<i>S</i>)-2-(4-Methylpiperazin-1-yl)-1-[3-(trifluoromethoxy)phenyl]ethyl}cyclohexanol Dihydrocholoride (<i>S</i>)-(−)-<b>17i</b></h3><div class="NLM_p last">The enantiomeric purity was determined to be >99.9% (with <0.1% of the undesired enantiomer): retention time, 7.85 min; [α]<sub class="stack">D</sub><sup class="stack">25</sup> −25.1° (<i>c</i> 10 mg/mL, MeOH). HRMS: calcd for C<sub>20</sub>H<sub>29</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> + H<sup>+</sup>, 387.2254; found (ESI, [M + H]<sup>+</sup>), 387.2249. Anal. (C<sub>20</sub>H<sub>29</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>·2.00HCl) C, H, N.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 1-{2-(3-Methylpiperazin-1-yl)-1-[3-(trifluoromethyl)phenyl]ethyl}cyclohexanol Dihydrocholoride <b>17j</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O, 400 MHz) δ 0.93−0.99 (m, 1H), 1.05 (d, <i>J</i> = 12.6 Hz, 1H), 1.13 (dd, <i>J</i> = 4.6, 11.1 Hz, 1H), 1.17−1.37 (m, 6H), 1.62 (d, <i>J</i> = 12.9 Hz, 1H), 2.79 (s, 3H), 3.09 (dd, <i>J</i> = 3.1, 10.9 Hz, 1H), 3.38 (bs, 8H), 3.66 (d, <i>J</i> = 13.5 Hz, 1H), 3.78 (t, <i>J</i> = 13.3 Hz, 1H), 7.45 (t, <i>J</i> = 7.7 Hz, 1H), 7.50 (d, <i>J</i> = 7.6 Hz, 2H), 7.57−7.59 (m, 2H). HRMS: calcd for C<sub>20</sub>H<sub>29</sub>F<sub>3</sub>N<sub>2</sub>O + H<sup>+</sup>, 371.2305; found (ESI, [M + H]<sup>+</sup>), 371.2290. Anal. Calcd for C<sub>20</sub>H<sub>29</sub>F<sub>3</sub>N<sub>2</sub>O·2.00HCl·0.3H<sub>2</sub>O: C, 53.53; H, 7.10; N, 6.24. Found: C, 53.60; H, 7.22; N, 6.21.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> General Procedure for Whole Cell Radioligand Binding Assay in Cells Expressing Human Norepinephrine Transporter (hNET)</h3><div class="NLM_p last">Twenty-four hours prior to assay, MDCK-Net6 cells stably transfected with human NET<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> were plated in 96-well plates at 3000−5000 cells/well in growth medium and maintained in a cell incubator (37 °C, 5% CO<sub>2</sub>). On day 2, growth medium was replaced with 80 µL of assay buffer (25 mM HEPES, 120 mM NaCl, 5 mM KCl, 2.5 mM CaCl<sub>2</sub>, 1.2 mM MgSO<sub>4</sub>, 2 mg/mL glucose (pH 7.4, 37 °C)) containing 0.2 mg/mL ascorbic acid and 1 µM pargyline. Ten microliter aliquots of test compound in assay buffer were added directly to triplicate wells to yield final test concentrations of 10−10000 nM. Data from wells containing desipramine (1 µM) were used to define nonspecific hNET binding (minimum hNET binding in the presence of an NRI). Total radioligand bound was defined by addition of 5 µL of binding buffer alone in the presence of [<sup>3</sup>H]nisoxetine. The radioligand binding reaction was initiated by addition of [<sup>3</sup>H]nisoxetine in 25 µL of assay buffer to each well for a final concentration of 3 nM. The total and nonspecific cpm values obtained for this assay were 2849 ± 69 and 188 ± 3.5, respectively. The <i>K</i><sub>D</sub> value estimated for [<sup>3</sup>H]nisoxetine was 10 nM using intact whole cells. Test compounds and cells were preincubated at 37 °C for 15 min prior to initiating the binding reaction by addition of radioligand. The cells in the assay buffer with test compound and radioligand were incubated for 2 h at 37 °C. The cells were washed twice with 200 µL of assay buffer at room temperature to remove unbound radioligand. After binding, cells were incubated for 1 h in Microscint20 scintillation fluid (PerkinElmer Life and Analytical Sciences, Boston, MA) and radiolabeled ligand binding quantified using a TopCount plate scintillation counter (PerkinElmer). Each compound was tested in two separate experiments at a minimum and up to four times in some cases.</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> General Procedure for Norepinephrine (NE) Uptake Assay in Cells Expressing Human Norepinephrine Transporter (hNET)</h3><div class="NLM_p last">On day 1, MDCK-Net6 cells, stably transfected with human NET,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> were plated at 3000 cells/well in a 96-well plate in growth medium and maintained in a cell incubator (37 °C, 5% CO<sub>2</sub>). On day 2, growth medium was replaced with 80 µL of assay buffer (25 mM HEPES, 120 mM NaCl, 5 mM KCl, 2.5 mM CaCl<sub>2</sub>, 1.2 mM MgSO<sub>4</sub>, 2 mg/mL glucose [pH 7.4, 37 °C]) containing 0.2 mg/ml ascorbic acid and 10 µM pargyline. Cells were equilibrated in 90 µL of assay buffer for 10 min at 37 °C prior to addition of compounds. A stock solution of desipramine was prepared in DMSO (10 mM) and delivered to triplicate wells containing cells for a final test concentration of 200 nM. Data from these wells were used to define nonspecific NE uptake (minimum NE uptake). Test compound stock solutions were prepared in DMSO/water (1:1) (10 mM) and diluted in assay buffer according to test range (1−10000 nM). A 10 µL aliquot of vehicle or various concentrations of antagonist was added directly to triplicate wells containing cells in 80 µL of assay buffer. The cells were preincubated with test compound for 15 min at 37 °C. To initiate uptake, [<sup>3</sup>H]NE (1-[7,8-<sup>3</sup>H]norepinephrine, ∼30 Ci/mmol from Amersham Biosciences) was diluted in assay buffer (50 nM final assay concentration) and delivered in 10 µL aliquots to each well and the plates were incubated for 10 min at 37 °C. Medium was then removed from wells, and cells were washed twice with 200 µL assay buffer to remove unincorporated [<sup>3</sup>H]NE label. The wells containing cells were then incubated for 1 h in 80 µL of Microscint20 scintillation fluid (PerkinElmer Life and Analytical Sciences, Boston, MA), and the [<sup>3</sup>H]NE accumulation was quantified using a Topcount scintillation counter (PerkinElmer). By use of the above detailed assay conditions, the typical <i>K</i><sub>m</sub> value for [<sup>3</sup>H]NE was 534 ± 92 nM and the <i>V</i><sub>max</sub> value was 5.5 ± 0.9 pmol/well. The total and nonspecific cpms obtained for these assays are 9415 ± 191 and 213 ± 7.1, respectively. Each compound was tested in two separate experiments at a minimum and up to four times in some cases.</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> General Procedure for Serotonin (hSERT) Uptake Assay in Cells Expressing Human Serotonin Transporter</h3><div class="NLM_p last">On day 1, JAR cells (human placental choriocarcinoma), purchased from ATCC (catalog no. HTB-144), were plated at 15 000 cells/well in 96-well plates containing growth medium (RPMI 1640 with 10% FBS) and maintained in a cell incubator (37 °C, 5% CO<sub>2</sub>). On day 2, cells were stimulated with staurosporine (40 nM) to increase the expression of the 5-HT transporter.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> On day 3, cells were removed from the cell incubator 2 h prior to assay and maintained at room temperature to equilibrate the growth medium to ambient oxygen concentration. Subsequently, the growth medium was replaced with 200 µL of assay buffer (25 mM HEPES, 120 mM NaCl, 5 mM KCl, 2.5 mM CaCl<sub>2</sub>, 1.2 mM MgSO<sub>4</sub>, 2 mg/mL glucose (pH 7.4, 37 °C)) containing 0.2 mg/mL ascorbic acid and 1 µM pargyline, and the cells were incubated for 5 min at 37 °C. A stock solution of paroxetine (AHR-4389-1) was prepared in DMSO (10 mM) and delivered to triplicate wells containing cells for a final test concentration of 1 µM. Data from these wells were used to define nonspecific 5-HT uptake (minimum 5-HT uptake in the presence of a SRI). Test compounds were prepared in DMSO/water (1:1) (10 mM) and diluted in assay buffer according to test range (1−1000 nM). An amount of 25 μL of assay buffer (maximum 5-HT uptake) or test compound was added directly to triplicate wells containing cells in 200 µL of assay buffer. The cells were incubated with the compound for 10 min (37 °C). To initiate the reaction, [<sup>3</sup>H]hydroxytryptamine creatinine sulfate diluted in assay buffer was delivered in 25 µL aliquots to each well for a final test concentration of 15 nM. The cells were incubated with the reaction mixture for 9 min at 37 °C. Decanting the supernatant from the plates terminated the reaction. The cells were washed twice with 200 µL of assay buffer (37 °C) to remove free radioligand. The plates were inverted and left to dry for 2 min, then reinverted and air-dried for an additional 10 min. Subsequently, the cells were lysed in 25 µL of 0.25 N NaOH (4 °C) and then placed on a shaker table and shaken vigorously for 5 min. After cell lysis, 75 µL of scintillation cocktail was added to the wells and the plates were sealed with film tape and replaced on the shake table for a minimum of 10 min. The plates were counted in a Wallac Microbeta counter (PerkinElmer) to collect the raw cpm data. By use of the above detailed assay conditions, the typical <i>K</i><sub>m</sub> value for [<sup>3</sup>H]hydroxytryptamine creatinine sulfate was 431 ± 86.2 nM and the <i>V</i><sub>max</sub> value was 11.5 ± 1.2 pmol/well. The total and nonspecific cpm values obtained for this assay are 4282 ± 206 and 79 ± 5.5, respectively. Each compound was tested in two separate experiments at a minimum and up to four times in some cases.</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> General Procedure for the Dopamine Transporter (hDAT) Membrane Binding Assay</h3><div class="NLM_p last">Frozen membrane samples from CHO cells expressing recombinant hDAT, purchased from Perkin-Elmer, Boston, MA (catalog no. RBHDATM, lot no. 2227), were diluted to 7.5 mL in binding buffer (50 mM Tris-HCl, pH 7.4, 100 mM NaCl), homogenized with a tissue-tearer (Polytron PT 1200C, Kinematica AG), and delivered at a volume of 75 µL to each well of a polypropylene 96-well plate. The binding reaction was carried out in polypropylene 96-well plates (Costar General Assay Plate, catalog no. 3359; Lid, catalog no. 3930). Homogenized membrane preparation was delivered at a volume of 75 µL to each well of a reaction plate. A stock solution of mazindol was prepared in DMSO (10 mM) and delivered to triplicate wells containing membranes for a final test concentration of 10 µM. Mazindol has been reported to be a dopamine transporter inhibitor (DRI)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> with an IC<sub>50</sub> value of 20.5 nM in our assays. Data from wells containing mazindol (10 µM) were used to define nonspecific (NSB) hDAT binding (minimum hDAT binding in the presence of a DRI). Total radioligand bound was defined by addition of 5 µL of binding buffer alone in the presence of radioligand <b>18</b>. Stock solutions of test compounds were prepared in DMSO/water (1:1) at a concentration of 10 mM. On day of assay, the test compound stock solution was diluted in assay buffer according to test range (3000−100000 nM) ensuring a maximal DMSO concentration of less than 0.5% in the assay reaction wells. Homogenized membranes were preincubated with test compound for 20 min at 4 °C before the initiation of the binding reaction. The binding reaction was initiated by addition of 25 µL of radioligand <b>18</b> diluted in binding buffer. The final concentration of radioligand <b>18</b> delivered was 32 nM. The <i>K</i><sub>D</sub> value estimated for radioligand <b>18</b> (lot no. 2227) in hDAT membranes was 29.7 nM. The plates containing the radioligand binding reactions were incubated for 2 h at 4 °C on a shaking table (Bellco, Vineland, NJ) at 3 rpm. The MultiScreen-FB opaque 96-well filtration plates containing Millipore glass fiber filters (Millipore glass fiber B, catalog no. MAFBN0B) were used to terminate the binding reactions and to separate bound from free radioligand. The plates were presoaked with 0.5% polyethylenimine (PEI, Sigma catalog no. P-3143) in water for a minimum of 2 h at room temperature to reduce nonspecific binding of radioligand <b>18</b> during the harvest procedure. Prior to harvesting of the reaction plates, the PEI solution was aspirated from the filter plates using a vacuum manifold. Aliquots of each mixture (90 µL of each 100 µL reaction well) were transferred from the reaction plates to the filter plates using a Zymark Rapid Plate-96 automated pipet station. The binding reaction was terminated by vacuum filtration through the glass fiber filters. The filter plates were aspirated at 5−10 in. Hg, and the wells are washed 9 times with 200 µL of wash buffer (50 mM Tris-HCl, 0.9% NaCl, pH 7.4, 4 °C) using a 12-channel aspiration/wash system. Plastic bottom supports were removed from the filter plates, and the plates were placed in plastic liners. A 100 µL aliquot of scintillation fluid was added to each well, and the top of each plate was sealed with adhesive film. The plates were vigorously shaken on an orbital shake table (Bellco) at 5 rpm for 10−15 min to ensure adequate equilibration of aqueous to solvent partitioning. The collection of raw cpm data was done using a Wallac Microbeta counter (Perkin-Elmer). The total and nonspecific cpm values obtained for this assay were 1976.3 ± 52.8 and 95.7 ± 3.2, respectively.</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Procedure for the Tail Suspension Test in Mice</h3><div class="NLM_p last">Male Swiss Webster mice (Charles River Laboratories, MA) weighing 20−35 g (2−3 months of age) were used for the study. Experimental groups consisted of 10 mice, randomly assigned to drug or vehicle (2% Tween-80/0.5% methylcellulose) treatment. The procedure followed in this study was a variant to the original report by Steru et al.<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> Thirty minutes following administration of (<i>S</i>)-(−)-<b>17i</b> (10, 17, and 30 mg/kg, ip) the mice were suspended upside down by the tail using adhesive laboratory tape (VWR International, PA) to a flat metal bar connected to a strain gauge within a tail suspension chamber (Med Associates, VT). The time spent immobile during a 6 min test session was automatically recorded. Eight mice were simultaneously tested in separate chambers. Data collected were expressed as a mean of immobility time, and statistical analysis was performed using a one-way ANOVA with least significant difference (LSD) post hoc test. Data represent group mean values ± SEM for each dose (<i>N</i> = 10 per group).</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Procedure for the <i>p</i>-Phenylquinone (PPQ) Model of Acute Visceral Pain</h3><div class="NLM_p last">Male CD-1 mice (Charles River; Kingston/Stoneridge, NY) weighing 20−25 g were maintained on a 12 h light/dark cycle (lights on at 0630) in groups of five on corncob bedding, and food and water were available ad libitum. Experimental groups consisted of eight mice randomly assigned to drug or vehicle (saline) treatment. The ability of compounds to attenuate acute visceral (abdominal) pain was assessed following an ip injection of 2 mg/kg PPQ (dissolved in 4−6% ethanol/distilled water). Following PPQ injection, mice were individually placed in a Plexiglas cage and the number of stretching movements was recorded during two 1 min periods, 5 and 10 min after injection. Compound (<i>S</i>)-(−)-<b>17i</b> (3, 10, and 30 mg/kg, sc) and desipramine (3, 10 and 30 mg/kg, sc) were administered 60 min prior to PPQ injection. Statistical analysis was done using a one-way ANOVA on raw data (total number of stretches). Significant main effects were analyzed further by subsequent least significant difference analysis. The criterion for significant differences was <i>p</i> < 0.05. Data are presented as percent blockade compared to vehicle (% blockade = {[(mean vehicle) − (drug)]/(mean vehicle)} × 100).</div></div><div id="sec4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Procedure for the OVX-Induced Thermoregulatory Dysfunction Telemetry Rat Model</h3><div class="NLM_p last">Tail-skin temperature (TST) was measured by a temperature and physical activity transmitter (PhysioTel TA10TA-F40, Data Sciences International) that was implanted subcutaneously in the dorsal scapular region of ovariectomized female SD rats. The tip of the temperature probe was tunneled subcutaneously 2.5 cm beyond the base of the tail. After a 7-day recovery period, rats were administered vehicle (2% Tween-80/0.5% methylcellulose), and TST was monitored continuously for 12 h (during the dark cycle). Twenty-four hours later rats were administered either vehicle or test compound and TST was monitored continuously for 12 h (during the dark cycle). All vehicle and test compounds were administered 1 h prior to the onset of the dark cycle. Test compound alterations in TST were analyzed using a 2 day paradigm. For both the vehicle (baseline) and compound testing, TST was recorded at 5 min intervals and an average TST was calculated for every 30 min time point. On day 1, an overall average baseline TST was established for each individual animal by taking the mean over the 12 h observation period. On day 2, test compound was administered and TST readings were reported as an average over every 30 min as described above. All data were analyzed as ΔTST (TST for each time point on day 2 minus average baseline TST for day 1). A one-way ANOVA was performed to obtain the average within-group standard deviation. For each 30 min interval, a <i>t</i> test was performed and evaluated to determine if the average ΔTST was statistically different (<i>p</i> ≥ 0.05) from baseline.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87"><a href="/doi/suppl/10.1021/jm8002262">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47200" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47200" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Crystallographic information in cif format, elemental analysis and purity results for all compounds tested in biological assays, raw data from rat telemetry studies, and data and procedures for pharmacokinetic studies. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm8002262/suppl_file/jm8002262-file002.pdf">jm8002262-file002.pdf (176.94 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm8002262/suppl_file/jm8002262-file004.cif">jm8002262-file004.cif (18.77 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm8002262" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85324" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85324" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paige E. Mahaney</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#167b777e7778736656616f73627e3875797b"><span class="__cf_email__" data-cfemail="e78a868f86898297a7909e82938fc984888a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lori K. Gavrin</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eugene J. Trybulski</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary P. Stack</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">An T. Vu</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen T. Cohn</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fei Ye</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Justin K. Belardi</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arthur A. Santilli</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph P. Sabatucci</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer Leiter</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Grace H. Johnston</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jenifer A. Bray</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin D. Burroughs</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott A. Cosmi</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liza Leventhal</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth J. Koury</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yingru Zhang</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheryl A. Mugford</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas M. Ho</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sharon J. Rosenzweig-Lipson</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Platt</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valerie A. Smith</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darlene C. Deecher</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Women’s Health and Musculoskeletal Biology, and Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, Chemical and Screening Sciences and Department of Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Department of Chemistry, Princeton University, Princeton, New Jersey 08544</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55066" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55066" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank members of the Discovery Analytical Chemistry group in Chemical Technologies at Wyeth, particularly Scott Brecker, Christopher Petucci, Rebecca Dooley, Diane Andraka, and Oliver McConnell for compound analysis. Their efforts and dedication are greatly appreciated. We also thank our management, Drs. M. Abou-Gharbia, R. Magolda, L. Freedman, and M. Pangalos for their support of this work.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86028" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86028" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 24 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Devilbiss, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterhouse, B. D.</span><span> </span><span class="NLM_article-title">Locus coeruleus regulates sensory encoding by neurons and networks in waking animals</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">9860</span><span class="NLM_x">–</span> <span class="NLM_lpage">9872</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1523%2FJNEUROSCI.1776-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=17005850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOmtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=9860-9872&author=D.+M.+Devilbissauthor=M.+E.+Pageauthor=B.+D.+Waterhouse&title=Locus+coeruleus+regulates+sensory+encoding+by+neurons+and+networks+in+waking+animals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Locus ceruleus regulates sensory encoding by neurons and networks in waking animals</span></div><div class="casAuthors">Devilbiss, David M.; Page, Michelle E.; Waterhouse, Barry D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">9860-9872</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Substantial evidence indicates that the locus ceruleus (LC)-norepinephrine (NE) projection system regulates behavioral state and state-dependent processing of sensory information.  Tonic LC discharge (0.1-5.0 Hz) is correlated with levels of arousal and demonstrates an optimal firing rate during good performance in a sustained attention task.  In addn., studies have shown that locally applied NE or LC stimulation can modulate the responsiveness of neurons, including those in the thalamus, to nonmonoaminergic synaptic inputs.  Many recent investigations further indicate that within sensory relay circuits of the thalamus both general and specific features of sensory information are represented within the collective firing patterns of like-modality neurons.  However, no studies have examd. the impact of NE or LC output on the discharge properties of ensembles of functionally related cells in intact, conscious animals.  Here, we provide evidence linking LC neuronal discharge and NE efflux with LC-mediated modulation of single-neuron and neuronal ensemble representations of sensory stimuli in the ventral posteriomedial thalamus of waking rats.  As such, the current study provides evidence that output from the LC across a physiol. range modulates single thalamic neuron responsiveness to synaptic input and representation of sensory information across ensembles of thalamic neurons in a manner that is consistent with the well documented actions of LC output on cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsgaI_wXOHRrVg90H21EOLACvtfcHk0lgdLRwj9UtlNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOmtLnM&md5=f5573599880c0828ba0ecc111e9a45d1</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1776-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1776-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DDevilbiss%26aufirst%3DD.%2BM.%26aulast%3DPage%26aufirst%3DM.%2BE.%26aulast%3DWaterhouse%26aufirst%3DB.%2BD.%26atitle%3DLocus%2520coeruleus%2520regulates%2520sensory%2520encoding%2520by%2520neurons%2520and%2520networks%2520in%2520waking%2520animals%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D9860%26epage%3D9872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Aston-Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, J. D.</span><span> </span><span class="NLM_article-title">Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance</span> <span class="citation_source-journal">J. Comp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">493</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1002%2Fcne.20723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=16254995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSjsLnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=493&publication_year=2005&pages=99-110&author=G.+Aston-Jonesauthor=J.+D.+Cohen&title=Adaptive+gain+and+the+role+of+the+locus+coeruleus-norepinephrine+system+in+optimal+performance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance</span></div><div class="casAuthors">Aston-Jones, Gary; Cohen, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">493</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-110</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Historically, the locus coeruleus-norepinephrine (LC-NE) system has been implicated in arousal, but recent findings suggest that this system plays a more complex and specific role in the control of behavior than investigators previously thought.  We review neurophysiol., anatomical, and modeling studies in monkey that support a new theory of LC-NE function.  LC neurons exhibit two modes of activity, phasic and tonic.  Phasic LC activation is driven by the outcome of task-related decision processes and is proposed to facilitate ensuing behaviors and to help optimize task performance.  When utility in the task wanes, LC neurons exhibit a tonic activity mode, assocd. with disengagement from the current task and a search for alternative behaviors.  Monkey LC receives prominent, direct inputs from the anterior cingulate (ACC) and orbitofrontal cortices (OFC), both of which are thought to monitor task-related utility.  We propose that these prefrontal areas produce the above patterns of LC activity to optimize the utility of performance on both short and long time scales.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIK-OMy49F4rVg90H21EOLACvtfcHk0lgdLRwj9UtlNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSjsLnF&md5=b26f44aa70a3b704408d66cd5a92e846</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1002%2Fcne.20723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.20723%26sid%3Dliteratum%253Aachs%26aulast%3DAston-Jones%26aufirst%3DG.%26aulast%3DCohen%26aufirst%3DJ.%2BD.%26atitle%3DAdaptive%2520gain%2520and%2520the%2520role%2520of%2520the%2520locus%2520coeruleus-norepinephrine%2520system%2520in%2520optimal%2520performance%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D2005%26volume%3D493%26spage%3D99%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Valentino, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Bockstaele, E. J.</span><span> </span><span class="NLM_article-title">Functional interactions between stress neuromediators and the locus coeruleus-norepinephrine system</span> <span class="citation_source-journal">Tech. Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2FS0921-0709%2805%2980026-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVektbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=465-486&author=R.+J.+Valentinoauthor=E.+J.+Van+Bockstaele&title=Functional+interactions+between+stress+neuromediators+and+the+locus+coeruleus-norepinephrine+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Functional interactions between stress neuromediators and the locus coeruleus-norepinephrine system</span></div><div class="casAuthors">Valentino, Rita J.; Van Bockstaele, Elisabeth J.</div><div class="citationInfo"><span class="NLM_cas:title">Techniques in the Behavioral and Neural Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">Handbook of Stress and the Brain, Part 1</span>),
    <span class="NLM_cas:pages">465-486</span>CODEN:
                <span class="NLM_cas:coden">TBSCEC</span>;
        ISSN:<span class="NLM_cas:issn">0921-0709</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Activation of the hypothalamic-pituitary-adrenal axis is considered a hallmark of the stress response.  Coincident with this, peripheral and central noradrenaline systems are activated.  By engaging medullary noradrenaline projections to the paraventricular nucleus of the hypothalamus, stressors regulate the endocrine limb of the stress response.  Engaging noradrenaline projections from the pontine nucleus, locus coeruleus (LC), to the forebrain may serve as a behavioral or cognitive limb of the stress response.  This chapter will focus on the impact of stress on the LC-noradrenaline system and its forebrain targets.  The body of evidence supporting the view that diverse stressors consistently activate this system will be briefly reviewed.  Convergent lines of evidence suggest that corticotropin-releasing factor (CRF) is a crit. substrate of the stress response that regulates activity of the LC-noradrenaline system during stress.  This chapter will discuss the impact of CRF and stressors on the LC-noradrenaline system from the level of individual LC neurons to the distributed network of LC projections.  The concept that stress regulates activity of the LC-noradrenaline system by integrating the actions of CRF with other neuromodulators will be developed and a circuitry underlying these interactions will be proposed.  These findings will be integrated with physiol. and behavioral studies that have suggested specific roles for the LC-noradrenaline system in the modulation of arousal and attention into the hypothesis that activation of this system is an important component of a cognitive limb of the stress response.  Finally, as the endocrine limb of the stress response exhibits plasticity, which is expressed with manipulations such as chronic stress or adrenalectomy, evidence will be reviewed which suggests that the limb comprising the LC-noradrenaline system exhibits similar plasticity, which may have both adaptive and pathol. consequences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozbVy-sN5rAbVg90H21EOLACvtfcHk0lgdLRwj9UtlNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVektbnI&md5=647cb8c0674806b75505667c07c34ebc</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2FS0921-0709%2805%2980026-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0921-0709%252805%252980026-4%26sid%3Dliteratum%253Aachs%26aulast%3DValentino%26aufirst%3DR.%2BJ.%26aulast%3DVan%2BBockstaele%26aufirst%3DE.%2BJ.%26atitle%3DFunctional%2520interactions%2520between%2520stress%2520neuromediators%2520and%2520the%2520locus%2520coeruleus-norepinephrine%2520system%26jtitle%3DTech.%2520Behav.%2520Neurosci.%26date%3D2005%26volume%3D15%26spage%3D465%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cirelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tononi, G.</span><span> </span><span class="NLM_article-title">Locus coeruleus control of state-dependent gene expression</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">5410</span><span class="NLM_x">–</span> <span class="NLM_lpage">5419</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1523%2FJNEUROSCI.0949-04.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=15190114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCgurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=5410-5419&author=C.+Cirelliauthor=G.+Tononi&title=Locus+coeruleus+control+of+state-dependent+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Locus ceruleus control of state-dependent gene expression</span></div><div class="casAuthors">Cirelli, Chiara; Tononi, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5410-5419</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Wakefulness and sleep are accompanied by changes in behavior and neural activity, as well as by the upregulation of different functional categories of genes.  However, the mechanisms responsible for such state-dependent changes in gene expression are unknown.  Here we investigate to what extent state-dependent changes in gene expression depend on the central noradrenergic (NA) system, which is active in wakefulness and reduces its firing during sleep.  We measured the levels of ∼5000 transcripts expressed in the cerebral cortex of control rats and in rats pretreated with DSP-4 [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine], a neurotoxin that removes the noradrenergic innervation of the cortex.  We found that NA depletion reduces the expression of ∼20% of known wakefulness-related transcripts.  Most of these transcripts are involved in synaptic plasticity and in the cellular response to stress.  In contrast, NA depletion increased the expression of the sleep-related gene encoding the translation elongation factor 2.  These results indicate that the activity of the central NA system during wakefulness modulates neuronal transcription to favor synaptic potentiation and counteract cellular stress, whereas its inactivity during sleep may play a permissive role to enhance brain protein synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQHrUe7PwppbVg90H21EOLACvtfcHk0lgX4bNr5f6eSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCgurY%253D&md5=88f9645109a82c3b08dd852216acf86b</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0949-04.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0949-04.2004%26sid%3Dliteratum%253Aachs%26aulast%3DCirelli%26aufirst%3DC.%26aulast%3DTononi%26aufirst%3DG.%26atitle%3DLocus%2520coeruleus%2520control%2520of%2520state-dependent%2520gene%2520expression%26jtitle%3DJ.%2520Neurosci.%26date%3D2004%26volume%3D24%26spage%3D5410%26epage%3D5419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Miyawaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasugi, T.</span><span> </span><span class="NLM_article-title">Chemical stimulation of the locus coeruleus: inhibitory effects on hemodynamics and renal sympathetic nerve activity</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">568</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2F0006-8993%2891%2991384-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=1687667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADyaK38XpvFykug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=568&publication_year=1991&pages=101-108&author=T.+Miyawakiauthor=H.+Kawamuraauthor=K.+Komatsuauthor=T.+Yasugi&title=Chemical+stimulation+of+the+locus+coeruleus%3A+inhibitory+effects+on+hemodynamics+and+renal+sympathetic+nerve+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1eR"><div class="casContent"><span class="casTitleNuber">1e</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical stimulation of the locus coeruleus:  inhibitory effects on hemodynamics and renal sympathetic nerve activity</span></div><div class="casAuthors">Miyawaki, Takashi; Kawamura, Hiroshi; Komatsu, Kazutoshi; Yasugi, Tadao</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">568</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">101-8</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The authors examd. the role of the locus ceruleus (LC) in the regulation of the hemodynamics and sympathetic nerve activity in anesthetized rats.  Unilateral microinjection into the LC of the excitatory amino acid, L-glutamate (Glu), elicited dose-dependent decreases in arterial pressure (AP) and heart rate (HR).  The bradycardic response was partially attenuated after i.v. injection of atropine sulfate, but the greater part of this response still remained.  Interruption of the ascending projections of the LC by midbrain transection did not affect the depressor and bradycardic responses elicited by chem. stimulation.  The renal sympathetic nerve activity showed transient but strong inhibition with this stimulation.  Cardiac output was measured using an electromagnetic flowmeter implanted in the ascending aorta.  The stroke vol. and total peripheral resistance (TPR) were calcd.  Microinjection of Glu elicited a significant decrease in TPR and slight decreases in cardiac output and stroke vol.  Microinjection of the inhibitory amino acid, GABA, or the α2-adrenergic agonist, clonidine, exerted no effect on AP and HR.  The results suggest that: (1) the LC neurons have an inhibitory influence on the sympathetic nervous system, and stimulation of these neurons can elicit depressor and bradycardic responses; (2) the depressor response was produced predominantly as a result of a decrease in vascular resistance, rather than a decrease in cardiac output; (3) these inhibitory responses may be provided other than via the ascending projections of the LC; and (4) the LC neurons do not have a tonic influence on the cardiovascular system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphtR3JDX4AuLVg90H21EOLACvtfcHk0lgX4bNr5f6eSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XpvFykug%253D%253D&md5=4bb2695435afbc5a2a9de0ee6d6a110f</span></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2891%2991384-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252891%252991384-D%26sid%3Dliteratum%253Aachs%26aulast%3DMiyawaki%26aufirst%3DT.%26aulast%3DKawamura%26aufirst%3DH.%26aulast%3DKomatsu%26aufirst%3DK.%26aulast%3DYasugi%26aufirst%3DT.%26atitle%3DChemical%2520stimulation%2520of%2520the%2520locus%2520coeruleus%253A%2520inhibitory%2520effects%2520on%2520hemodynamics%2520and%2520renal%2520sympathetic%2520nerve%2520activity%26jtitle%3DBrain%2520Res.%26date%3D1991%26volume%3D568%26spage%3D101%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Sarvey, J.</span><span> </span><span class="NLM_article-title">Protein synthesis in long-term potentiation and norepinephrine-induced long-lasting potentiation in hippocampus</span> <span class="citation_source-journal">Neurol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1998&pages=329-353&author=J.+Sarvey&title=Protein+synthesis+in+long-term+potentiation+and+norepinephrine-induced+long-lasting+potentiation+in+hippocampus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarvey%26aufirst%3DJ.%26atitle%3DProtein%2520synthesis%2520in%2520long-term%2520potentiation%2520and%2520norepinephrine-induced%2520long-lasting%2520potentiation%2520in%2520hippocampus%26jtitle%3DNeurol.%2520Neurobiol.%26date%3D1998%26volume%3D35%26spage%3D329%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fricchione, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefano, G. B.</span><span> </span><span class="NLM_article-title">Placebo neural systems: nitric oxide, morphine and the dopamine brain reward and motivation circuitries</span> <span class="citation_source-journal">Med. Sci. Monit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_elocation-id">MS54−MS65</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&author=G.+Fricchioneauthor=G.+B.+Stefano&title=Placebo+neural+systems%3A+nitric+oxide%2C+morphine+and+the+dopamine+brain+reward+and+motivation+circuitries"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFricchione%26aufirst%3DG.%26aulast%3DStefano%26aufirst%3DG.%2BB.%26atitle%3DPlacebo%2520neural%2520systems%253A%2520nitric%2520oxide%252C%2520morphine%2520and%2520the%2520dopamine%2520brain%2520reward%2520and%2520motivation%2520circuitries%26jtitle%3DMed.%2520Sci.%2520Monit.%26date%3D2005%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kalivas, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkow, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seamans, J.</span><span> </span><span class="NLM_article-title">Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=647-650&author=P.+W.+Kalivasauthor=N.+Volkowauthor=J.+Seamans&title=Unmanageable+motivation+in+addiction%3A+a+pathology+in+prefrontal-accumbens+glutamate+transmission"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKalivas%26aufirst%3DP.%2BW.%26aulast%3DVolkow%26aufirst%3DN.%26aulast%3DSeamans%26aufirst%3DJ.%26atitle%3DUnmanageable%2520motivation%2520in%2520addiction%253A%2520a%2520pathology%2520in%2520prefrontal-accumbens%2520glutamate%2520transmission%26jtitle%3DNeuron%26date%3D2005%26volume%3D45%26spage%3D647%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pochon, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehericy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poline, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Bihan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, B.</span><span> </span><span class="NLM_article-title">The neural system that bridges reward and cognition in humans: an fMRI study</span> <span class="citation_source-journal">Proc. Nat. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">5669</span><span class="NLM_x">–</span> <span class="NLM_lpage">5674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1073%2Fpnas.082111099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=11960021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFKltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=5669-5674&author=J.+B.+Pochonauthor=R.+Levyauthor=P.+Fossatiauthor=S.+Lehericyauthor=J.+B.+Polineauthor=B.+Pillonauthor=D.+Le+Bihanauthor=B.+Dubois&title=The+neural+system+that+bridges+reward+and+cognition+in+humans%3A+an+fMRI+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">The neural system that bridges reward and cognition in humans: an fMRI study</span></div><div class="casAuthors">Pochon, J. B.; Levy, R.; Fossati, P.; Lehericy, S.; Poline, J. B.; Pillon, B.; Le Bihan, D.; Dubois, B.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5669-5674</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We test the hypothesis that motivational and cognitive processes are linked by a specific neural system to reach maximal efficiency.  We studied six normal subjects performing a working memory paradigm (n-back tasks) assocd. with different levels of monetary reward during an fMRI session.  The study showed specific brain activation in relation with changes in both the cognitive loading and the reward assocd. with task performance.  First, the working memory tasks activated a network including the dorsolateral prefrontal cortex [Brodmann area (BA) 9/46] and, in addn., in the lateral frontopolar areas (BA 10), but only in the more demanding condition (3-back task).  This result suggests that lateral prefrontal areas are organized in a caudo-rostral continuum in relation with the increase in executive requirement.  Second, reward induces an increased activation in the areas already activated by working memory processing and in a supplementary region, the medial frontal pole (BA 10), regardless of the level of cognitive processing.  It is postulated that the latter region plays a specific role in monitoring the reward value of ongoing cognitive processes.  Third, we detected areas where the signal decreases (ventral-BA 11/47 and subgenual prefrontal cortices) in relation with both the increase of cognitive demand and the reward.  The deactivation may represent an emotional gating aimed at inhibiting adverse emotional signals to maximize the level of performance.  Taken together, these results suggest a balance between increasing activity in cortical cognitive areas and decreasing activity in the limbic and paralimbic structures during ongoing higher cognitive processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFHH0LhnRdP7Vg90H21EOLACvtfcHk0lgX4bNr5f6eSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFKltbo%253D&md5=6b369e1ec0c675029cf26d880745bd47</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1073%2Fpnas.082111099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.082111099%26sid%3Dliteratum%253Aachs%26aulast%3DPochon%26aufirst%3DJ.%2BB.%26aulast%3DLevy%26aufirst%3DR.%26aulast%3DFossati%26aufirst%3DP.%26aulast%3DLehericy%26aufirst%3DS.%26aulast%3DPoline%26aufirst%3DJ.%2BB.%26aulast%3DPillon%26aufirst%3DB.%26aulast%3DLe%2BBihan%26aufirst%3DD.%26aulast%3DDubois%26aufirst%3DB.%26atitle%3DThe%2520neural%2520system%2520that%2520bridges%2520reward%2520and%2520cognition%2520in%2520humans%253A%2520an%2520fMRI%2520study%26jtitle%3DProc.%2520Nat.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D5669%26epage%3D5674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kumar, V. N.</span><span> </span><span class="NLM_article-title">Interrelation between thermoregulation and sleep regulation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci., India, Sect. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">524</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsVWktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2003&pages=507-524&author=V.+N.+Kumar&title=Interrelation+between+thermoregulation+and+sleep+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Interrelation between thermoregulation and sleep regulation</span></div><div class="casAuthors">Kumar, Velayudhan Mohan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Indian National Science Academy, Part B: Biological Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">507-524</span>CODEN:
                <span class="NLM_cas:coden">PINSD5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Indian National Science Academy</span>)
        </div><div class="casAbstract">A review on the interrelation between thermoregulation and sleep regulation and particularly the role of the medial preoptic area (mPOA) , including discussions on the changes in body temp. and sleep in response to local injection of neurotransmitters at the mPOA and the roles of noradrenergic terminals in the mPOA in regulating body temp. and sleep.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLivH5lzUqebVg90H21EOLACvtfcHk0lgsFAGFQX_TZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsVWktLY%253D&md5=af031fe00407f9a745f8497c45bb3e17</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DV.%2BN.%26atitle%3DInterrelation%2520between%2520thermoregulation%2520and%2520sleep%2520regulation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%252C%2520India%252C%2520Sect.%2520B%26date%3D2003%26volume%3D69%26spage%3D507%26epage%3D524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Riedel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorward, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, P. I.</span><span> </span><span class="NLM_article-title">Central adrenoceptors modify hypothalamic thermoregulatory patterns of autonomic activity in conscious rabbits</span> <span class="citation_source-journal">Auton. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2F0165-1838%2881%2990085-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADyaL3MXktFymt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1981&pages=525-533&author=W.+Riedelauthor=P.+K.+Dorwardauthor=P.+I.+Korner&title=Central+adrenoceptors+modify+hypothalamic+thermoregulatory+patterns+of+autonomic+activity+in+conscious+rabbits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Central adrenoceptors modify hypothalamic thermoregulatory patterns of autonomic activity in conscious rabbits</span></div><div class="casAuthors">Riedel, Walter; Dorward, Patricia K.; Korner, P. I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Autonomic Nervous System</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2-4</span>),
    <span class="NLM_cas:pages">525-33</span>CODEN:
                <span class="NLM_cas:coden">JASYDS</span>;
        ISSN:<span class="NLM_cas:issn">0165-1838</span>.
    </div><div class="casAbstract">In conscious rabbits with indwelling intracisternal (i.c.) catheters i.c. injection of noradrenaline bitartrate (I bitartrate)  [51-40-1] (20-2000 ng) elicited dose-related cutaneous vasoconstriction of the ear skin vessels and redn. in renal sympathetic vasoconstrictor activity (integrated mass discharge).  There was shivering and a rise in the animals core temp., so that the injections of I mimicked the normal thermoregulatory pattern of cooling.  In 5 other rabbits with implanted hypothalamic thermodes the responses of the ear temp., renal sympathetic nerve activity and respiration rate to hypothalamic heating and cooling were studied.  The animals were studied: under control conditions, after i.c. administration of I, and 24 h after 6-hydroxydopamine (6-OHDA) when there is marked depletion of central nervous system noradrenergic transmitter stores.  After the drugs the temp.-response curves were displaced from control in approx. parallel fashion with little change in gain.  I elicited shifts that were directionally opposite to those produced by 6-OHDA, suggesting that the changes in thermoregulatory properties were specific effects of the transmitter.  Previous studies also suggest that the site of modulation of the thermoregulatory response is at bulbospinal levels, at least as far as the renal sympathetic response was concerned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6x9CxWaksNLVg90H21EOLACvtfcHk0lgsFAGFQX_TZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXktFymt7w%253D&md5=f8b4bcb441af78be24d9e27a9ea02ff1</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2F0165-1838%2881%2990085-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1838%252881%252990085-0%26sid%3Dliteratum%253Aachs%26aulast%3DRiedel%26aufirst%3DW.%26aulast%3DDorward%26aufirst%3DP.%2BK.%26aulast%3DKorner%26aufirst%3DP.%2BI.%26atitle%3DCentral%2520adrenoceptors%2520modify%2520hypothalamic%2520thermoregulatory%2520patterns%2520of%2520autonomic%2520activity%2520in%2520conscious%2520rabbits%26jtitle%3DAuton.%2520Neurosci.%26date%3D1981%26volume%3D3%26spage%3D525%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lahti, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyornila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hissa, R.</span><span> </span><span class="NLM_article-title">The influence of 6-OHDA on hypothermia produced by intrahypothalamically-injected carbachol in the pigeon</span> <span class="citation_source-journal">Experientia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1980&pages=1188&author=H.+Lahtiauthor=A.+Pyornilaauthor=R.+Hissa&title=The+influence+of+6-OHDA+on+hypothermia+produced+by+intrahypothalamically-injected+carbachol+in+the+pigeon"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLahti%26aufirst%3DH.%26aulast%3DPyornila%26aufirst%3DA.%26aulast%3DHissa%26aufirst%3DR.%26atitle%3DThe%2520influence%2520of%25206-OHDA%2520on%2520hypothermia%2520produced%2520by%2520intrahypothalamically-injected%2520carbachol%2520in%2520the%2520pigeon%26jtitle%3DExperientia%26date%3D1980%26volume%3D36%26spage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Michel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruhe, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oelke, M.</span><span> </span><span class="NLM_article-title">Tolerability of amine uptake inhibitors in urologic diseases</span> <span class="citation_source-journal">Curr. Drug Safety</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.2174%2F157488606775252601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVWmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=73-85&author=M.+C.+Michelauthor=H.+G.+Ruheauthor=A.+A.+de+Grootauthor=R.+Castroauthor=M.+Oelke&title=Tolerability+of+amine+uptake+inhibitors+in+urologic+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Tolerability of amine uptake inhibitors in urologic diseases</span></div><div class="casAuthors">Michel, Martin C.; Ruhe, Henricus G.; de Groot, Annemieke A.; Castro, Ramiro; Oelke, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Safety</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-85</span>CODEN:
                <span class="NLM_cas:coden">CDSUBQ</span>;
        ISSN:<span class="NLM_cas:issn">1574-8863</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Inhibitors of serotonin (5-HT) and/or noradrenaline (NA) reuptake have been developed for pharmacol. treatment of major depressive disorder.  Insights in the role of 5-HT and NA in the neurol. control of the lower urinary tract have also led to their application in common urol. conditions such as stress urinary incontinence (SUI), nocturnal enuresis and ejaculatory disorders.  The European approval of the 5-HT and NA reuptake inhibitor (SNRI) duloxetine for treatment of SUI underlines the importance of a new approach in SUI, but has also given rise to questions about the safety of antidepressants in urol.  This paper reviews the safety of 5-HT and NA reuptake inhibitors in their on- and off-label use in urol.  A systematic Medline search was performed for randomized controlled trials, meta-analyses and practice guidelines dealing with antidepressants in urol.  The safety profiles of the drugs in the urol. population were compared with data from psychiatric populations.  Tricyclic antidepressants are assocd. with serious cardiovascular side effects.  In addn., anticholinergic and antihistaminic side effects are common.  Although recently questions have been raised regarding the cardiovascular safety profile of venlafaxine, most selective 5-HT reuptake inhibitors and SNRI have not been assocd. with serious cardiovascular effects.  Their most common side effect is nausea.  However, nausea tends to be mild and, importantly, transient.  Patient counselling about side effects and up-titrating doses may be useful strategies for minimizing discomfort and withdrawals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOXIcQjLzWQ7Vg90H21EOLACvtfcHk0lgsFAGFQX_TZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVWmur8%253D&md5=be53d26f331c8a2051b7661498137779</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.2174%2F157488606775252601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157488606775252601%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DM.%2BC.%26aulast%3DRuhe%26aufirst%3DH.%2BG.%26aulast%3Dde%2BGroot%26aufirst%3DA.%2BA.%26aulast%3DCastro%26aufirst%3DR.%26aulast%3DOelke%26aufirst%3DM.%26atitle%3DTolerability%2520of%2520amine%2520uptake%2520inhibitors%2520in%2520urologic%2520diseases%26jtitle%3DCurr.%2520Drug%2520Safety%26date%3D2006%26volume%3D1%26spage%3D73%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Michel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oelke, M.</span><span> </span><span class="NLM_article-title">Duloxetine in the treatment of stress urinary incontinence</span> <span class="citation_source-journal">Women’s Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.2217%2F17455057.1.3.345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFeqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=345-348&author=M.+C.+Michelauthor=M.+Oelke&title=Duloxetine+in+the+treatment+of+stress+urinary+incontinence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Duloxetine in the treatment of stress urinary incontinence</span></div><div class="casAuthors">Michel, Martin C.; Oelke, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Women's Health</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-358</span>CODEN:
                <span class="NLM_cas:coden">WHOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1745-5057</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  This manuscript reviews the pharmacodynamics and pharmacokinetics of duloxetine and its efficacy and safety in women with stress urinary incontinence.  Duloxetine is a selective inhibitor of neuronal serotonin and norepinephrine uptake which increases urethral striated muscle activity and bladder capacity.  Duloxetine is readily absorbed and extensively metabolized; cytochrome P 450 1A2 (CYP1A2) inhibiting drugs can markedly increase duloxetine exposure.  The clin. efficacy of duloxetine has consistently been demonstrated in several randomized, double-blind studies in women with moderate-to-severe stress urinary incontinence, but the addnl. benefit relative to placebo was moderate.  Duloxetine treatment is frequently assocd. with adverse events such as nausea, dry mouth, fatigue, insomnia and constipation, but serious adverse events are rare.  Therefore, duloxetine appears suitable for the treatment of stress urinary incontinence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6COtI0VzGTbVg90H21EOLACvtfcHk0lgMPCED5obD0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFeqs7g%253D&md5=9861a3efce1324f9e9d8f4ccead279d0</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.2217%2F17455057.1.3.345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F17455057.1.3.345%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DM.%2BC.%26aulast%3DOelke%26aufirst%3DM.%26atitle%3DDuloxetine%2520in%2520the%2520treatment%2520of%2520stress%2520urinary%2520incontinence%26jtitle%3DWomen%25E2%2580%2599s%2520Health%26date%3D2005%26volume%3D1%26spage%3D345%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Osborne, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. M.</span><span> </span><span class="NLM_article-title">Duloxetine in the treatment of stress urinary incontinence</span> <span class="citation_source-journal">J. Pharm. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVyrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2005&pages=337-340&author=K.+L.+Osborneauthor=S.+M.+Davis&title=Duloxetine+in+the+treatment+of+stress+urinary+incontinence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Duloxetine in the treatment of stress urinary incontinence</span></div><div class="casAuthors">Osborne, Kristie L.; Davis, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy Technology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">337-340</span>CODEN:
                <span class="NLM_cas:coden">JPTEEB</span>;
        ISSN:<span class="NLM_cas:issn">8755-1225</span>.
    
            (<span class="NLM_cas:orgname">Harvey Whitney Books Co.</span>)
        </div><div class="casAbstract">Objective: To review the available literature regarding the use of duloxetine in the treatment of stress urinary incontinence.  Data Sources: Clin. trials were obtained through a PubMed search (1966-Dec. 2004) with the key words duloxetine, urinary incontinence, and stress.  Data Synthesis: This article analyzes 5 clin. studies comparing duloxetine with placebo.  The randomized, double-blind, multicenter trials were performed in the US and throughout the world and had strict inclusion criteria to enroll only patients with confirmed stress urinary incontinence.  All trials showed a statistically significant decrease in incontinence episode frequency of 50-60% for duloxetine compared with a placebo response of 27-40%.  Conclusions: Duloxetine appears to be an effective treatment for stress urinary incontinence.  Addnl. trials comparing duloxetine with pelvic floor muscle training would better define duloxetine's place in therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzCMGuu2R43LVg90H21EOLACvtfcHk0lgMPCED5obD0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVyrug%253D%253D&md5=1311c4425b432731dc632f437380de9c</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOsborne%26aufirst%3DK.%2BL.%26aulast%3DDavis%26aufirst%3DS.%2BM.%26atitle%3DDuloxetine%2520in%2520the%2520treatment%2520of%2520stress%2520urinary%2520incontinence%26jtitle%3DJ.%2520Pharm.%2520Technol.%26date%3D2005%26volume%3D21%26spage%3D337%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">McCormack, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, G. M.</span><span> </span><span class="NLM_article-title">Duloxetine: in stress urinary incontinence</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">2567</span><span class="NLM_x">–</span> <span class="NLM_lpage">2573</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=2567-2573&author=P.+L.+McCormackauthor=G.+M.+Keating&title=Duloxetine%3A+in+stress+urinary+incontinence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCormack%26aufirst%3DP.%2BL.%26aulast%3DKeating%26aufirst%3DG.%2BM.%26atitle%3DDuloxetine%253A%2520in%2520stress%2520urinary%2520incontinence%26jtitle%3DDrugs%26date%3D2004%26volume%3D64%26spage%3D2567%26epage%3D2573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Preskorn, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, R.</span><span> </span><span class="NLM_article-title">Other Antidepressants</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktVGntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2004&pages=263-324&author=S.+H.+Preskornauthor=R.+Ross&title=Other+Antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Other antidepressants</span></div><div class="casAuthors">Preskorn, S. H.; Ross, R.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">Antidepressants</span>),
    <span class="NLM_cas:pages">263-324</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  This chapter reviews the following antidepressants, which do not belong to one of the major classes described in the three preceding chapters: bupropion, mirtazapine and mianserin, nefazodone and trazodone, reboxetine, venlafaxine, duloxetine, milnacipran, and tianeptine.  Unlike the selective serotonin reuptake inhibitors (SSRIs), many of these antidepressants have an ascending rather than a flat dose-response curve.  The chapter provides a brief review of the chem., pharmacol., metab., safety and adverse effects, clin. use, and therapeutic indications of each antidepressant.  Bupropion is a weak dual uptake inhibitor of both dopamine and norepinephrine (NE).  Information concerning its pharmacodynamic and pharmacokinetic properties is limited, primarily because of the age of the drug (clin. trials begun in the mid-1970s).  Bupropion's most serious side effect is dose-dependent seizures, so that the highest recommended doses are 450 and 400 mg/day for the immediate release (IR) and sustained release (SR) formulations, resp.  Other adverse effects include restlessness, activation, tremors, insomnia, and nausea.  Bupropion was found to be an effective antidepressant in several double-blind studies that generally used doses higher than the max. recommended dose of 450 mg/day.  Despite fairly modest evidence of antidepressant efficacy, bupropion may be useful in a no. of clin. situations, including for patients with prominent psychomotor retardation, Parkinson's disease, or attention-deficit/hyperactivity disorder; for patients who have failed to respond to other antidepressants; and for patients who cannot tolerate sexual side effects of other antidepressants.  Bupropion has also been approved as an aid in smoking cessation.  Mirtazapine and its forerunner mianserin, are tetracyclic compds. with a unique mechanism of action.  Mirtazapine is an α2-antagonist that increases noradrenergic and serotonergic neurotransmission, the primary mechanism thought to underlie its antidepressant activity.  Mirtazapine does not cause many of the side effects assocd. with the SSRIs (e.g., nausea, loose stools, disturbed sleep pathol., sexual dysfunction) and causes minimal anticholinergic effects, no quinidine-like effects, and no effects on blood pressure.  Sedation can be a problem, esp. early in treatment, although this may be an advantage for patients with prominent insomnia, anxiety, or agitation.  Mirtazapine can cause increased appetite and wt. gain, transient neutropenia, and transient mild elevations of liver function tests.  Three cases of agranulocytosis were reported out of 3,000 patients in the mirtazapine clin. trial program, an incidence too low to draw any conclusion about cause and effect.  Although postmarketing experience has not found an unusual no. of cases of agranulocytosis, the package insert in the United States contains a warning that a white blood cell count should be done if a patient taking mirtazapine develops signs of fever or infection.  Because of its unique mechanism of action, mirtazapine may be efficacious for patients who have not benefited from other types of antidepressants.  Nefazodone and trazodone have chem. related structures that incorporate 5-HT2A receptor blockade plus weak 5-HT uptake blockade and possibly NE uptake blockade.  Trazodone is widely used as a nonhabit-forming sleep aid rather than as an antidepressant.  The antihistaminergic properties of trazodone are partly responsible for its popularity as a sleep aid, but can cause significant problems with daytime sedation when it is used as an antidepressant; however, it may be useful for treating agitation in geriatric patients.  Nefazodone, a more potent serotonin re-uptake inhibitor (SRI) than trazodone, was designed with the goal of producing a better antidepressant than trazodone, although it is a much weaker SRI than the SSRIs or venlafaxine.  Because it substantially inhibits CYP 3A3/4, nefazodone can elevate levels of coprescribed drugs metabolized via CYP 3A/3/4.  Nefazodone produces less activation and sexual dysfunction than the SSRIs and venlafaxine; it does not cause blood pressure elevation or disturb sleep physiol.; it improves subjective sleep quality.  The incidence and severity of the following adverse effects increase in a dose-dependent fashion as a function of the starting dose of nefazodone: dizziness/lightheadedness, confusion, sedation, gastrointestinal side effects.  Nefazodone appears to have efficacy in patients with clin. depression and prominent anxiety.  Although there appears to be greater interpatient variability in response to nefazodone than to many of the other newer antidepressants, nefazodone can be a useful option for patients who are unable to tolerate the adverse effects of the SSRIs.  Reboxetine is a selective NE reuptake pump inhibitor.  Its most common adverse effects are insomnia, sweating, constipation, dry mouth, and urinary hesitancy.  Most of the published trials of reboxetine have been active rather than placebo-controlled and results were not published in full with rigorous peer review, compromising the ability to make an assessment of efficacy.  Sufficient evidence of the efficacy of reboxetine in major depression has not been presented to receive approval for marketing in the United States, but reboxetine is available in several other countries.  Venlafaxine, a phenylethylamine, first inhibits the neuronal uptake pump for serotonin (SE) and then at higher concns. inhibits the uptake pump for NE.  Unlike tertiary amine tricyclic antidepressants (TCAs), which also inhibit the SE and NE uptake pumps, venlafaxine has low affinity for most other neural receptors and does not inhibit sodium fast channels, making it relatively safe in overdose.  Its adverse effects change qual. as the dose increases because of progressively greater blockade of NE uptake with increasing doses.  At low doses, the adverse-effect profile is similar to an SSRI with nausea, loose stools, sexual dysfunction, while venlafaxine at higher doses can produce generally mild increases in blood pressure, diaphoresis, tachycardia, tremors, and anxiety.  A disadvantage of venlafaxine relative to the SSRIs is the potential for dose-dependent blood pressure elevation, most likely due to the NE uptake inhibition caused by higher doses; however, this adverse effect is infrequently obsd. at doses below 225 mg/day.  Venlafaxine and the SSRIs have similar advantages over the TCAs and monoamine oxidase inhibitors.  Venlafaxine also has a no. of potential advantages over the SSRIs, including an ascending dose-antidepressant response curve, with possible greater overall efficacy at higher doses, evidence of more rapid onset of antidepressant action, evidence of superior efficacy in hospitalized patients with major depressive disorder compared with placebo or fluoxetine, and minimal effects on CYP enzymes in contrast to fluoxetine, fluvoxamine, paroxetine, and the non-SSRI, bupropion.  Duloxetine is a SE-NE re-uptake pump inhibitor, which is pending approval in the United States and other countries in late 2003.  It will be the third member of this pharmacol. class, which also contains venlafaxine and milnacipran (sibutramine, the fourth member of this class, is marketed for obesity rather than major depression).  Only a limited no. of articles have been published on this compd. but more should be expected shortly after its market introduction.  The manufacturer is initially seeking indications for both major depression and urinary incontinence.  Due to its inhibition of the SE and NE uptake pumps, duloxetine will undoubtedly carry a warning against use in combination with monoamine oxidase inhibitors.  It is also a moderate inhibitor of CYP 2D6, so that modest dose redns. and careful monitoring will be needed when prescribing duloxetine in combination with drugs that are preferentially metabolized by CYP 2D6, particularly those with narrow therapeutic indexes.  The most common side effects identified in clin. trials to date appear to be nausea, dry mouth, dizziness, constipation, insomnia, asthenia, and hypertension, consistent with its mechanisms of action.  Clin. trials to date have demonstrated rates of response and remission in patients with major depression that are comparable to other marketed antidepressants reviewed in this book.  Although milnacipran is marketed in France, Japan, and a few other countries, its development in the United States was discontinued.  It is an SE and NE reuptake inhibitor in the same class as venlafaxine, duloxetine, and the anti-obesity drug, sibutramine.  Milnacipran would be predicted to be susceptible to the same pharmacodynamic drug-drug interactions as other drugs in this class, but would not be expected to be involved in any CYP enzyme-mediated drug-drug interactions.  Milnacipran at doses of 50-200 mg/day has a favorable adverse-effect profile when compared with tertiary amine TCAs, including a lower incidence of abnormal liver function tests.  At doses of 50 or 100 mg twice a day but not 100 mg once a day, it caused a lower incidence of nausea and anxiety but a higher incidence of headache, dry mouth, and dysuria than did fluoxetine, 20 mg/day, or fluvoxamine, 100 mg twice a day.  As with other drugs in this class, dysuria is the most common troublesome and dose-dependent adverse effect (occurring in up to 7% of patients).  High-dose milnacipran has been reported to cause blood pressure elevation.  Like reboxetine, most of the published trials of milnacipran have been active rather than placebo-controlled and results were not published in full with rigorous peer review, compromising the ability to make an assessment of efficacy; however, findings to date suggest that milnacipran produces a superior antidepressant response compared with placebo at doses of 50 and 100 mg twice a day.  Tianeptine is marketed in France but few other countries around the world and there is little knowledge of this drug in the United States and other English-speaking countries.  However, a surprising amt. of research, particularly preclin., has been done with tianeptine, in part because of its apparent novel mechanism of action: Tianeptine, in contrast to most other antidepressants, increases SE uptake into neurons rather than blocking it.  However, its side-effect profile is similar to that of other newer antidepressants, with low abuse potential and a low risk of adverse effects on the cardiovascular system, the cholinergic systems, sleep/arousal, cognition, psychomotor functioning, and wt.  The most common adverse effects include nausea, constipation, abdominal pain, headache, dizziness, and altered dreaming.  Hepatotoxicity has been reported but is rare.  Like reboxetine and milnacipran, most of the published trials of tianeptine have been active rather than placebo-controlled and results were not published in full with rigorous peer review, compromising the ability to assess efficacy; however, trials to date do suggest efficacy in patients with major depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwEp5f1kPkH7Vg90H21EOLACvtfcHk0lgMPCED5obD0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktVGntbc%253D&md5=dd7cffe17e6ec1a58c507a02251641b5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPreskorn%26aufirst%3DS.%2BH.%26aulast%3DRoss%26aufirst%3DR.%26atitle%3DOther%2520Antidepressants%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2004%26volume%3D157%26spage%3D263%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Carminati, G. G.i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deriaz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertschy, G.</span><span> </span><span class="NLM_article-title">Low dose vanlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms</span> <span class="citation_source-journal">Prog. Neuropsychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">312</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2Fj.pnpbp.2005.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=16307837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVWks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2006&pages=312-315&author=G.+G.i.+Carminatiauthor=N.+Deriazauthor=G.+Bertschy&title=Low+dose+vanlafaxine+in+three+adolescents+and+young+adults+with+autistic+disorder+improves+self-injurious+behavior+and+attention+deficit%2Fhyperactivity+disorders+%28ADHD%29-like+symptoms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms</span></div><div class="casAuthors">Carminati, Giuliana Galli; Deriaz, Nicolas; Bertschy, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">312-315</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In our clin. practice, we have had good experiences with venlafaxine in the treatment of self-injurious behavior (SIB) and attention deficit/hyperactivity disorders (ADHD)-like symptoms in patients with pervasive developmental disorders (PDD), and we report here three cases of possible therapeutic response: (A) a 17-yr-old boy with autism and severe behavioral symptoms, including aggression toward self or property, SIB and hyperactivity, who appeared to respond to low-dose venlafaxine (18.75 mg/day); (B) a 23-yr-old woman with autism hyperactivity who appeared to respond to low-dose venlafaxine (18.75 mg/day); (C) a 17-yr-old girl with autism hyperactivity who appeared to respond to low-dose venlafaxine (18.75 mg/day).  Follow-ups occurred resp. 18, 36 and 6 mo after treatment initiation, making it possible to observe the stability of the clin. improvement in these cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosMh_ruuM69LVg90H21EOLACvtfcHk0lgMPCED5obD0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVWks74%253D&md5=c01183c070884a6452cd7e6e786ab6d2</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2005.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2005.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DCarminati%26aufirst%3DG.%2BG.i.%26aulast%3DDeriaz%26aufirst%3DN.%26aulast%3DBertschy%26aufirst%3DG.%26atitle%3DLow%2520dose%2520vanlafaxine%2520in%2520three%2520adolescents%2520and%2520young%2520adults%2520with%2520autistic%2520disorder%2520improves%2520self-injurious%2520behavior%2520and%2520attention%2520deficit%252Fhyperactivity%2520disorders%2520%2528ADHD%2529-like%2520symptoms%26jtitle%3DProg.%2520Neuropsychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2006%26volume%3D30%26spage%3D312%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Arnold, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crofford, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlreich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Detke, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyengar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. J.</span><span> </span><span class="NLM_article-title">A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2974</span><span class="NLM_x">–</span> <span class="NLM_lpage">2984</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1002%2Fart.20485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=15457467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2cXoslGgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=2974-2984&author=L.+M.+Arnoldauthor=Y.+Luauthor=L.+J.+Croffordauthor=M.+Wohlreichauthor=M.+J.+Detkeauthor=S.+Iyengarauthor=D.+J.+Goldstein&title=A+double-blind%2C+multicenter+trial+comparing+duloxetine+with+placebo+in+the+treatment+of+fibromyalgia+patients+with+or+without+major+depressive+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder</span></div><div class="casAuthors">Arnold, Lesley M.; Lu, Yili; Crofford, Leslie J.; Wohlreich, Madelaine; Detke, Michael J.; Iyengar, Smriti; Goldstein, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2974-2984</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The aim was to assess the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in subjects with primary fibromyalgia, with or without current major depressive disorder.  This study was a randomized, double-blind, placebo-controlled trial conducted in 18 outpatient research centers in the US.  A total of 207 subjects meeting the American College of Rheumatol. criteria for primary fibromyalgia were enrolled (89% female, 87% white, mean age 49 yr, 38% with current major depressive disorder).  After single-blind placebo treatment for 1 wk, subjects were randomly assigned to receive duloxetine 60 mg twice a day (n = 104) or placebo (n = 103) for 12 wk.  Co-primary outcome measures were the Fibromyalgia Impact Questionnaire (FIQ) total score (score range 0-80, with 0 indicating no impact) and FIQ pain score (score range 0-10).  Secondary outcome measures included mean tender point pain threshold, no. of tender points, FIQ fatigue, tiredness on awakening, and stiffness scores, Clin. Global Impression of Severity (CGI-Severity) scale, Patient Global Impression of Improvement (PGI-Improvement) scale, Brief Pain Inventory (short form), Medical Outcomes Study Short Form 36, Quality of Life in Depression Scale, and Sheehan Disability Scale.  Compared with placebo-treated subjects, duloxetine-treated subjects improved significantly more (P = 0.027) on the FIQ total score, with a treatment difference of -5.53 (95% confidence interval -10.43, -0.63), but not significantly more on the FIQ pain score (P = 0.130).  Compared with placebo-treated subjects, duloxetine-treated subjects had significantly greater redns. in Brief Pain Inventory av. pain severity score (P = 0.008), Brief Pain Inventory av. interference from pain score (P = 0.004), no. of tender points (P = 0.002), and FIQ stiffness score (P = 0.048), and had significantly greater improvement in mean tender point pain threshold (P = 0.002), CGI-Severity (P = 0.048), PGI-Improvement (P = 0.033), and several quality-of-life measures.  Duloxetine treatment improved fibromyalgia symptoms and pain severity regardless of baseline status of major depressive disorder.  Compared with placebo-treated female subjects (n = 92), duloxetine-treated female subjects (n = 92) demonstrated significantly greater improvement on most efficacy measures, while duloxetine-treated male subjects (n = 12) failed to improve significantly on any efficacy measure.  The treatment effect on significant pain redn. in female subjects was independent of the effect on mood or anxiety.  Duloxetine was safely administered and well tolerated.  In this randomized, controlled, 12-wk trial (with a 1-wk placebo lead-in phase), duloxetine was an effective and safe treatment for many of the symptoms assocd. with fibromyalgia in subjects with or without major depressive disorder, particularly for women, who had significant improvement across most outcome measures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdrZHNfd9FP7Vg90H21EOLACvtfcHk0lhu03b9A-IArg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXoslGgsbo%253D&md5=7ce74fa526755954bdd06000ea2e1e52</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1002%2Fart.20485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.20485%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DL.%2BM.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DCrofford%26aufirst%3DL.%2BJ.%26aulast%3DWohlreich%26aufirst%3DM.%26aulast%3DDetke%26aufirst%3DM.%2BJ.%26aulast%3DIyengar%26aufirst%3DS.%26aulast%3DGoldstein%26aufirst%3DD.%2BJ.%26atitle%3DA%2520double-blind%252C%2520multicenter%2520trial%2520comparing%2520duloxetine%2520with%2520placebo%2520in%2520the%2520treatment%2520of%2520fibromyalgia%2520patients%2520with%2520or%2520without%2520major%2520depressive%2520disorder%26jtitle%3DArthritis%2520Rheum.%26date%3D2004%26volume%3D50%26spage%3D2974%26epage%3D2984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Arnold, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchett, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Souza, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyengar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernicke, J. F.</span><span> </span><span class="NLM_article-title">A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2005&pages=5-15&author=L.+M.+Arnoldauthor=A.+Rosenauthor=Y.+L.+Pritchettauthor=D.+N.+D%E2%80%99Souzaauthor=D.+J.+Goldsteinauthor=S.+Iyengarauthor=J.+F.+Wernicke&title=A+randomized%2C+double-blind%2C+placebo-controlled+trial+of+duloxetine+in+the+treatment+of+women+with+fibromyalgia+with+or+without+major+depressive+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DL.%2BM.%26aulast%3DRosen%26aufirst%3DA.%26aulast%3DPritchett%26aufirst%3DY.%2BL.%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DD.%2BN.%26aulast%3DGoldstein%26aufirst%3DD.%2BJ.%26aulast%3DIyengar%26aufirst%3DS.%26aulast%3DWernicke%26aufirst%3DJ.%2BF.%26atitle%3DA%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%2520of%2520duloxetine%2520in%2520the%2520treatment%2520of%2520women%2520with%2520fibromyalgia%2520with%2520or%2520without%2520major%2520depressive%2520disorder%26jtitle%3DPain%26date%3D2005%26volume%3D119%26spage%3D5%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sayar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aksu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ak, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosun, M.</span><span> </span><span class="NLM_article-title">Venlafaxine treatment of fibromyalgia</span> <span class="citation_source-journal">Ann. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1561</span><span class="NLM_x">–</span> <span class="NLM_lpage">1565</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2003&pages=1561-1565&author=K.+Sayarauthor=G.+Aksuauthor=I.+Akauthor=M.+Tosun&title=Venlafaxine+treatment+of+fibromyalgia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSayar%26aufirst%3DK.%26aulast%3DAksu%26aufirst%3DG.%26aulast%3DAk%26aufirst%3DI.%26aulast%3DTosun%26aufirst%3DM.%26atitle%3DVenlafaxine%2520treatment%2520of%2520fibromyalgia%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2003%26volume%3D37%26spage%3D1561%26epage%3D1565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemrick-Luecke, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlkeld, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiligenstein, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehlert, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, K. W.</span><span> </span><span class="NLM_article-title">Atomoxetine increases extracellular levels of norepinephrine and dopamine in the prefrontal cortex of rat: a potential mechanism for efficacy in attention hyperactivity disorder</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=699-711&author=F.+P.+Bymasterauthor=J.+S.+Katnerauthor=D.+J.+Nelsonauthor=S.+K.+Hemrick-Lueckeauthor=P.+J.+Threlkeldauthor=J.+H.+Heiligensteinauthor=S.+M.+Morinauthor=D.+R.+Gehlertauthor=K.+W.+Perry&title=Atomoxetine+increases+extracellular+levels+of+norepinephrine+and+dopamine+in+the+prefrontal+cortex+of+rat%3A+a+potential+mechanism+for+efficacy+in+attention+hyperactivity+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DKatner%26aufirst%3DJ.%2BS.%26aulast%3DNelson%26aufirst%3DD.%2BJ.%26aulast%3DHemrick-Luecke%26aufirst%3DS.%2BK.%26aulast%3DThrelkeld%26aufirst%3DP.%2BJ.%26aulast%3DHeiligenstein%26aufirst%3DJ.%2BH.%26aulast%3DMorin%26aufirst%3DS.%2BM.%26aulast%3DGehlert%26aufirst%3DD.%2BR.%26aulast%3DPerry%26aufirst%3DK.%2BW.%26atitle%3DAtomoxetine%2520increases%2520extracellular%2520levels%2520of%2520norepinephrine%2520and%2520dopamine%2520in%2520the%2520prefrontal%2520cortex%2520of%2520rat%253A%2520a%2520potential%2520mechanism%2520for%2520efficacy%2520in%2520attention%2520hyperactivity%2520disorder%26jtitle%3DNeuropsychopharmacology%26date%3D2002%26volume%3D27%26spage%3D699%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Krell, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leuchter, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, M.</span><span> </span><span class="NLM_article-title">Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain</span> <span class="citation_source-journal">Psychosomatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=379-384&author=H.+V.+Krellauthor=A.+F.+Leuchterauthor=I.+A.+Cookauthor=M.+Abrams&title=Evaluation+of+reboxetine%2C+a+noradrenergic+antidepressant%2C+for+the+treatment+of+fibromyalgia+and+chronic+low+back+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrell%26aufirst%3DH.%2BV.%26aulast%3DLeuchter%26aufirst%3DA.%2BF.%26aulast%3DCook%26aufirst%3DI.%2BA.%26aulast%3DAbrams%26aufirst%3DM.%26atitle%3DEvaluation%2520of%2520reboxetine%252C%2520a%2520noradrenergic%2520antidepressant%252C%2520for%2520the%2520treatment%2520of%2520fibromyalgia%2520and%2520chronic%2520low%2520back%2520pain%26jtitle%3DPsychosomatics%26date%3D2005%26volume%3D46%26spage%3D379%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Berigan, T.</span><span> </span><span class="NLM_article-title">Use of atomoxetine adjunctively in fybromyalgia syndrome</span> <span class="citation_source-journal">Can. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">500</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=15362262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A280%3ADC%252BD2cvlsValsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2004&pages=499-500&author=T.+Berigan&title=Use+of+atomoxetine+adjunctively+in+fybromyalgia+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">The use of atomoxetine adjunctively in fibromyalgia syndrome</span></div><div class="casAuthors">Berigan Tim</div><div class="citationInfo"><span class="NLM_cas:title">Canadian journal of psychiatry. Revue canadienne de psychiatrie</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">499-500</span>
        ISSN:<span class="NLM_cas:issn">0706-7437</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTesu-fHiMb9besJRIHUP1ofW6udTcc2ebR5hcSn7kQI7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cvlsValsg%253D%253D&md5=531650ac7fbf1bbf281ea5dd4cb062b5</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerigan%26aufirst%3DT.%26atitle%3DUse%2520of%2520atomoxetine%2520adjunctively%2520in%2520fybromyalgia%2520syndrome%26jtitle%3DCan.%2520J.%2520Psychiatry%26date%3D2004%26volume%3D49%26spage%3D499%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Yardley, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husbands, G. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, Gary, Butch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bicksler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muth, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sielecki, A. R.</span><span> </span><span class="NLM_article-title">2-Phenyl-2-(1-hydroxylcycloalkyl)ethylamine derivatives: synthesis and antidepressant activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2899</span><span class="NLM_x">–</span> <span class="NLM_lpage">2905</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00172a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=2899-2905&author=J.+P.+Yardleyauthor=G.+E.+M.+Husbandsauthor=J.+Stack%2C+Gary%2C+Butchauthor=J.+Bickslerauthor=J.+A.+Moyerauthor=E.+A.+Muthauthor=T.+Andreeauthor=H.+Fletcherauthor=M.+N.+G.+Jamesauthor=A.+R.+Sielecki&title=2-Phenyl-2-%281-hydroxylcycloalkyl%29ethylamine+derivatives%3A+synthesis+and+antidepressant+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm00172a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00172a035%26sid%3Dliteratum%253Aachs%26aulast%3DYardley%26aufirst%3DJ.%2BP.%26aulast%3DHusbands%26aufirst%3DG.%2BE.%2BM.%26aulast%3DStack%252C%2BGary%252C%2BButch%26aufirst%3DJ.%26aulast%3DBicksler%26aufirst%3DJ.%26aulast%3DMoyer%26aufirst%3DJ.%2BA.%26aulast%3DMuth%26aufirst%3DE.%2BA.%26aulast%3DAndree%26aufirst%3DT.%26aulast%3DFletcher%26aufirst%3DH.%26aulast%3DJames%26aufirst%3DM.%2BN.%2BG.%26aulast%3DSielecki%26aufirst%3DA.%2BR.%26atitle%3D2-Phenyl-2-%25281-hydroxylcycloalkyl%2529ethylamine%2520derivatives%253A%2520synthesis%2520and%2520antidepressant%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D2899%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Mason, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deecher, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richmond, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahaney, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trybulski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneker, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span> </span><span class="NLM_article-title">Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1124%2Fjpet.107.125716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=17673606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynsbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2007&pages=720-729&author=J.+N.+Masonauthor=D.+C.+Deecherauthor=R.+L.+Richmondauthor=G.+Stackauthor=P.+E.+Mahaneyauthor=E.+J.+Trybulskiauthor=R.+C.+Winnekerauthor=R.+D.+Blakely&title=Desvenlafaxine+succinate+identifies+novel+antagonist+binding+determinants+in+the+human+norepinephrine+transporter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter</span></div><div class="casAuthors">Mason, John N.; Deecher, Darlene C.; Richmond, Rhonda L.; Stack, Gary; Mahaney, Paige E.; Trybulski, Eugene; Winneker, Richard C.; Blakely, Randy D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">720-729</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Desvenlafaxine succinate (DVS) is a recently introduced antagonist of the human norepinephrine and serotonin transporters (hNET and hSERT, resp.), currently in clin. development for use in the treatment of major depressive disorder and vasomotor symptoms assocd. with menopause.  Initial evaluation of the pharmacol. properties of DVS revealed significantly reduced potency for the hNET expressed in membranes compared with whole cells when competing for [3H]nisoxetine (NIS) binding.  Using hNET in transfected human embryonic kidney-293 cells, this difference in potency for DVS at sites labeled by [3H]NIS was found to distinguish DVS, the DVS analog rac-1-[1-(3-chloro-phenyl)-2-(4-methylpiperazin-1-yl)-ethyl]cyclohexanol (WY-46824), methylphenidate, and the cocaine analog 3β-(4-iodophenyl)tropane-2β-carboxylic acid Me ester (RTI-55) from other hNET antagonists, such as NIS, mazindol, tricyclic antidepressants, and cocaine.  These differences seem not to arise from prepn.-specific perturbations of ligand intrinsic affinity or antagonist-sp. surface trafficking but rather from protein conformational alterations that perturb the relationships between distinct hNET binding sites.  In an initial search for mol. features that differentially define antagonist binding determinants, we document that Val148 in hNET transmembrane domain 3 selectively disrupts NIS binding but not that of DVS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooe8l03U5I17Vg90H21EOLACvtfcHk0liRix9mjBAMMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynsbzM&md5=5e4e4e39e1fbf412fb6dd7af67fc33a1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.125716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.125716%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%2BN.%26aulast%3DDeecher%26aufirst%3DD.%2BC.%26aulast%3DRichmond%26aufirst%3DR.%2BL.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DMahaney%26aufirst%3DP.%2BE.%26aulast%3DTrybulski%26aufirst%3DE.%2BJ.%26aulast%3DWinneker%26aufirst%3DR.%2BC.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26atitle%3DDesvenlafaxine%2520succinate%2520identifies%2520novel%2520antagonist%2520binding%2520determinants%2520in%2520the%2520human%2520norepinephrine%2520transporter%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D323%26spage%3D720%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Reith, M. E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meisler, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sershen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lajtha, A.</span><span> </span><span class="NLM_article-title">Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1123</span><span class="NLM_x">–</span> <span class="NLM_lpage">1129</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1986&pages=1123-1129&author=M.+E.+A.+Reithauthor=B.+E.+Meislerauthor=H.+Sershenauthor=A.+Lajtha&title=Structural+requirements+for+cocaine+congeners+to+interact+with+dopamine+and+serotonin+uptake+sites+in+mouse+brain+and+to+induce+stereotyped+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReith%26aufirst%3DM.%2BE.%2BA.%26aulast%3DMeisler%26aufirst%3DB.%2BE.%26aulast%3DSershen%26aufirst%3DH.%26aulast%3DLajtha%26aufirst%3DA.%26atitle%3DStructural%2520requirements%2520for%2520cocaine%2520congeners%2520to%2520interact%2520with%2520dopamine%2520and%2520serotonin%2520uptake%2520sites%2520in%2520mouse%2520brain%2520and%2520to%2520induce%2520stereotyped%2520behavior%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1986%26volume%3D35%26spage%3D1123%26epage%3D1129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Madras, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahey, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canfield, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spealman, R. D.</span><span> </span><span class="NLM_article-title">Effects of cocaine and related drugs in nonhuman primates. I. [<sup>3</sup>H]Cocaine binding sites in caudate-putamen</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=2529364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADyaL1MXmtV2jur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1989&pages=131-141&author=B.+K.+Madrasauthor=M.+A.+Faheyauthor=J.+Borgmanauthor=D.+R.+Canfieldauthor=R.+D.+Spealman&title=Effects+of+cocaine+and+related+drugs+in+nonhuman+primates.+I.+%5B3H%5DCocaine+binding+sites+in+caudate-putamen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of cocaine and related drugs in nonhuman primates.  I.  [3H]Cocaine binding sites in caudate-putamen</span></div><div class="casAuthors">Madras, Bertha K.; Fahey, Michele A.; Bergman, Jack; Canfield, Don R.; Spealman, Roger D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-41</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Specific binding sites for [3H]cocaine were identified in caudate-putamen membranes prepd. from nonhuman primate brains (Macaca fascicularis and Saimiri sciureus).  Satn. of the sites was detd. in competition studies using a fixed concn. of [3H]cocaine (2.7 nM) and increasing concns. of unlabeled cocaine (1 pM-100 μM).  Computer resoln. of the shallow displacement curve (nH, 0.58) revealed that a 2-component binding model [Kd1, 19.2 nM, max. binding1 (Bmax1), 28.3 pmol/g of tissue; Kd2, 1120 nM, Bmax2, 431 pmol/g of tissue] was statistically preferred over a 1-component model (K50, 283 nM, Bmax, 471 pmol/g of tissue).  Binding of [3H]cocaine was NaCl-dependent, with specific binding reduced by 72% when NaCl (100 mM) was omitted from the incubation medium.  [3H]cocaine was displaced stereoselectively by the enantiomers of cocaine and by the diastereoisomers of cocaine and its phenyltropane analog.  Cocaine congeners displaced specifically bound [3H]cocaine with IC50 values ranging from 17 nM to >100 μM in the following rank order of potency: WIN 35,428 > WIN 35,065-2 > (-)-cocaine > WIN 35,981 > (-)-norcocaine > WIN 35,140 > (+)-cocaine, (+)-pseudococaine > 3α-tropanyl-1H-indolecarboxylic acid ester > 1αH-tropan-3-yl-3,5-dichlorobenzoate > benzoylecgonine, benzoylnorecgonine, and (-)-pseudococaine.  Several monoamine uptake inhibitors structurally unrelated to cocaine also displaced [3H]cocaine with IC50 values ranging from 1.6 nM to 50 μM.  The rank order of potency was: (±)-trans-3-(3',4'-dichlorophenyl)-N-methyl-1-indanamine > mazindol > nomifensine > methylphenidate, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl-4-(3-phenylpropyl)piperazine, N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine > (-)-cocaine > 1-amino-4-phenylbicyclo-[2,2,2]-octane > bupropion, nisoxetine > desipramine, talsupram > citalopram.  Other drugs, including the dopamine releasing agent (+)-amphetamine and the dopamine receptor agonists (-)-apomorphine, (+)-4-propyl-9-hydroxy-naphthoxazine, quinpirole, and SKF 38393 were weak displacers of [3H]cocaine.  Monoamine neurotransmitters were also relatively weak, but dopamine was considered more potent than either norepinephrine or serotonin.  The affinities of the cocaine congeners and other monoamine uptake inhibitors at [3H]cocaine binding sites correspond closely with their reported potencies for inhibiting uptake of dopamine (r, 0.93), but not norepinephrine or serotonin (r, 0.54 and 0.38, resp.).  The results are consistent with the view that [3H]cocaine binding sites in monkey caudate-putamen are assocd. with elements of the dopamine uptake system and mediate the inhibitory effects of cocaine on dopamine transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaAo6KhEy2t7Vg90H21EOLACvtfcHk0liRix9mjBAMMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXmtV2jur4%253D&md5=fa81bb26f5fbd9c460d2477d96980b6b</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMadras%26aufirst%3DB.%2BK.%26aulast%3DFahey%26aufirst%3DM.%2BA.%26aulast%3DBorgman%26aufirst%3DJ.%26aulast%3DCanfield%26aufirst%3DD.%2BR.%26aulast%3DSpealman%26aufirst%3DR.%2BD.%26atitle%3DEffects%2520of%2520cocaine%2520and%2520related%2520drugs%2520in%2520nonhuman%2520primates.%2520I.%2520%255B3H%255DCocaine%2520binding%2520sites%2520in%2520caudate-putamen%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1989%26volume%3D251%26spage%3D131%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Steru, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chermat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thierry, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, P.</span><span> </span><span class="NLM_article-title">The tail suspension test: a new method for screening antidepressants in mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1985&pages=367-370&author=L.+Steruauthor=R.+Chermatauthor=B.+Thierryauthor=P.+Simon&title=The+tail+suspension+test%3A+a+new+method+for+screening+antidepressants+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSteru%26aufirst%3DL.%26aulast%3DChermat%26aufirst%3DR.%26aulast%3DThierry%26aufirst%3DB.%26aulast%3DSimon%26aufirst%3DP.%26atitle%3DThe%2520tail%2520suspension%2520test%253A%2520a%2520new%2520method%2520for%2520screening%2520antidepressants%2520in%2520mice%26jtitle%3DPsychopharmacology%26date%3D1985%26volume%3D85%26spage%3D367%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Porsolt, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chermat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenegre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avril, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janvier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steru, L.</span><span> </span><span class="NLM_article-title">Use of the automated tail suspension test for the primary screening of psychotropic agents</span> <span class="citation_source-journal">Arch. Int. Pharmacodyn. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=2889430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADyaL2sXlsVKksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=1987&pages=11-30&author=R.+D.+Porsoltauthor=R.+Chermatauthor=A.+Lenegreauthor=I.+Avrilauthor=S.+Janvierauthor=L.+Steru&title=Use+of+the+automated+tail+suspension+test+for+the+primary+screening+of+psychotropic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Use of the automated tail suspension test for the primary screening of psychotropic agents</span></div><div class="casAuthors">Porsolt, R. D.; Chermat, R.; Lenegre, A.; Avril, I.; Janvier, S.; Steru, L.</div><div class="citationInfo"><span class="NLM_cas:title">Archives Internationales de Pharmacodynamie et de Therapie</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-30</span>CODEN:
                <span class="NLM_cas:coden">AIPTAK</span>;
        ISSN:<span class="NLM_cas:issn">0003-9780</span>.
    </div><div class="casAbstract">An animal model for screening psychotropic agents is described.  Mice, when suspended by the tail, will alternate between active attempts to escape and immobility.  A specially developed computerized device (ITEMATIC-TST) automatically measures the duration of immobility of 6 mice at one time and at the same time provides a measure of the energy expended by each animal, the power of the movements.  Use of these 2 parameters enables activity profiles to be generated which can distinguish different classes of psychotropic activity.  Immobility is decreased by antidepressants and psychostimulants, but increased by neuroleptics and minor tranquilizers.  Minor tranquilizers can be distinguished from neuroleptics in that they decrease the power of the movements, whereas neuroleptics are without effect on this parameter.  The present expts. examd. whether the activity profiles generated in this procedure could indeed be useful for primary psychotropic screening.  The results largely confirm the usefulness of this model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1DQphbIM5yLVg90H21EOLACvtfcHk0liRix9mjBAMMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlsVKksrk%253D&md5=266f283122e69a86186d304aa0f940cc</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPorsolt%26aufirst%3DR.%2BD.%26aulast%3DChermat%26aufirst%3DR.%26aulast%3DLenegre%26aufirst%3DA.%26aulast%3DAvril%26aufirst%3DI.%26aulast%3DJanvier%26aufirst%3DS.%26aulast%3DSteru%26aufirst%3DL.%26atitle%3DUse%2520of%2520the%2520automated%2520tail%2520suspension%2520test%2520for%2520the%2520primary%2520screening%2520of%2520psychotropic%2520agents%26jtitle%3DArch.%2520Int.%2520Pharmacodyn.%2520Ther.%26date%3D1987%26volume%3D288%26spage%3D11%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Teste, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinjard, P.</span><span> </span><span class="NLM_article-title">Electrotherapy in mice: dopaminergic and noradrenergic effects in the tail suspension test</span> <span class="citation_source-journal">Fundam. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=2341112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A280%3ADyaK3c3ls1SqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1990&pages=39-47&author=J.+F.+Testeauthor=I.+Martinauthor=P.+Rinjard&title=Electrotherapy+in+mice%3A+dopaminergic+and+noradrenergic+effects+in+the+tail+suspension+test"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Electrotherapy in mice: dopaminergic and noradrenergic effects in the Tail Suspension Test</span></div><div class="casAuthors">Teste J F; Martin I; Rinjard P</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & clinical pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-47</span>
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    </div><div class="casAbstract">The Tail Suspension Test (TST) is a psychotropic screening test which is used principally to detect antidepressant activity.  Electrotherapy (ECT) is used to treat depressions which are resistant to the usual antidepressant drugs and has proved to have a profile in the TST approaching that of antidepressants after treating mice at the rate of 2 shocks per day for 5 days.  The results of a single treatment were not statistically different from those of the control group, whereas single daily treatment for 5 days showed a reduction in immobility which did not differ significantly from the control group.  The reduction in immobility, induced by 5 days of ECT treatment twice daily, was antagonized by sulpiride and prazosin but not by yohimbine, methysergide, metergoline and DL propranolol.  The results suggest that electrotherapy leads to an increase in noradrenergic and dopaminergic activities expressed by a reduction in immobility in the TST.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAv6SAeOkkbIHWj6b1v8uTfW6udTcc2eYnzYHM-mG3zbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c3ls1SqtA%253D%253D&md5=ad81c4945c61ae070b06d6a749758024</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTeste%26aufirst%3DJ.%2BF.%26aulast%3DMartin%26aufirst%3DI.%26aulast%3DRinjard%26aufirst%3DP.%26atitle%3DElectrotherapy%2520in%2520mice%253A%2520dopaminergic%2520and%2520noradrenergic%2520effects%2520in%2520the%2520tail%2520suspension%2520test%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D1990%26volume%3D4%26spage%3D39%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cryan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mombereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassout, A.</span><span> </span><span class="NLM_article-title">The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2Fj.neubiorev.2005.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=15890404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFWlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2005&pages=571-625&author=J.+F.+Cryanauthor=C.+Mombereauauthor=A.+Vassout&title=The+tail+suspension+test+as+a+model+for+assessing+antidepressant+activity%3A+review+of+pharmacological+and+genetic+studies+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13dR"><div class="casContent"><span class="casTitleNuber">13d</span><div class="casTitle"><span class="NLM_cas:atitle">The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice</span></div><div class="casAuthors">Cryan, John F.; Mombereau, Cedric; Vassout, Annick</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience and Biobehavioral Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">571-625</span>CODEN:
                <span class="NLM_cas:coden">NBREDE</span>;
        ISSN:<span class="NLM_cas:issn">0149-7634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Since its introduction almost 20 years ago, the tail suspension test has become one of the most widely used models for assessing antidepressant-like activity in mice.  The test is based on the fact that animals subjected to the short-term, inescapable stress of being suspended by their tail, will develop an immobile posture.  Various antidepressant medications reverse the immobility and promote the occurrence of escape-related behavior.  This review focuses on the utility this test as part of a research program aimed at understanding the mechanism of action of antidepressants.  We discuss the inherent difficulties in modeling depression in rodents.  We describe how the tail suspension differs from the closely related forced swim test.  Further, we address some key issues assocd. with using the TST as a model of antidepressant action.  We discuss issues regarding whether it satisfies criteria to be a valid model for assessing depression-related behavioral traits.  We elaborate on the tests' ease of use, strain differences obsd. in the test and gender effects in the test.  We focus on the utility of the test for genetic anal.  Furthermore, we discuss the concept of whether immobility maybe a behavioral trait relevant to depression.  All of the available pharmacol. data using the test in genetically modified mice is collated.  Special attention is given to selective breeding programs such as the Rouen 'depressed' mice which have been bred for high and low immobility in the tail suspension test.  We provide an extensive pooling of the pharmacol. studies published to date using the test.  Finally, we provide novel pharmacol. validation of an automated system (Bioseb) for assessing immobility.  Taken together, we conclude that the tail suspension test is a useful test for assessing the behavioral effects of antidepressant compds. and other pharmacol. and genetic manipulations relevant to depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPJ-qSeXwP-LVg90H21EOLACvtfcHk0liK13ECa7HPLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFWlurk%253D&md5=e76fb149061f03dbe30fa94202d87b37</span></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2005.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2005.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DCryan%26aufirst%3DJ.%2BF.%26aulast%3DMombereau%26aufirst%3DC.%26aulast%3DVassout%26aufirst%3DA.%26atitle%3DThe%2520tail%2520suspension%2520test%2520as%2520a%2520model%2520for%2520assessing%2520antidepressant%2520activity%253A%2520review%2520of%2520pharmacological%2520and%2520genetic%2520studies%2520in%2520mice%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2005%26volume%3D29%26spage%3D571%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Ripoll, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dailly, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hascoet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourin, M.</span><span> </span><span class="NLM_article-title">Antidepressant-like effects in various mice strains in the tail suspension test</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2FS0166-4328%2803%2900034-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=12900045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFyisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2003&pages=193-200&author=N.+Ripollauthor=J.+P.+Davidauthor=E.+Daillyauthor=M.+Hascoetauthor=M.+Bourin&title=Antidepressant-like+effects+in+various+mice+strains+in+the+tail+suspension+test"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like effects in various mice strains in the tail suspension test</span></div><div class="casAuthors">Ripoll, Nadege; David, Denis Joseph Paul; Dailly, Eric; Hascoet, Martine; Bourin, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">193-200</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Several studies have reported rodent strain differences in the response to antidepressants in animal models of depression.  The aim of the present study was to investigate the potential contribution of genetic factors to antidepressant response in an animal model of depression: the tail suspension test (TST).  For this study 4 mice strains (Swiss and NMRI, 2 outbred strains and DBA/2 and C57BL/6J Rj, 2 inbred strains) were submitted to the TST after acute administration of 5 antidepressants: the tricyclic antidepressants (TCAs) imipramine and desipramine, the selective serotonin (5-HT) reuptake inhibitors (SSRIs) paroxetine and citalopram and the dopamine reuptake inhibitor bupropion.  The C57BL/6J Rj strain had a longer baseline immobility time in comparison to the other strains.  All antidepressants studied in this work decreased immobility time in the Swiss and C57BL/6J Rj strains.  However, the Swiss strain displayed greater sensitivity to citalopram (from 2 mg/kg) and C57BL/6J Rj to paroxetine (from 0.5 mg/kg).  This latter presented a greater size-effect with citalopram than with other strains and reached > 60% from 8 mg/kg.  Moreover the size-effect of desipramine, paroxetine, and bupropion in Swiss mice was greater than in the other strains in the TST.  The NMRI and DBA/2 mice only responded to 5-HT reuptake inhibitors, both selective (paroxetine, citalopram) or non-selective (imipramine).  The NMRI strain was more sensitive to imipramine and presented a size-effect (43% at 8 mg/kg) superior to those of other strains.  DBA/2 strain was more sensitive to citalopram than paroxetine and imipramine.  The authors' results suggest that response to an antidepressant treatment is under control of genetic factors and that the strain of mouse is an important parameter to consider.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRT0MS5Wb4lLVg90H21EOLACvtfcHk0liK13ECa7HPLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFyisrg%253D&md5=20e317b1c83b188a0c438f20d68ba750</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0166-4328%2803%2900034-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-4328%252803%252900034-2%26sid%3Dliteratum%253Aachs%26aulast%3DRipoll%26aufirst%3DN.%26aulast%3DDavid%26aufirst%3DJ.%2BP.%26aulast%3DDailly%26aufirst%3DE.%26aulast%3DHascoet%26aufirst%3DM.%26aulast%3DBourin%26aufirst%3DM.%26atitle%3DAntidepressant-like%2520effects%2520in%2520various%2520mice%2520strains%2520in%2520the%2520tail%2520suspension%2520test%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2003%26volume%3D143%26spage%3D193%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Siegmund, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadmus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, G.</span><span> </span><span class="NLM_article-title">A method for evaluating both non-narcotic and narcotic analgesics</span> <span class="citation_source-journal">Proc. Soc. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1957&pages=279-731&author=E.+Siegmundauthor=R.+Cadmusauthor=G.+Lu&title=A+method+for+evaluating+both+non-narcotic+and+narcotic+analgesics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiegmund%26aufirst%3DE.%26aulast%3DCadmus%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DG.%26atitle%3DA%2520method%2520for%2520evaluating%2520both%2520non-narcotic%2520and%2520narcotic%2520analgesics%26jtitle%3DProc.%2520Soc.%2520Exp.%2520Biol.%2520Med.%26date%3D1957%26volume%3D95%26spage%3D279%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhart, G. F.</span><span> </span><span class="NLM_article-title">Spinal serotonin receptors mediate descending facilitation of a nociceptive reflex from the nuclei reticualris gigantocellularis and gigantocellularis pars alpha in the rat</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">550</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2F0006-8993%2891%2990402-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=1888999" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=550&publication_year=1991&pages=35-48&author=M.+Zhouauthor=G.+F.+Gebhart&title=Spinal+serotonin+receptors+mediate+descending+facilitation+of+a+nociceptive+reflex+from+the+nuclei+reticualris+gigantocellularis+and+gigantocellularis+pars+alpha+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2891%2990402-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252891%252990402-H%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DGebhart%26aufirst%3DG.%2BF.%26atitle%3DSpinal%2520serotonin%2520receptors%2520mediate%2520descending%2520facilitation%2520of%2520a%2520nociceptive%2520reflex%2520from%2520the%2520nuclei%2520reticualris%2520gigantocellularis%2520and%2520gigantocellularis%2520pars%2520alpha%2520in%2520the%2520rat%26jtitle%3DBrain%2520Res.%26date%3D1991%26volume%3D550%26spage%3D35%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Holden, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proudfit, H. K.</span><span> </span><span class="NLM_article-title">Microinjection of morphine in the A7 catecholamine cell group produces opposing effects on nociception that are mediated by alpha1- and alpha2-adrenoceptors</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">990</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1999&pages=979-990&author=J.+E.+Holdenauthor=E.+J.+Schwartzauthor=H.+K.+Proudfit&title=Microinjection+of+morphine+in+the+A7+catecholamine+cell+group+produces+opposing+effects+on+nociception+that+are+mediated+by+alpha1-+and+alpha2-adrenoceptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolden%26aufirst%3DJ.%2BE.%26aulast%3DSchwartz%26aufirst%3DE.%2BJ.%26aulast%3DProudfit%26aufirst%3DH.%2BK.%26atitle%3DMicroinjection%2520of%2520morphine%2520in%2520the%2520A7%2520catecholamine%2520cell%2520group%2520produces%2520opposing%2520effects%2520on%2520nociception%2520that%2520are%2520mediated%2520by%2520alpha1-%2520and%2520alpha2-adrenoceptors%26jtitle%3DNeuroscience%26date%3D1999%26volume%3D91%26spage%3D979%26epage%3D990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gebhart, G.</span><span> </span><span class="NLM_article-title">Modulatory Effects of Descending Systems on Spinal Dorsal Horn Neurons</span>. In  <span class="citation_source-book">Spinal Afferent Processing</span>; <span class="NLM_contrib-group">Yaksh, T. L.</span>, Ed.; <span class="NLM_publisher-name">Plenum</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1986</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">391</span>− <span class="NLM_lpage">416</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&pages=391-416&author=G.+Gebhart&title=Spinal+Afferent+Processing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGebhart%26aufirst%3DG.%26atitle%3DModulatory%2520Effects%2520of%2520Descending%2520Systems%2520on%2520Spinal%2520Dorsal%2520Horn%2520Neurons%26btitle%3DSpinal%2520Afferent%2520Processing%26aulast%3DYaksh%26aufirst%3DT.%2BL.%26pub%3DPlenum%26date%3D1986%26spage%3D391%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fields, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinricher, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, P.</span><span> </span><span class="NLM_article-title">Neurotransmitters in nociceptive modulatory circuits</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1146%2Fannurev.ne.14.030191.001251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=1674413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADyaK3MXlt1Ohs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1991&pages=219-245&author=H.+L.+Fieldsauthor=M.+M.+Heinricherauthor=P.+Mason&title=Neurotransmitters+in+nociceptive+modulatory+circuits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotransmitters in nociceptive modulatory circuits</span></div><div class="casAuthors">Fields, Howard L.; Heinricher, Mary M.; Mason, Peggy</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">219-45</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    </div><div class="casAbstract">A review, with 169 refs.  The roles of enkephalin, excitatory amino acids, norepinephrine, neurotensin, and serotonin within the rostral ventromedial medulla (RVM) and in the dorsal horn region in the modulation of pain are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlF1JpMq9hU7Vg90H21EOLACvtfcHk0lj8YPT9XwS2Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlt1Ohs7c%253D&md5=3715cea898264507bbe171b2bbd31c90</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1146%2Fannurev.ne.14.030191.001251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.ne.14.030191.001251%26sid%3Dliteratum%253Aachs%26aulast%3DFields%26aufirst%3DH.%2BL.%26aulast%3DHeinricher%26aufirst%3DM.%2BM.%26aulast%3DMason%26aufirst%3DP.%26atitle%3DNeurotransmitters%2520in%2520nociceptive%2520modulatory%2520circuits%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1991%26volume%3D14%26spage%3D219%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Fields, H. L.; Basbaum, A.</span><span> </span><span class="NLM_article-title">Central Nervous System Mechanisms of Pain Modulation</span>. In  <span class="citation_source-book">Textbook of Pain</span>; <span class="NLM_contrib-group">Wall, P. D.; Melzack, R.</span>, Eds.; <span class="NLM_publisher-name">Churchill Livingstone</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">1999</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">309</span>− <span class="NLM_lpage">329</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=309-329&author=H.+L.+Fields&author=A.+Basbaumauthor=P.+D.+Wall&author=R.+Melzack&title=Textbook+of+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFields%26aufirst%3DH.%2BL.%26atitle%3DCentral%2520Nervous%2520System%2520Mechanisms%2520of%2520Pain%2520Modulation%26btitle%3DTextbook%2520of%2520Pain%26aulast%3DWall%26aufirst%3DP.%2BD.%26pub%3DChurchill%2520Livingstone%26date%3D1999%26spage%3D309%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">Descending control of pain</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2FS0301-0082%2802%2900009-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=12034378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVarsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2002&pages=355-474&author=M.+J.+Millan&title=Descending+control+of+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Descending control of pain</span></div><div class="casAuthors">Millan, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">355-474</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Upon receipt in the dorsal horn (DH) of the spinal cord, nociceptive (pain-signalling) information from the viscera, skin and other organs is subject to extensive processing by a diversity of mechanisms, certain of which enhance, and certain of which inhibit, its transfer to higher centers.  In this regard, a network of descending pathways projecting from cerebral structures to the DH plays a complex and crucial role.  Specific centrifugal pathways either suppress (descending inhibition) or potentiate (descending facilitation) passage of nociceptive messages to the brain.  Engagement of descending inhibition by the opioid analgesic, morphine, fulfils an important role in its pain-relieving properties, while induction of analgesia by the adrenergic agonist, clonidine, reflects actions at α2-adrenoceptors (α2-ARs) in the DH normally recruited by descending pathways.  However, opioids and adrenergic agents exploit but a tiny fraction of the vast panoply of mechanisms now known to be involved in the induction and/or expression of descending controls.  For example, no drug interfering with descending facilitation is currently available for clin. use.  The present review focuses on: (1) the organization of descending pathways and their pathophysiol. significance; (2) the role of individual transmitters and specific receptor types in the modulation and expression of mechanisms of descending inhibition and facilitation and (3) the advantages and limitations of established and innovative analgesic strategies which act by manipulation of descending controls.  Knowledge of descending pathways has increased exponentially in recent years, so this is an opportune moment to survey their operation and therapeutic relevance to the improved management of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgzpGfk_Zv97Vg90H21EOLACvtfcHk0lj8YPT9XwS2Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVarsr0%253D&md5=9826f6eb6f47fb3e9d663adf496f5456</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2802%2900009-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252802%252900009-6%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DDescending%2520control%2520of%2520pain%26jtitle%3DProg.%2520Neurobiol.%26date%3D2002%26volume%3D66%26spage%3D355%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Leventhal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, K. E.</span><span> </span><span class="NLM_article-title">Differential and synergistic effects of selective norepinephrine and serotonin reuptake inhibitors in rodent models of pain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">1178</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1124%2Fjpet.106.109728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=17142646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1Wgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=1178-1186&author=L.+Leventhalauthor=V.+Smithauthor=G.+Hornbyauthor=T.+H.+Andreeauthor=M.+R.+Brandtauthor=K.+E.+Rogers&title=Differential+and+synergistic+effects+of+selective+norepinephrine+and+serotonin+reuptake+inhibitors+in+rodent+models+of+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Differential and synergistic effects of selective norepinephrine and serotonin reuptake inhibitors in rodent models of pain</span></div><div class="casAuthors">Leventhal, Liza; Smith, Valerie; Hornby, Geoffrey; Andree, Terrance H.; Brandt, Michael R.; Rogers, Kathryn E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1178-1185</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">There is increasing recognition that norepinephrine (NE) and serotonin (5-HT) reuptake inhibitors (NRIs and SRIs) are efficacious in treating some types of pain.  To date, studies have not systematically evaluated the relative activity at the NE and/or 5-HT transporter required for maximal efficacy in rodent pain models.  Known selective NE and 5-HT reuptake inhibitors reboxetine, desipramine, fluoxetine, and paroxetine were evaluated in both in vitro and in vivo assays.  Using the spinal nerve ligation model of neuropathic pain, the compds. differentially reversed tactile allodynia.  Evaluation of a broader spectrum of reuptake inhibitors in the para-phenylquinone (PPQ)-induced abdominal constriction model, a model of acute visceral pain, demonstrated that both the SRIs and the NRIs significantly blocked abdominal constrictions.  However, the magnitude of this effect was greater following treatment with compds. having greater affinity for NRI compared with SRI affinity.  In addn., isobolog. analyses indicated significant synergistic effects for all combinations of desipramine and fluoxetine in the PPQ model of visceral pain.  Collectively, the present results support the hypothesis that compds. with greater NRI activity should be more effective for the treatment of pain than compds. having only SRI activity, and this hypothesis is also supported by clin. data.  These studies also suggest that the potency and effectiveness of NRIs might be enhanced by the presence of 5-HT activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqnBpxtWsSO7Vg90H21EOLACvtfcHk0lj8YPT9XwS2Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1Wgtbc%253D&md5=dd017f412b5f784c2d6492596d8371b5</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.109728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.109728%26sid%3Dliteratum%253Aachs%26aulast%3DLeventhal%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DV.%26aulast%3DHornby%26aufirst%3DG.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DBrandt%26aufirst%3DM.%2BR.%26aulast%3DRogers%26aufirst%3DK.%2BE.%26atitle%3DDifferential%2520and%2520synergistic%2520effects%2520of%2520selective%2520norepinephrine%2520and%2520serotonin%2520reuptake%2520inhibitors%2520in%2520rodent%2520models%2520of%2520pain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D1178%26epage%3D1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Berendsen, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weekers, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kloosterboer, H. J.</span><span> </span><span class="NLM_article-title">Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">419</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2FS0014-2999%2801%2900966-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=11348629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtlChtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2001&pages=47-54&author=H.+H.+Berendsenauthor=A.+H.+Weekersauthor=H.+J.+Kloosterboer&title=Effect+of+tibolone+and+raloxifene+on+the+tail+temperature+of+oestrogen-deficient+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats</span></div><div class="casAuthors">Berendsen, H. H. G.; Weekers, A. H. J.; Kloosterboer, H. J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-54</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Estradiol, clonidine, tibolone and raloxifene were tested for their effects on the tail temp. of estrogen deficient rats, a potential new model that can be used to test compds. that may be of use in the treatment of hot flushes in humans.  Rats underwent ovariectomies or sham operations and their tail temp. and phys. activity were measured telemetrically.  Estrogen depletion affected tail temp. in the rats' active, but not their resting phase.  During the transition from the resting to the active phase, tail temp. in normal rats dropped by about 6, but only by approx. 1 after ovariectomy.  Treatment of the ovariectomized rats with estrogen, clonidine or tibolone dose-dependently restored the drop in tail temp.  However, raloxifene did not change the tail temp. of ovariectomized rats.  Thus, tibolone and raloxifene have different effects on the temp. regulation in the tail.  This method of measuring tail temp. free of stress in ovariectomized rats may serve as a useful procedure for selecting compds. that are of potential use in the treatment of hot flushes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKjW2gIyOPH7Vg90H21EOLACvtfcHk0liBjiLOUz16tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtlChtLY%253D&md5=b83ee7386c42053956d0a0471c0dba5a</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2801%2900966-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252801%252900966-9%26sid%3Dliteratum%253Aachs%26aulast%3DBerendsen%26aufirst%3DH.%2BH.%26aulast%3DWeekers%26aufirst%3DA.%2BH.%26aulast%3DKloosterboer%26aufirst%3DH.%2BJ.%26atitle%3DEffect%2520of%2520tibolone%2520and%2520raloxifene%2520on%2520the%2520tail%2520temperature%2520of%2520oestrogen-deficient%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D419%26spage%3D47%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sipe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leventhal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burroughs, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosmi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deecher, D. C.</span><span> </span><span class="NLM_article-title">Serotonin 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1028</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2Fj.brainres.2004.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=15527744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsFSrtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1028&publication_year=2004&pages=191-202&author=K.+Sipeauthor=L.+Leventhalauthor=K.+Burroughsauthor=S.+Cosmiauthor=G.+H.+Johnstonauthor=D.+C.+Deecher&title=Serotonin+2A+receptors+modulate+tail-skin+temperature+in+two+rodent+models+of+estrogen+deficiency-related+thermoregulatory+dysfunction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction</span></div><div class="casAuthors">Sipe, Kimberly; Leventhal, Liza; Burroughs, Kevin; Cosmi, Scott; Johnston, Grace H.; Deecher, Darlene C.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1028</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">191-202</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Menopause-assocd. thermoregulatory dysfunction, including hot flushes and night sweats, is effectively treated by hormonal therapies that include estrogens.  Evidence suggests that estrogen regulates serotonin 2A (5-HT2A) receptor expression and that 5-HT2A receptors are involved in thermoregulation.  Therefore, the role of 5-HT2A receptors in thermoregulation was assessed in two rat models of ovariectomy-induced thermoregulatory dysfunction.  The first model is based on measurement of the tail-skin temp. (TST) increase following naloxone-induced withdrawal in morphine-dependent ovariectomized (OVX) rats (MD model), while the second model relies on telemetric assessment of diurnal TST changes in ovariectomized rats (telemetry model).  Treatment with a 5-HT2A/2C receptor agonist, (-)-2,5-dimethoxy-4-iodoamphetamine hydrochloride (DOI), prevented the naloxone-induced TST increase in the MD model and restored normal active-phase TST in the telemetry model.  The selective 5-HT2A receptor antagonist, MDL-100907, had no effect on the naloxone-induced flush when administered alone in the MD model, but it decreased DOI's ability to abate the flush.  In the telemetry model, MDL-100907 attenuated the DOI-induced decrease in active-phase TST.  Interestingly, MDL-100907 increased TST in both models when given alone, with the TST increase occurring prior to the naloxone-induced flush in the MD model.  To evaluate the role of central nervous system (CNS) 5-HT2A receptors in TST regulation, DOI was administered in combination with a known peripheral 5-HT2A/2C receptor antagonist, xylamidine, in the MD model.  Xylamidine had no effect on DOI's ability to abate the naloxone-induced flush.  These results indicate that activation of central 5-HT2A receptors restores temp. regulation in two rodent models of ovariectomy-induced thermoregulatory dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLGpyDIO6zFrVg90H21EOLACvtfcHk0liBjiLOUz16tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsFSrtbs%253D&md5=c02dd86937455c1da8b0ed27917aab8c</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2004.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2004.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DSipe%26aufirst%3DK.%26aulast%3DLeventhal%26aufirst%3DL.%26aulast%3DBurroughs%26aufirst%3DK.%26aulast%3DCosmi%26aufirst%3DS.%26aulast%3DJohnston%26aufirst%3DG.%2BH.%26aulast%3DDeecher%26aufirst%3DD.%2BC.%26atitle%3DSerotonin%25202A%2520receptors%2520modulate%2520tail-skin%2520temperature%2520in%2520two%2520rodent%2520models%2520of%2520estrogen%2520deficiency-related%2520thermoregulatory%2520dysfunction%26jtitle%3DBrain%2520Res.%26date%3D2004%26volume%3D1028%26spage%3D191%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Deecher, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfinito, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leventhal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosmi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchenthaler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneker, R.</span><span> </span><span class="NLM_article-title">Alleviation of thermoregulatory dysfunction with the new serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized rodent models</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">1376</span><span class="NLM_x">–</span> <span class="NLM_lpage">1383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2007&pages=1376-1383&author=D.+C.+Deecherauthor=P.+Alfinitoauthor=L.+Leventhalauthor=G.+H.+Johnstonauthor=S.+Cosmiauthor=I.+Merchenthalerauthor=R.+Winneker&title=Alleviation+of+thermoregulatory+dysfunction+with+the+new+serotonin+and+norepinephrine+reuptake+inhibitor+desvenlafaxine+succinate+in+ovariectomized+rodent+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeecher%26aufirst%3DD.%2BC.%26aulast%3DAlfinito%26aufirst%3DP.%26aulast%3DLeventhal%26aufirst%3DL.%26aulast%3DJohnston%26aufirst%3DG.%2BH.%26aulast%3DCosmi%26aufirst%3DS.%26aulast%3DMerchenthaler%26aufirst%3DI.%26aulast%3DWinneker%26aufirst%3DR.%26atitle%3DAlleviation%2520of%2520thermoregulatory%2520dysfunction%2520with%2520the%2520new%2520serotonin%2520and%2520norepinephrine%2520reuptake%2520inhibitor%2520desvenlafaxine%2520succinate%2520in%2520ovariectomized%2520rodent%2520models%26jtitle%3DEndocrinology%26date%3D2007%26volume%3D148%26spage%3D1376%26epage%3D1383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maswood, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfinito, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosmi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leventhal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deecher, D. C.</span><span> </span><span class="NLM_article-title">Evalulation of the selective serotonin reuptake inhibitor, fluoxetine, in ovariectomized (OVX) rat models of temperature regulation</span> <span class="citation_source-journal">Neuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2006&pages=330-338&author=N.+Maswoodauthor=P.+D.+Alfinitoauthor=S.+Cosmiauthor=L.+Leventhalauthor=G.+H.+Johnstonauthor=D.+C.+Deecher&title=Evalulation+of+the+selective+serotonin+reuptake+inhibitor%2C+fluoxetine%2C+in+ovariectomized+%28OVX%29+rat+models+of+temperature+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaswood%26aufirst%3DN.%26aulast%3DAlfinito%26aufirst%3DP.%2BD.%26aulast%3DCosmi%26aufirst%3DS.%26aulast%3DLeventhal%26aufirst%3DL.%26aulast%3DJohnston%26aufirst%3DG.%2BH.%26aulast%3DDeecher%26aufirst%3DD.%2BC.%26atitle%3DEvalulation%2520of%2520the%2520selective%2520serotonin%2520reuptake%2520inhibitor%252C%2520fluoxetine%252C%2520in%2520ovariectomized%2520%2528OVX%2529%2520rat%2520models%2520of%2520temperature%2520regulation%26jtitle%3DNeuroendocrinology%26date%3D2006%26volume%3D85%26spage%3D330%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Pawlyk, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosmi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfinito, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maswood, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deecher, D. C.</span><span> </span><span class="NLM_article-title">Effects of the 5-HT2A antagonist mirtazapine in rat models of thermoregulation</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1123</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2Fj.brainres.2006.09.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=17067560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eksrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1123&publication_year=2006&pages=135-144&author=A.+C.+Pawlykauthor=S.+Cosmiauthor=P.+D.+Alfinitoauthor=N.+Maswoodauthor=D.+C.+Deecher&title=Effects+of+the+5-HT2A+antagonist+mirtazapine+in+rat+models+of+thermoregulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the 5-HT2A antagonist mirtazapine in rat models of thermoregulation</span></div><div class="casAuthors">Pawlyk, Aaron C.; Cosmi, Scott; Alfinito, Peter D.; Maswood, Navin; Deecher, Darlene C.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1123</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">135-144</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Thermoregulation is a complex intercommunicative function requiring coordination between core body temp. (CBT), the central nervous system, and peripheral vasculature.  In menopausal women, dysregulation of thermoregulatory mechanisms leads to hot flushes and night sweats.  A previous study in ovariectomized (OVX) rats has suggested that mirtazapine can alleviate thermoregulatory dysfunction by blocking 5-HT2A receptor signaling.  This is in opposition to other work in which 5-HT2A receptor blockade appeared to exacerbate thermoregulatory dysfunction in OVX rats.  Thus, the goals of the present study were to reexamine the effects of mirtazapine on temp. regulation in OVX rat models and explore further the role of 5-HT2A receptor blockade.  Mirtazapine exhibited potent functional antagonism (EC50 = 0.62 nM) at the cloned human 5-HT2A receptor.  In the morphine-dependent model of thermoregulatory dysfunction, mirtazapine (10 mg/kg, i.p.) induced an increase in tail-skin temp. (TST) prior to naloxone administration.  In the telemetry model, mirtazapine (0.3-3 mg/kg, i.p.) caused an increase in TST.  However, at the highest dose tested (10 mg/kg, i.p.), mirtazapine induced a small but significant decrease in TST followed by an increase in TST.  To examine this finding further, mirtazapine's effect on CBT was detd.  Administration of mirtazapine (1-3 mg/kg, i.p.) resulted in a slight decrease in CBT but at the 10 mg/kg dose a dramatic decrease (- 3.6°) in CBT was obsd.  These data support the concept that 5-HT2A receptors play a role in temp. regulation but that functional blockade of these receptors by mirtazapine is not a likely mechanism for restoring thermoregulatory processes in OVX rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUCakZiyPqdbVg90H21EOLACvtfcHk0lh2mXHtrQbdZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eksrzE&md5=3ded0feab3044de87f60d3e5e8f7cb3f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2006.09.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2006.09.050%26sid%3Dliteratum%253Aachs%26aulast%3DPawlyk%26aufirst%3DA.%2BC.%26aulast%3DCosmi%26aufirst%3DS.%26aulast%3DAlfinito%26aufirst%3DP.%2BD.%26aulast%3DMaswood%26aufirst%3DN.%26aulast%3DDeecher%26aufirst%3DD.%2BC.%26atitle%3DEffects%2520of%2520the%25205-HT2A%2520antagonist%2520mirtazapine%2520in%2520rat%2520models%2520of%2520thermoregulation%26jtitle%3DBrain%2520Res.%26date%3D2006%26volume%3D1123%26spage%3D135%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Pacholczyk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, S. G.</span><span> </span><span class="NLM_article-title">Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1038%2F350350a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=2008212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADyaK3MXlsFaiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1991&pages=350-354&author=T.+Pacholczykauthor=R.+D.+Blakelyauthor=S.+G.+Amara&title=Expression+cloning+of+a+cocaine-+and+antidepressant-sensitive+human+noradrenaline+transporter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter</span></div><div class="casAuthors">Pacholczyk, Tadeusz; Blakely, Randy D.; Amara, Susan G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">6316</span>),
    <span class="NLM_cas:pages">350-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">At most synapses, chem. signalling is terminated by a rapid reaccumulation of neurotransmitter into presynaptic terminals.  Uptake systems for the biogenic amines are the initial site of action for therapeutic antidepressants and drugs such as cocaine and the amphetamines.  A cDNA clone encoding a human noradrenaline transporter was isolated.  The cDNA sequence predicts a protein of 617 amino acids, with 12-13 highly hydrophobic regions compatible with membrane-spanning domains.  Expression of the cDNA clone in transfected HeLa cells indicates that noradrenaline transport activity is sodium-dependent and sensitive to selective noradrenaline transport inhibitors.  Transporter RNA is localized to the brainstem and the adrenal gland.  The predicted protein sequence demonstrates significant amino-acid identity with the Na+/γ-aminobutyric acid transporter, thus identifying a new gene family for neurotransmitter transporter proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8wD9ty6pC27Vg90H21EOLACvtfcHk0lh2mXHtrQbdZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsFaiurg%253D&md5=1362c3278dbb943e28a0b6e3819652df</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2F350350a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F350350a0%26sid%3Dliteratum%253Aachs%26aulast%3DPacholczyk%26aufirst%3DT.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26aulast%3DAmara%26aufirst%3DS.%2BG.%26atitle%3DExpression%2520cloning%2520of%2520a%2520cocaine-%2520and%2520antidepressant-sensitive%2520human%2520noradrenaline%2520transporter%26jtitle%3DNature%26date%3D1991%26volume%3D350%26spage%3D350%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Ramamoorthy, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamoorthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papapetropoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catravas, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leibach, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganapathy, V.</span><span> </span><span class="NLM_article-title">Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in choriocarcinoma cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">17189</span><span class="NLM_x">–</span> <span class="NLM_lpage">17195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=17189-17195&author=J.+D.+Ramamoorthyauthor=S.+Ramamoorthyauthor=A.+Papapetropoulosauthor=J.+D.+Catravasauthor=F.+H.+Leibachauthor=V.+Ganapathy&title=Cyclic+AMP-independent+up-regulation+of+the+human+serotonin+transporter+by+staurosporine+in+choriocarcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamamoorthy%26aufirst%3DJ.%2BD.%26aulast%3DRamamoorthy%26aufirst%3DS.%26aulast%3DPapapetropoulos%26aufirst%3DA.%26aulast%3DCatravas%26aufirst%3DJ.%2BD.%26aulast%3DLeibach%26aufirst%3DF.%2BH.%26aulast%3DGanapathy%26aufirst%3DV.%26atitle%3DCyclic%2520AMP-independent%2520up-regulation%2520of%2520the%2520human%2520serotonin%2520transporter%2520by%2520staurosporine%2520in%2520choriocarcinoma%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D17189%26epage%3D17195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Pristupa, Z. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niznik, H. B.</span><span> </span><span class="NLM_article-title">Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [<sup>3</sup>H]WIN 35,428 and [<sup>3</sup>H]GBR 12,935 binding</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=8302271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=125-35&author=Z.+B.+Pristupaauthor=J.+M.+Wilsonauthor=B.+J.+Hoffmanauthor=S.+J.+Kishauthor=H.+B.+Niznik&title=Pharmacological+heterogeneity+of+the+cloned+and+native+human+dopamine+transporter%3A+disassociation+of+%5B3H%5DWIN+35%2C428+and+%5B3H%5DGBR+12%2C935+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding</span></div><div class="casAuthors">Pristupa, Zdenek B.; Wilson, Julie M.; Hoffman, Beth J.; Kish, Stephen J.; Niznik, Hyman B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-35</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Controversy exists as to whether the functional state of the dopamine (DA) transporter is identical to sites mediating the specific binding of selective DA transporter radioligands.  Therefore, the authors compared the pharmacol. profile of numerous dopamine transport substrates and inhibitors on [3H]DA uptake with the binding of [3H]WIN 35,428 and [3H]GBR 12,935 to COS-7 cells transiently expressing the cloned human DA transporter.  [3H]DA uptake and [3H]WIN 35,428 binding was specific, saturable, and to a single class of binding sites with an estd. Km/Vmax of ∼2 μM and 6 pmol/min/105 cells for DA uptake and Kd/Bmax values of ∼10 nM and 113 fmol/105 cells for [3H]WIN 35,428.  [3H]DA uptake was inhibited in a concn.-dependent and uniphasic manner by dopaminergic agents with an appropriate rank order of potency for the DA transporter.  Although most uptake blockers inhibited [3H]WIN 35,428 binding in a uniphasic manner, WIN 35,428, Lu 19,005, D-amphetamine, and DA clearly displayed the presence of both high and low affinity components.  Comparison of the Ki values for the inhibition of [3H]DA uptake with [3H]WIN 35,428 binding reveals that, for uptake blockers and D-amphetamine, it is the high affinity component that shares pharmacol. identity with effects on DA uptake (r = 0.9985), whereas for DA it is the low affinity site.  In striking contrast, however, [3H]GBR 12,935 binding to COS-7 cells could not be made to exhibit a pharmacol. profile indicative of the DA transporter and suggests that the site regulating functional [3H]DA uptake may not be identical with sites labeled by [3H]GBR 12,935 in these cells.  Moreover, these sites appear unrelated to those previously described in native membranes as "piperazine acceptor" or P 450 proteins.  Comparison of Ki values and rank order of potency for the inhibition of [3H]WIN 35,428 or [3H]GBR 12,935 binding to human caudate membranes reveals pharmacol. homol., but not identity, with that of the cloned DA uptake process.  Taken together, these data suggest that 1) [3H]WIN 35,428 recognizes two sites of the DA transporter, of which only one appears to represent the functional state of the protein, and 2) [3H]WIN 35,428 and [3H]GBR 12,935 do not appear to bind the same functional form/state of the DA transporter.  Whether the nonidentity of binding sites is a manifestation of some post-translational regulatory event (e.g., phosphorylation/accessory binding protein) or caused by the existence of multiple mol. forms of the DA transporter is currently unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU2Vc8HuOAsLVg90H21EOLACvtfcHk0lh2mXHtrQbdZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFemu7c%253D&md5=a6ce271aad17d6f7f282bd716bbd1ddf</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPristupa%26aufirst%3DZ.%2BB.%26aulast%3DWilson%26aufirst%3DJ.%2BM.%26aulast%3DHoffman%26aufirst%3DB.%2BJ.%26aulast%3DKish%26aufirst%3DS.%2BJ.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26atitle%3DPharmacological%2520heterogeneity%2520of%2520the%2520cloned%2520and%2520native%2520human%2520dopamine%2520transporter%253A%2520disassociation%2520of%2520%255B3H%255DWIN%252035%252C428%2520and%2520%255B3H%255DGBR%252012%252C935%2520binding%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D45%26spage%3D125%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d','cit1e'],'ref2':['cit2'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6a','cit6b'],'ref7':['cit7a','cit7b','cit7c'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13a','cit13b','cit13c','cit13d'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':['cit17a','cit17b','cit17c','cit17d'],'ref18':['cit18'],'ref19':['cit19a','cit19b'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yi-Wen Liu, Zhuo-Ya Mao, Xiao-Di Nie, Chang-Mei Si, Bang-Guo Wei, <span class="NLM_string-name hlFld-ContribAuthor">Guo-Qiang Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Approach to Tertiary-Type β-Hydroxyl Carboxamides Through Sc(OTf)3-Catalyzed Addition of Ynamides and Ketones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (24)
                                     , 16254-16261. <a href="https://doi.org/10.1021/acs.joc.9b02854" title="DOI URL">https://doi.org/10.1021/acs.joc.9b02854</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b02854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b02854%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DApproach%252Bto%252BTertiary-Type%252B%2525CE%2525B2-Hydroxyl%252BCarboxamides%252BThrough%252BSc%252528OTf%2525293-Catalyzed%252BAddition%252Bof%252BYnamides%252Band%252BKetones%26aulast%3DLiu%26aufirst%3DYi-Wen%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20102019%26date%3D12122019%26date%3D28112019%26volume%3D84%26issue%3D24%26spage%3D16254%26epage%3D16261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  O’Neill</span>, <span class="hlFld-ContribAuthor ">Adedayo  Adedoyin</span>, <span class="hlFld-ContribAuthor ">Jenifer A.  Bray</span>, <span class="hlFld-ContribAuthor ">Darlene C.  Deecher</span>, <span class="hlFld-ContribAuthor ">Andrew  Fensome</span>, <span class="hlFld-ContribAuthor ">Joel A.  Goldberg</span>, <span class="hlFld-ContribAuthor ">Jim  Harrison</span>, <span class="hlFld-ContribAuthor ">Liza  Leventhal</span>, <span class="hlFld-ContribAuthor ">Charles  Mann</span>, <span class="hlFld-ContribAuthor ">Lilly  Mark</span>, <span class="hlFld-ContribAuthor ">Lisa  Nogle</span>, <span class="hlFld-ContribAuthor ">Nicole R.  Sullivan</span>, <span class="hlFld-ContribAuthor ">Taylor B.  Spangler</span>, <span class="hlFld-ContribAuthor ">Eugene A.  Terefenko</span>, <span class="hlFld-ContribAuthor ">Eugene J.  Trybulski</span>, <span class="hlFld-ContribAuthor ">Albert J.  Uveges</span>, <span class="hlFld-ContribAuthor ">An  Vu</span>, <span class="hlFld-ContribAuthor ">Garth T.  Whiteside</span>, and <span class="hlFld-ContribAuthor ">Puwen  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (19)
                                     , 6824-6831. <a href="https://doi.org/10.1021/jm200733r" title="DOI URL">https://doi.org/10.1021/jm200733r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200733r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200733r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BSelective%252BNorepinephrine%252BInhibitors%25253A%252B1-%2525282-Morpholin-2-ylethyl%252529-3-aryl-1%25252C3-dihydro-2%25252C1%25252C3-benzothiadiazole%252B2%25252C2-Dioxides%252B%252528WYE-114152%252529%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DDavid%2BJ.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D08062011%26date%3D14092011%26date%3D13102011%26volume%3D54%26issue%3D19%26spage%3D6824%26epage%3D6831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  O’Neill</span>, <span class="hlFld-ContribAuthor ">Adedayo  Adedoyin</span>, <span class="hlFld-ContribAuthor ">Peter D.  Alfinito</span>, <span class="hlFld-ContribAuthor ">Jenifer A.  Bray</span>, <span class="hlFld-ContribAuthor ">Scott  Cosmi</span>, <span class="hlFld-ContribAuthor ">Darlene C.  Deecher</span>, <span class="hlFld-ContribAuthor ">Andrew  Fensome</span>, <span class="hlFld-ContribAuthor ">Jim  Harrison</span>, <span class="hlFld-ContribAuthor ">Liza  Leventhal</span>, <span class="hlFld-ContribAuthor ">Charles  Mann</span>, <span class="hlFld-ContribAuthor ">Casey C.  McComas</span>, <span class="hlFld-ContribAuthor ">Nicole R.  Sullivan</span>, <span class="hlFld-ContribAuthor ">Taylor B.  Spangler</span>, <span class="hlFld-ContribAuthor ">Albert J.  Uveges</span>, <span class="hlFld-ContribAuthor ">Eugene J.  Trybulski</span>, <span class="hlFld-ContribAuthor ">Garth T.  Whiteside</span> and <span class="hlFld-ContribAuthor ">Puwen  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Selective Norepinephrine Reuptake Inhibitors: 4-[3-Aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (11)
                                     , 4511-4521. <a href="https://doi.org/10.1021/jm100053t" title="DOI URL">https://doi.org/10.1021/jm100053t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100053t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100053t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BSelective%252BNorepinephrine%252BReuptake%252BInhibitors%25253A%252B4-%25255B3-Aryl-2%25252C2-dioxido-2%25252C1%25252C3-benzothiadiazol-1%2525283H%252529-yl%25255D-1-%252528methylamino%252529butan-2-ols%252B%252528WYE-103231%252529%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DDavid%2BJ.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D14012010%26date%3D12052010%26date%3D10062010%26volume%3D53%26issue%3D11%26spage%3D4511%26epage%3D4521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lori K.  Gavrin</span>, <span class="hlFld-ContribAuthor ">Paige E.  Mahaney</span>, <span class="hlFld-ContribAuthor ">Douglas  Jenkins</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Nogle</span>, <span class="hlFld-ContribAuthor ">Cheryl A.  Mugford</span>, <span class="hlFld-ContribAuthor ">Christine  Huselton</span>, <span class="hlFld-ContribAuthor ">Jennifer  Leiter</span>, <span class="hlFld-ContribAuthor ">Grace H.  Johnston</span>, <span class="hlFld-ContribAuthor ">Jenifer A.  Bray</span>, <span class="hlFld-ContribAuthor ">Kevin D.  Burroughs</span>, <span class="hlFld-ContribAuthor ">Scott A.  Cosmi</span>, <span class="hlFld-ContribAuthor ">Peter  Alfinito</span>, <span class="hlFld-ContribAuthor ">Douglas M.  Ho</span>, <span class="hlFld-ContribAuthor ">Darlene C.  Deecher</span> and <span class="hlFld-ContribAuthor ">Eugene J.  Trybulski</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of WAY-260022, a Potent and Selective Inhibitor of the Norepinephrine Transporter. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>1 </em>
                                    (3)
                                     , 91-95. <a href="https://doi.org/10.1021/ml100009p" title="DOI URL">https://doi.org/10.1021/ml100009p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml100009p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml100009p%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BWAY-260022%25252C%252Ba%252BPotent%252Band%252BSelective%252BInhibitor%252Bof%252Bthe%252BNorepinephrine%252BTransporter%26aulast%3DGavrin%26aufirst%3DLori%2BK.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D13012010%26date%3D03032010%26date%3D25032010%26date%3D10062010%26volume%3D1%26issue%3D3%26spage%3D91%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">An T.  Vu</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Cohn</span>, <span class="hlFld-ContribAuthor ">Puwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Callain Y.  Kim</span>, <span class="hlFld-ContribAuthor ">Paige E.  Mahaney</span>, <span class="hlFld-ContribAuthor ">Jenifer A.  Bray</span>, <span class="hlFld-ContribAuthor ">Grace H.  Johnston</span>, <span class="hlFld-ContribAuthor ">Elizabeth J.  Koury</span>, <span class="hlFld-ContribAuthor ">Scott A.  Cosmi</span>, <span class="hlFld-ContribAuthor ">Darlene C.  Deecher</span>, <span class="hlFld-ContribAuthor ">Valerie A.  Smith</span>, <span class="hlFld-ContribAuthor ">James E.  Harrison</span>, <span class="hlFld-ContribAuthor ">Liza  Leventhal</span>, <span class="hlFld-ContribAuthor ">Garth T.  Whiteside</span>, <span class="hlFld-ContribAuthor ">Jeffrey D.  Kennedy</span> and <span class="hlFld-ContribAuthor ">Eugene J.  Trybulski</span>  . </span><span class="cited-content_cbyCitation_article-title">1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as Potent and Selective Norepinephrine Reuptake Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (5)
                                     , 2051-2062. <a href="https://doi.org/10.1021/jm901559e" title="DOI URL">https://doi.org/10.1021/jm901559e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901559e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901559e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1-%252528Indolin-1-yl%252529-1-phenyl-3-propan-2-olamines%252Bas%252BPotent%252Band%252BSelective%252BNorepinephrine%252BReuptake%252BInhibitors%26aulast%3DVu%26aufirst%3DAn%2BT.%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D21102009%26date%3D02022010%26date%3D11032010%26volume%3D53%26issue%3D5%26spage%3D2051%26epage%3D2062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Puwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Eugene A.  Terefenko</span>, <span class="hlFld-ContribAuthor ">Jenifer  Bray</span>, <span class="hlFld-ContribAuthor ">Darlene  Deecher</span>, <span class="hlFld-ContribAuthor ">Andrew  Fensome</span>, <span class="hlFld-ContribAuthor ">Jim  Harrison</span>, <span class="hlFld-ContribAuthor ">Callain  Kim</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Koury</span>, <span class="hlFld-ContribAuthor ">Lilly  Mark</span>, <span class="hlFld-ContribAuthor ">Casey C.  McComas</span>, <span class="hlFld-ContribAuthor ">Cheryl A.  Mugford</span>, <span class="hlFld-ContribAuthor ">Eugene J.  Trybulski</span>, <span class="hlFld-ContribAuthor ">An T.  Vu</span>, <span class="hlFld-ContribAuthor ">Garth T.  Whiteside</span> and <span class="hlFld-ContribAuthor ">Paige E.  Mahaney</span>  . </span><span class="cited-content_cbyCitation_article-title">1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: Potent, Selective, and Orally Efficacious Norepinephrine Reuptake Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (18)
                                     , 5703-5711. <a href="https://doi.org/10.1021/jm900888c" title="DOI URL">https://doi.org/10.1021/jm900888c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm900888c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm900888c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1-%252Bor%252B3-%2525283-Amino-2-hydroxy-1-phenyl%252Bpropyl%252529-1%25252C3-dihydro-2H-benzimidazol-2-ones%25253A%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BEfficacious%252BNorepinephrine%252BReuptake%252BInhibitors%26aulast%3DZhang%26aufirst%3DPuwen%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D17062009%26date%3D01092009%26date%3D24092009%26volume%3D52%26issue%3D18%26spage%3D5703%26epage%3D5711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ikuo  Fujimori</span>, <span class="hlFld-ContribAuthor ">Tomoya  Yukawa</span>, <span class="hlFld-ContribAuthor ">Taku  Kamei</span>, <span class="hlFld-ContribAuthor ">Yoshihisa  Nakada</span>, <span class="hlFld-ContribAuthor ">Nobuki  Sakauchi</span>, <span class="hlFld-ContribAuthor ">Masami  Yamada</span>, <span class="hlFld-ContribAuthor ">Yusuke  Ohba</span>, <span class="hlFld-ContribAuthor ">Maiko  Takiguchi</span>, <span class="hlFld-ContribAuthor ">Masako  Kuno</span>, <span class="hlFld-ContribAuthor ">Izumi  Kamo</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Teruki  Hamada</span>, <span class="hlFld-ContribAuthor ">Tomoko  Igari</span>, <span class="hlFld-ContribAuthor ">Teruaki  Okuda</span>, <span class="hlFld-ContribAuthor ">Satoshi  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Tsukamoto</span>, <span class="hlFld-ContribAuthor ">Yuji  Ishichi</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Ueno</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 5000-5014. <a href="https://doi.org/10.1016/j.bmc.2015.05.017" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.05.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.05.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Ba%252Bnovel%252Bseries%252Bof%252Bperipheral-selective%252Bnoradrenaline%252Breuptake%252Binhibitor%26aulast%3DFujimori%26aufirst%3DIkuo%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D5000%26epage%3D5014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christine  Philippe</span>, <span class="hlFld-ContribAuthor ">Julia  Kaffy</span>, <span class="hlFld-ContribAuthor ">Thierry  Milcent</span>, <span class="hlFld-ContribAuthor ">Danièle  Bonnet-Delpon</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of fluorinated analogues of monoamine reuptake inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2012,</strong> <em>134 </em>, 136-145. <a href="https://doi.org/10.1016/j.jfluchem.2011.02.018" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2011.02.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2011.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2011.02.018%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bfluorinated%252Banalogues%252Bof%252Bmonoamine%252Breuptake%252Binhibitors%26aulast%3DPhilippe%26aufirst%3DChristine%26date%3D2012%26volume%3D134%26spage%3D136%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">GT  Whiteside</span>, <span class="hlFld-ContribAuthor ">JM  Dwyer</span>, <span class="hlFld-ContribAuthor ">JE  Harrison</span>, <span class="hlFld-ContribAuthor ">CE  Beyer</span>, <span class="hlFld-ContribAuthor ">T  Cummons</span>, <span class="hlFld-ContribAuthor ">L  Manzino</span>, <span class="hlFld-ContribAuthor ">L  Mark</span>, <span class="hlFld-ContribAuthor ">GH  Johnston</span>, <span class="hlFld-ContribAuthor ">BW  Strassle</span>, <span class="hlFld-ContribAuthor ">A  Adedoyin</span>, <span class="hlFld-ContribAuthor ">P  Lu</span>, <span class="hlFld-ContribAuthor ">MJ  Piesla</span>, <span class="hlFld-ContribAuthor ">CM  Pulicicchio</span>, <span class="hlFld-ContribAuthor ">JCL  Erve</span>, <span class="hlFld-ContribAuthor ">BJ  Platt</span>, <span class="hlFld-ContribAuthor ">ZA  Hughes</span>, <span class="hlFld-ContribAuthor ">KE  Rogers</span>, <span class="hlFld-ContribAuthor ">DC  Deecher</span>, <span class="hlFld-ContribAuthor ">EJ  Trybulski</span>, <span class="hlFld-ContribAuthor ">JD  Kennedy</span>, <span class="hlFld-ContribAuthor ">P  Zhang</span>, <span class="hlFld-ContribAuthor ">L  Leventhal</span>. </span><span class="cited-content_cbyCitation_article-title">WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depression. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2010,</strong> <em>160 </em>
                                    (5)
                                     , 1105-1118. <a href="https://doi.org/10.1111/j.1476-5381.2010.00690.x" title="DOI URL">https://doi.org/10.1111/j.1476-5381.2010.00690.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1476-5381.2010.00690.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1476-5381.2010.00690.x%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DWAY-318068%25253A%252Ba%252Bnovel%25252C%252Bpotent%252Band%252Bselective%252Bnoradrenaline%252Bre-uptake%252Binhibitor%252Bwith%252Bactivity%252Bin%252Brodent%252Bmodels%252Bof%252Bpain%252Band%252Bdepression%26aulast%3DWhiteside%26aufirst%3DGT%26date%3D2010%26date%3D2010%26volume%3D160%26issue%3D5%26spage%3D1105%26epage%3D1118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph P.  Sabatucci</span>, <span class="hlFld-ContribAuthor ">Paige E.  Mahaney</span>, <span class="hlFld-ContribAuthor ">Jennifer  Leiter</span>, <span class="hlFld-ContribAuthor ">Grace  Johnston</span>, <span class="hlFld-ContribAuthor ">Kevin  Burroughs</span>, <span class="hlFld-ContribAuthor ">Scott  Cosmi</span>, <span class="hlFld-ContribAuthor ">Yingru  Zhang</span>, <span class="hlFld-ContribAuthor ">Douglas  Ho</span>, <span class="hlFld-ContribAuthor ">Darlene C.  Deecher</span>, <span class="hlFld-ContribAuthor ">Eugene  Trybulski</span>. </span><span class="cited-content_cbyCitation_article-title">Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (9)
                                     , 2809-2812. <a href="https://doi.org/10.1016/j.bmcl.2010.03.059" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.03.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.03.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.03.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHeterocyclic%252Bcycloalkanol%252Bethylamines%252Bas%252Bnorepinephrine%252Breuptake%252Binhibitors%26aulast%3DSabatucci%26aufirst%3DJoseph%2BP.%26date%3D2010%26volume%3D20%26issue%3D9%26spage%3D2809%26epage%3D2812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Fensome</span>, <span class="hlFld-ContribAuthor ">Joel  Goldberg</span>, <span class="hlFld-ContribAuthor ">Casey C.  McComas</span>, <span class="hlFld-ContribAuthor ">Eugene J.  Trybulski</span>, <span class="hlFld-ContribAuthor ">Richard P.  Woodworth</span>, <span class="hlFld-ContribAuthor ">Darlene C.  Deecher</span>, <span class="hlFld-ContribAuthor ">Garth T.  Whiteside</span>, <span class="hlFld-ContribAuthor ">Puwen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (5)
                                     , 1555-1558. <a href="https://doi.org/10.1016/j.bmcl.2010.01.056" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.01.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.01.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.01.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bnorepinephrine%252Breuptake%252Binhibitors%252Bwith%252Bbenzothiadiazine%252Bdioxide%252Bor%252Bdihydrosulfostyril%252Bcores%26aulast%3DFensome%26aufirst%3DAndrew%26date%3D2010%26volume%3D20%26issue%3D5%26spage%3D1555%26epage%3D1558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gavin D.  Heffernan</span>, <span class="hlFld-ContribAuthor ">Richard D.  Coghlan</span>, <span class="hlFld-ContribAuthor ">Eric S.  Manas</span>, <span class="hlFld-ContribAuthor ">Robert E.  McDevitt</span>, <span class="hlFld-ContribAuthor ">Yanfang  Li</span>, <span class="hlFld-ContribAuthor ">Paige E.  Mahaney</span>, <span class="hlFld-ContribAuthor ">Albert J.  Robichaud</span>, <span class="hlFld-ContribAuthor ">Christine  Huselton</span>, <span class="hlFld-ContribAuthor ">Peter  Alfinito</span>, <span class="hlFld-ContribAuthor ">Jenifer A.  Bray</span>, <span class="hlFld-ContribAuthor ">Scott A.  Cosmi</span>, <span class="hlFld-ContribAuthor ">Grace H.  Johnston</span>, <span class="hlFld-ContribAuthor ">Thomas  Kenney</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Koury</span>, <span class="hlFld-ContribAuthor ">Richard C.  Winneker</span>, <span class="hlFld-ContribAuthor ">Darlene C.  Deecher</span>, <span class="hlFld-ContribAuthor ">Eugene J.  Trybulski</span>. </span><span class="cited-content_cbyCitation_article-title">Dual acting norepinephrine reuptake inhibitors and 5-HT2A receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2009,</strong> <em>17 </em>
                                    (22)
                                     , 7802-7815. <a href="https://doi.org/10.1016/j.bmc.2009.09.023" title="DOI URL">https://doi.org/10.1016/j.bmc.2009.09.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2009.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2009.09.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDual%252Bacting%252Bnorepinephrine%252Breuptake%252Binhibitors%252Band%252B5-HT2A%252Breceptor%252Bantagonists%25253A%252BIdentification%25252C%252Bsynthesis%252Band%252Bactivity%252Bof%252Bnovel%252B4-aminoethyl-3-%252528phenylsulfonyl%252529-1H-indoles%26aulast%3DHeffernan%26aufirst%3DGavin%2BD.%26date%3D2009%26volume%3D17%26issue%3D22%26spage%3D7802%26epage%3D7815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paige E.  Mahaney</span>, <span class="hlFld-ContribAuthor ">Callain Y.  Kim</span>, <span class="hlFld-ContribAuthor ">Richard D.  Coghlan</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Cohn</span>, <span class="hlFld-ContribAuthor ">Gavin D.  Heffernan</span>, <span class="hlFld-ContribAuthor ">Christine A.  Huselton</span>, <span class="hlFld-ContribAuthor ">Eugene A.  Terefenko</span>, <span class="hlFld-ContribAuthor ">An T.  Vu</span>, <span class="hlFld-ContribAuthor ">Puwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Kevin D.  Burroughs</span>, <span class="hlFld-ContribAuthor ">Scott A.  Cosmi</span>, <span class="hlFld-ContribAuthor ">Jenifer A.  Bray</span>, <span class="hlFld-ContribAuthor ">Grace H.  Johnston</span>, <span class="hlFld-ContribAuthor ">Darlene C.  Deecher</span>, <span class="hlFld-ContribAuthor ">Eugene J.  Trybulski</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (19)
                                     , 5807-5810. <a href="https://doi.org/10.1016/j.bmcl.2009.07.050" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.07.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.07.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.07.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bthe%252B1-amino-3-%2525281H-indol-1-yl%252529-3-phenylpropan-2-ol%252Bseries%252Bof%252Bmonoamine%252Breuptake%252Binhibitors%26aulast%3DMahaney%26aufirst%3DPaige%2BE.%26date%3D2009%26volume%3D19%26issue%3D19%26spage%3D5807%26epage%3D5810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Callain Y.  Kim</span>, <span class="hlFld-ContribAuthor ">Paige E.  Mahaney</span>, <span class="hlFld-ContribAuthor ">Oliver  McConnell</span>, <span class="hlFld-ContribAuthor ">Yingru  Zhang</span>, <span class="hlFld-ContribAuthor ">Eric  Manas</span>, <span class="hlFld-ContribAuthor ">Douglas M.  Ho</span>, <span class="hlFld-ContribAuthor ">Darlene C.  Deecher</span>, <span class="hlFld-ContribAuthor ">Eugene J.  Trybulski</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (17)
                                     , 5029-5032. <a href="https://doi.org/10.1016/j.bmcl.2009.07.053" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.07.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.07.053%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bnew%252Bseries%252Bof%252Bmonoamine%252Breuptake%252Binhibitors%25252C%252Bthe%252B1-amino-3-%2525281H-indol-1-yl%252529-3-phenylpropan-2-ols%26aulast%3DKim%26aufirst%3DCallain%2BY.%26date%3D2009%26volume%3D19%26issue%3D17%26spage%3D5029%26epage%3D5032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">An T.  Vu</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Cohn</span>, <span class="hlFld-ContribAuthor ">Eugene A.  Terefenko</span>, <span class="hlFld-ContribAuthor ">William J.  Moore</span>, <span class="hlFld-ContribAuthor ">Puwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Paige E.  Mahaney</span>, <span class="hlFld-ContribAuthor ">Eugene J.  Trybulski</span>, <span class="hlFld-ContribAuthor ">Igor  Goljer</span>, <span class="hlFld-ContribAuthor ">Rebecca  Dooley</span>, <span class="hlFld-ContribAuthor ">Jenifer A.  Bray</span>, <span class="hlFld-ContribAuthor ">Grace H.  Johnston</span>, <span class="hlFld-ContribAuthor ">Jennifer  Leiter</span>, <span class="hlFld-ContribAuthor ">Darlene C.  Deecher</span>. </span><span class="cited-content_cbyCitation_article-title">3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (9)
                                     , 2464-2467. <a href="https://doi.org/10.1016/j.bmcl.2009.03.054" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.03.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.03.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.03.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3-%252528Arylamino%252529-3-phenylpropan-2-olamines%252Bas%252Ba%252Bnew%252Bseries%252Bof%252Bdual%252Bnorepinephrine%252Band%252Bserotonin%252Breuptake%252Binhibitors%26aulast%3DVu%26aufirst%3DAn%2BT.%26date%3D2009%26volume%3D19%26issue%3D9%26spage%3D2464%26epage%3D2467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob  Andersen</span>, <span class="hlFld-ContribAuthor ">Anders S.  Kristensen</span>, <span class="hlFld-ContribAuthor ">Benny  Bang-Andersen</span>, <span class="hlFld-ContribAuthor ">Kristian  Strømgaard</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2009,</strong> <em>30 </em>
                                    (25)
                                     , 3677. <a href="https://doi.org/10.1039/b903035m" title="DOI URL">https://doi.org/10.1039/b903035m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/b903035m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fb903035m%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bunderstanding%252Bof%252Bthe%252Binteraction%252Bof%252Bantidepressant%252Bdrugs%252Bwith%252Bserotonin%252Band%252Bnorepinephrine%252Btransporters%26aulast%3DAndersen%26aufirst%3DJacob%26date%3D2009%26volume%3D30%26issue%3D25%26spage%3D3677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Puwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Eugene A.  Terefenko</span>, <span class="hlFld-ContribAuthor ">Casey C.  McComas</span>, <span class="hlFld-ContribAuthor ">Paige E.  Mahaney</span>, <span class="hlFld-ContribAuthor ">An  Vu</span>, <span class="hlFld-ContribAuthor ">Eugene  Trybulski</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Koury</span>, <span class="hlFld-ContribAuthor ">Grace  Johnston</span>, <span class="hlFld-ContribAuthor ">Jenifer  Bray</span>, <span class="hlFld-ContribAuthor ">Darlene  Deecher</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (23)
                                     , 6067-6070. <a href="https://doi.org/10.1016/j.bmcl.2008.10.026" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.10.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.10.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bactivity%252Bof%252Bnovel%252B1-%252Bor%252B3-%2525283-amino-1-phenyl%252Bpropyl%252529-1%25252C3-dihydro-2H-benzimidazol-2-ones%252Bas%252Bselective%252Bnorepinephrine%252Breuptake%252Binhibitors%26aulast%3DZhang%26aufirst%3DPuwen%26date%3D2008%26volume%3D18%26issue%3D23%26spage%3D6067%26epage%3D6070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Casey C.  McComas</span>, <span class="hlFld-ContribAuthor ">An T.  Vu</span>, <span class="hlFld-ContribAuthor ">Paige E.  Mahaney</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Cohn</span>, <span class="hlFld-ContribAuthor ">Andrew  Fensome</span>, <span class="hlFld-ContribAuthor ">Michael A.  Marella</span>, <span class="hlFld-ContribAuthor ">Lisa  Nogle</span>, <span class="hlFld-ContribAuthor ">Eugene J.  Trybulski</span>, <span class="hlFld-ContribAuthor ">Fei  Ye</span>, <span class="hlFld-ContribAuthor ">Puwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Peter  Alfinito</span>, <span class="hlFld-ContribAuthor ">Jenifer  Bray</span>, <span class="hlFld-ContribAuthor ">Grace  Johnston</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Koury</span>, <span class="hlFld-ContribAuthor ">Darlene C.  Deecher</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: A new class of selective norepinephrine reuptake inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (18)
                                     , 4929-4931. <a href="https://doi.org/10.1016/j.bmcl.2008.08.060" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.08.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.08.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.08.060%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bactivity%252Bof%252B1-%2525283-amino-1-phenylpropyl%252529indolin-2-ones%25253A%252BA%252Bnew%252Bclass%252Bof%252Bselective%252Bnorepinephrine%252Breuptake%252Binhibitors%26aulast%3DMcComas%26aufirst%3DCasey%2BC.%26date%3D2008%26volume%3D18%26issue%3D18%26spage%3D4929%26epage%3D4931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8002262&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of marketed SSRIs, SNRIs, and NRIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8002262&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0004.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Cycloalkanol Ethylamine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8002262&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) LDA (2.5 equiv), THF, −78 °C to room temp, then cyclohexanone, −78 °C (83−99%); (b) BOP reagent, 1-Boc-piperazine, CH<sub>2</sub>Cl<sub>2</sub> (59−87%); (c) BH<sub>3</sub>−THF, reflux, then aqueous HCl (51−69%); (d) HCHO, HCO<sub>2</sub>H, H<sub>2</sub>O, then HCl/MeOH (58−79%).</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. ORTEP view of 1-[(1<i>R</i>)-1-(3-chlorophenyl)-2-(4-methylpiperazin-1-yl)ethyl]cyclohexanol [(<i>R</i>)-(+)-<b>17g</b>].</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8002262&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0007.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of (<i>S</i>)-(−)-<b>17i</b> in the tail-suspension test in male mice. A vehicle of 2% Tween-80/0.5% methylcellulose in water was used for delivery of test compounds. Data represent group mean ± SEM for each dose (<i>N</i> = 10 per group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8002262&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0008.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of (<i>S</i>)-(−)-<b>17i</b> in the mouse <i>p</i>-phenylquinone model of acute visceral (abdominal) pain. A vehicle of saline was used for dosing. Data are presented as percent blockade compared to vehicle (% blockade = [(mean vehicle) − (drug)/(mean vehicle)] × 100) ± SEM for each dose (<i>N</i> = 8 per group); ∗ signifies a <i>p</i> value of <0.05 vs saline vehicle (ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8002262&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/medium/jm-2008-002262_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0009.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of ip and po administration of (<i>S</i>)-(−)-<b>17i</b> in a telemetric rat model of ovariectomized (OVX)-induced thermoregulatory dysfunction; ∗ signifies a <i>p</i> value of <0.05 vs 2% Tween-80 /0.5% methylcellulose in water vehicle. The onset of an effect was defined as the first half-hour interval of two consecutive significant (<i>p</i> < 0.05) half-hour intervals. The treatment effect was defined to have ended when there are two consecutive nonsignificant (<i>p</i> ≥ 0.05) half-hour intervals. Braces mark periods of significant effects. Error bars represent standard error of the mean of each data point.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm8002262/production/images/large/jm-2008-002262_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8002262&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i88">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48135" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48135" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 24 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Devilbiss, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterhouse, B. D.</span><span> </span><span class="NLM_article-title">Locus coeruleus regulates sensory encoding by neurons and networks in waking animals</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">9860</span><span class="NLM_x">–</span> <span class="NLM_lpage">9872</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1523%2FJNEUROSCI.1776-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=17005850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOmtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=9860-9872&author=D.+M.+Devilbissauthor=M.+E.+Pageauthor=B.+D.+Waterhouse&title=Locus+coeruleus+regulates+sensory+encoding+by+neurons+and+networks+in+waking+animals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Locus ceruleus regulates sensory encoding by neurons and networks in waking animals</span></div><div class="casAuthors">Devilbiss, David M.; Page, Michelle E.; Waterhouse, Barry D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">9860-9872</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Substantial evidence indicates that the locus ceruleus (LC)-norepinephrine (NE) projection system regulates behavioral state and state-dependent processing of sensory information.  Tonic LC discharge (0.1-5.0 Hz) is correlated with levels of arousal and demonstrates an optimal firing rate during good performance in a sustained attention task.  In addn., studies have shown that locally applied NE or LC stimulation can modulate the responsiveness of neurons, including those in the thalamus, to nonmonoaminergic synaptic inputs.  Many recent investigations further indicate that within sensory relay circuits of the thalamus both general and specific features of sensory information are represented within the collective firing patterns of like-modality neurons.  However, no studies have examd. the impact of NE or LC output on the discharge properties of ensembles of functionally related cells in intact, conscious animals.  Here, we provide evidence linking LC neuronal discharge and NE efflux with LC-mediated modulation of single-neuron and neuronal ensemble representations of sensory stimuli in the ventral posteriomedial thalamus of waking rats.  As such, the current study provides evidence that output from the LC across a physiol. range modulates single thalamic neuron responsiveness to synaptic input and representation of sensory information across ensembles of thalamic neurons in a manner that is consistent with the well documented actions of LC output on cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsgaI_wXOHRrVg90H21EOLACvtfcHk0lhSLzAHJWnygg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOmtLnM&md5=f5573599880c0828ba0ecc111e9a45d1</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1776-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1776-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DDevilbiss%26aufirst%3DD.%2BM.%26aulast%3DPage%26aufirst%3DM.%2BE.%26aulast%3DWaterhouse%26aufirst%3DB.%2BD.%26atitle%3DLocus%2520coeruleus%2520regulates%2520sensory%2520encoding%2520by%2520neurons%2520and%2520networks%2520in%2520waking%2520animals%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D9860%26epage%3D9872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Aston-Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, J. D.</span><span> </span><span class="NLM_article-title">Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance</span> <span class="citation_source-journal">J. Comp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">493</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1002%2Fcne.20723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=16254995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSjsLnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=493&publication_year=2005&pages=99-110&author=G.+Aston-Jonesauthor=J.+D.+Cohen&title=Adaptive+gain+and+the+role+of+the+locus+coeruleus-norepinephrine+system+in+optimal+performance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance</span></div><div class="casAuthors">Aston-Jones, Gary; Cohen, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">493</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-110</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Historically, the locus coeruleus-norepinephrine (LC-NE) system has been implicated in arousal, but recent findings suggest that this system plays a more complex and specific role in the control of behavior than investigators previously thought.  We review neurophysiol., anatomical, and modeling studies in monkey that support a new theory of LC-NE function.  LC neurons exhibit two modes of activity, phasic and tonic.  Phasic LC activation is driven by the outcome of task-related decision processes and is proposed to facilitate ensuing behaviors and to help optimize task performance.  When utility in the task wanes, LC neurons exhibit a tonic activity mode, assocd. with disengagement from the current task and a search for alternative behaviors.  Monkey LC receives prominent, direct inputs from the anterior cingulate (ACC) and orbitofrontal cortices (OFC), both of which are thought to monitor task-related utility.  We propose that these prefrontal areas produce the above patterns of LC activity to optimize the utility of performance on both short and long time scales.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIK-OMy49F4rVg90H21EOLACvtfcHk0liqhAz4qXwnCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSjsLnF&md5=b26f44aa70a3b704408d66cd5a92e846</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1002%2Fcne.20723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.20723%26sid%3Dliteratum%253Aachs%26aulast%3DAston-Jones%26aufirst%3DG.%26aulast%3DCohen%26aufirst%3DJ.%2BD.%26atitle%3DAdaptive%2520gain%2520and%2520the%2520role%2520of%2520the%2520locus%2520coeruleus-norepinephrine%2520system%2520in%2520optimal%2520performance%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D2005%26volume%3D493%26spage%3D99%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Valentino, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Bockstaele, E. J.</span><span> </span><span class="NLM_article-title">Functional interactions between stress neuromediators and the locus coeruleus-norepinephrine system</span> <span class="citation_source-journal">Tech. Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2FS0921-0709%2805%2980026-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVektbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=465-486&author=R.+J.+Valentinoauthor=E.+J.+Van+Bockstaele&title=Functional+interactions+between+stress+neuromediators+and+the+locus+coeruleus-norepinephrine+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Functional interactions between stress neuromediators and the locus coeruleus-norepinephrine system</span></div><div class="casAuthors">Valentino, Rita J.; Van Bockstaele, Elisabeth J.</div><div class="citationInfo"><span class="NLM_cas:title">Techniques in the Behavioral and Neural Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">Handbook of Stress and the Brain, Part 1</span>),
    <span class="NLM_cas:pages">465-486</span>CODEN:
                <span class="NLM_cas:coden">TBSCEC</span>;
        ISSN:<span class="NLM_cas:issn">0921-0709</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Activation of the hypothalamic-pituitary-adrenal axis is considered a hallmark of the stress response.  Coincident with this, peripheral and central noradrenaline systems are activated.  By engaging medullary noradrenaline projections to the paraventricular nucleus of the hypothalamus, stressors regulate the endocrine limb of the stress response.  Engaging noradrenaline projections from the pontine nucleus, locus coeruleus (LC), to the forebrain may serve as a behavioral or cognitive limb of the stress response.  This chapter will focus on the impact of stress on the LC-noradrenaline system and its forebrain targets.  The body of evidence supporting the view that diverse stressors consistently activate this system will be briefly reviewed.  Convergent lines of evidence suggest that corticotropin-releasing factor (CRF) is a crit. substrate of the stress response that regulates activity of the LC-noradrenaline system during stress.  This chapter will discuss the impact of CRF and stressors on the LC-noradrenaline system from the level of individual LC neurons to the distributed network of LC projections.  The concept that stress regulates activity of the LC-noradrenaline system by integrating the actions of CRF with other neuromodulators will be developed and a circuitry underlying these interactions will be proposed.  These findings will be integrated with physiol. and behavioral studies that have suggested specific roles for the LC-noradrenaline system in the modulation of arousal and attention into the hypothesis that activation of this system is an important component of a cognitive limb of the stress response.  Finally, as the endocrine limb of the stress response exhibits plasticity, which is expressed with manipulations such as chronic stress or adrenalectomy, evidence will be reviewed which suggests that the limb comprising the LC-noradrenaline system exhibits similar plasticity, which may have both adaptive and pathol. consequences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozbVy-sN5rAbVg90H21EOLACvtfcHk0lh2wr2r-LBg5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVektbnI&md5=647cb8c0674806b75505667c07c34ebc</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2FS0921-0709%2805%2980026-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0921-0709%252805%252980026-4%26sid%3Dliteratum%253Aachs%26aulast%3DValentino%26aufirst%3DR.%2BJ.%26aulast%3DVan%2BBockstaele%26aufirst%3DE.%2BJ.%26atitle%3DFunctional%2520interactions%2520between%2520stress%2520neuromediators%2520and%2520the%2520locus%2520coeruleus-norepinephrine%2520system%26jtitle%3DTech.%2520Behav.%2520Neurosci.%26date%3D2005%26volume%3D15%26spage%3D465%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cirelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tononi, G.</span><span> </span><span class="NLM_article-title">Locus coeruleus control of state-dependent gene expression</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">5410</span><span class="NLM_x">–</span> <span class="NLM_lpage">5419</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1523%2FJNEUROSCI.0949-04.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=15190114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCgurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=5410-5419&author=C.+Cirelliauthor=G.+Tononi&title=Locus+coeruleus+control+of+state-dependent+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Locus ceruleus control of state-dependent gene expression</span></div><div class="casAuthors">Cirelli, Chiara; Tononi, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5410-5419</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Wakefulness and sleep are accompanied by changes in behavior and neural activity, as well as by the upregulation of different functional categories of genes.  However, the mechanisms responsible for such state-dependent changes in gene expression are unknown.  Here we investigate to what extent state-dependent changes in gene expression depend on the central noradrenergic (NA) system, which is active in wakefulness and reduces its firing during sleep.  We measured the levels of ∼5000 transcripts expressed in the cerebral cortex of control rats and in rats pretreated with DSP-4 [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine], a neurotoxin that removes the noradrenergic innervation of the cortex.  We found that NA depletion reduces the expression of ∼20% of known wakefulness-related transcripts.  Most of these transcripts are involved in synaptic plasticity and in the cellular response to stress.  In contrast, NA depletion increased the expression of the sleep-related gene encoding the translation elongation factor 2.  These results indicate that the activity of the central NA system during wakefulness modulates neuronal transcription to favor synaptic potentiation and counteract cellular stress, whereas its inactivity during sleep may play a permissive role to enhance brain protein synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQHrUe7PwppbVg90H21EOLACvtfcHk0lh2wr2r-LBg5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCgurY%253D&md5=88f9645109a82c3b08dd852216acf86b</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0949-04.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0949-04.2004%26sid%3Dliteratum%253Aachs%26aulast%3DCirelli%26aufirst%3DC.%26aulast%3DTononi%26aufirst%3DG.%26atitle%3DLocus%2520coeruleus%2520control%2520of%2520state-dependent%2520gene%2520expression%26jtitle%3DJ.%2520Neurosci.%26date%3D2004%26volume%3D24%26spage%3D5410%26epage%3D5419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Miyawaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasugi, T.</span><span> </span><span class="NLM_article-title">Chemical stimulation of the locus coeruleus: inhibitory effects on hemodynamics and renal sympathetic nerve activity</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">568</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2F0006-8993%2891%2991384-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=1687667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADyaK38XpvFykug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=568&publication_year=1991&pages=101-108&author=T.+Miyawakiauthor=H.+Kawamuraauthor=K.+Komatsuauthor=T.+Yasugi&title=Chemical+stimulation+of+the+locus+coeruleus%3A+inhibitory+effects+on+hemodynamics+and+renal+sympathetic+nerve+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1eR"><div class="casContent"><span class="casTitleNuber">1e</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical stimulation of the locus coeruleus:  inhibitory effects on hemodynamics and renal sympathetic nerve activity</span></div><div class="casAuthors">Miyawaki, Takashi; Kawamura, Hiroshi; Komatsu, Kazutoshi; Yasugi, Tadao</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">568</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">101-8</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The authors examd. the role of the locus ceruleus (LC) in the regulation of the hemodynamics and sympathetic nerve activity in anesthetized rats.  Unilateral microinjection into the LC of the excitatory amino acid, L-glutamate (Glu), elicited dose-dependent decreases in arterial pressure (AP) and heart rate (HR).  The bradycardic response was partially attenuated after i.v. injection of atropine sulfate, but the greater part of this response still remained.  Interruption of the ascending projections of the LC by midbrain transection did not affect the depressor and bradycardic responses elicited by chem. stimulation.  The renal sympathetic nerve activity showed transient but strong inhibition with this stimulation.  Cardiac output was measured using an electromagnetic flowmeter implanted in the ascending aorta.  The stroke vol. and total peripheral resistance (TPR) were calcd.  Microinjection of Glu elicited a significant decrease in TPR and slight decreases in cardiac output and stroke vol.  Microinjection of the inhibitory amino acid, GABA, or the α2-adrenergic agonist, clonidine, exerted no effect on AP and HR.  The results suggest that: (1) the LC neurons have an inhibitory influence on the sympathetic nervous system, and stimulation of these neurons can elicit depressor and bradycardic responses; (2) the depressor response was produced predominantly as a result of a decrease in vascular resistance, rather than a decrease in cardiac output; (3) these inhibitory responses may be provided other than via the ascending projections of the LC; and (4) the LC neurons do not have a tonic influence on the cardiovascular system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphtR3JDX4AuLVg90H21EOLACvtfcHk0lj-fg9ZJqg8iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XpvFykug%253D%253D&md5=4bb2695435afbc5a2a9de0ee6d6a110f</span></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2891%2991384-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252891%252991384-D%26sid%3Dliteratum%253Aachs%26aulast%3DMiyawaki%26aufirst%3DT.%26aulast%3DKawamura%26aufirst%3DH.%26aulast%3DKomatsu%26aufirst%3DK.%26aulast%3DYasugi%26aufirst%3DT.%26atitle%3DChemical%2520stimulation%2520of%2520the%2520locus%2520coeruleus%253A%2520inhibitory%2520effects%2520on%2520hemodynamics%2520and%2520renal%2520sympathetic%2520nerve%2520activity%26jtitle%3DBrain%2520Res.%26date%3D1991%26volume%3D568%26spage%3D101%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Sarvey, J.</span><span> </span><span class="NLM_article-title">Protein synthesis in long-term potentiation and norepinephrine-induced long-lasting potentiation in hippocampus</span> <span class="citation_source-journal">Neurol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1998&pages=329-353&author=J.+Sarvey&title=Protein+synthesis+in+long-term+potentiation+and+norepinephrine-induced+long-lasting+potentiation+in+hippocampus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarvey%26aufirst%3DJ.%26atitle%3DProtein%2520synthesis%2520in%2520long-term%2520potentiation%2520and%2520norepinephrine-induced%2520long-lasting%2520potentiation%2520in%2520hippocampus%26jtitle%3DNeurol.%2520Neurobiol.%26date%3D1998%26volume%3D35%26spage%3D329%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fricchione, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefano, G. B.</span><span> </span><span class="NLM_article-title">Placebo neural systems: nitric oxide, morphine and the dopamine brain reward and motivation circuitries</span> <span class="citation_source-journal">Med. Sci. Monit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_elocation-id">MS54−MS65</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&author=G.+Fricchioneauthor=G.+B.+Stefano&title=Placebo+neural+systems%3A+nitric+oxide%2C+morphine+and+the+dopamine+brain+reward+and+motivation+circuitries"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFricchione%26aufirst%3DG.%26aulast%3DStefano%26aufirst%3DG.%2BB.%26atitle%3DPlacebo%2520neural%2520systems%253A%2520nitric%2520oxide%252C%2520morphine%2520and%2520the%2520dopamine%2520brain%2520reward%2520and%2520motivation%2520circuitries%26jtitle%3DMed.%2520Sci.%2520Monit.%26date%3D2005%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kalivas, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkow, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seamans, J.</span><span> </span><span class="NLM_article-title">Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=647-650&author=P.+W.+Kalivasauthor=N.+Volkowauthor=J.+Seamans&title=Unmanageable+motivation+in+addiction%3A+a+pathology+in+prefrontal-accumbens+glutamate+transmission"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKalivas%26aufirst%3DP.%2BW.%26aulast%3DVolkow%26aufirst%3DN.%26aulast%3DSeamans%26aufirst%3DJ.%26atitle%3DUnmanageable%2520motivation%2520in%2520addiction%253A%2520a%2520pathology%2520in%2520prefrontal-accumbens%2520glutamate%2520transmission%26jtitle%3DNeuron%26date%3D2005%26volume%3D45%26spage%3D647%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pochon, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehericy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poline, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Bihan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, B.</span><span> </span><span class="NLM_article-title">The neural system that bridges reward and cognition in humans: an fMRI study</span> <span class="citation_source-journal">Proc. Nat. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">5669</span><span class="NLM_x">–</span> <span class="NLM_lpage">5674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1073%2Fpnas.082111099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=11960021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFKltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=5669-5674&author=J.+B.+Pochonauthor=R.+Levyauthor=P.+Fossatiauthor=S.+Lehericyauthor=J.+B.+Polineauthor=B.+Pillonauthor=D.+Le+Bihanauthor=B.+Dubois&title=The+neural+system+that+bridges+reward+and+cognition+in+humans%3A+an+fMRI+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">The neural system that bridges reward and cognition in humans: an fMRI study</span></div><div class="casAuthors">Pochon, J. B.; Levy, R.; Fossati, P.; Lehericy, S.; Poline, J. B.; Pillon, B.; Le Bihan, D.; Dubois, B.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5669-5674</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We test the hypothesis that motivational and cognitive processes are linked by a specific neural system to reach maximal efficiency.  We studied six normal subjects performing a working memory paradigm (n-back tasks) assocd. with different levels of monetary reward during an fMRI session.  The study showed specific brain activation in relation with changes in both the cognitive loading and the reward assocd. with task performance.  First, the working memory tasks activated a network including the dorsolateral prefrontal cortex [Brodmann area (BA) 9/46] and, in addn., in the lateral frontopolar areas (BA 10), but only in the more demanding condition (3-back task).  This result suggests that lateral prefrontal areas are organized in a caudo-rostral continuum in relation with the increase in executive requirement.  Second, reward induces an increased activation in the areas already activated by working memory processing and in a supplementary region, the medial frontal pole (BA 10), regardless of the level of cognitive processing.  It is postulated that the latter region plays a specific role in monitoring the reward value of ongoing cognitive processes.  Third, we detected areas where the signal decreases (ventral-BA 11/47 and subgenual prefrontal cortices) in relation with both the increase of cognitive demand and the reward.  The deactivation may represent an emotional gating aimed at inhibiting adverse emotional signals to maximize the level of performance.  Taken together, these results suggest a balance between increasing activity in cortical cognitive areas and decreasing activity in the limbic and paralimbic structures during ongoing higher cognitive processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFHH0LhnRdP7Vg90H21EOLACvtfcHk0lj-fg9ZJqg8iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFKltbo%253D&md5=6b369e1ec0c675029cf26d880745bd47</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1073%2Fpnas.082111099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.082111099%26sid%3Dliteratum%253Aachs%26aulast%3DPochon%26aufirst%3DJ.%2BB.%26aulast%3DLevy%26aufirst%3DR.%26aulast%3DFossati%26aufirst%3DP.%26aulast%3DLehericy%26aufirst%3DS.%26aulast%3DPoline%26aufirst%3DJ.%2BB.%26aulast%3DPillon%26aufirst%3DB.%26aulast%3DLe%2BBihan%26aufirst%3DD.%26aulast%3DDubois%26aufirst%3DB.%26atitle%3DThe%2520neural%2520system%2520that%2520bridges%2520reward%2520and%2520cognition%2520in%2520humans%253A%2520an%2520fMRI%2520study%26jtitle%3DProc.%2520Nat.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D5669%26epage%3D5674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kumar, V. N.</span><span> </span><span class="NLM_article-title">Interrelation between thermoregulation and sleep regulation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci., India, Sect. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">524</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsVWktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2003&pages=507-524&author=V.+N.+Kumar&title=Interrelation+between+thermoregulation+and+sleep+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Interrelation between thermoregulation and sleep regulation</span></div><div class="casAuthors">Kumar, Velayudhan Mohan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Indian National Science Academy, Part B: Biological Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">507-524</span>CODEN:
                <span class="NLM_cas:coden">PINSD5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Indian National Science Academy</span>)
        </div><div class="casAbstract">A review on the interrelation between thermoregulation and sleep regulation and particularly the role of the medial preoptic area (mPOA) , including discussions on the changes in body temp. and sleep in response to local injection of neurotransmitters at the mPOA and the roles of noradrenergic terminals in the mPOA in regulating body temp. and sleep.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLivH5lzUqebVg90H21EOLACvtfcHk0lj-fg9ZJqg8iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsVWktLY%253D&md5=af031fe00407f9a745f8497c45bb3e17</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DV.%2BN.%26atitle%3DInterrelation%2520between%2520thermoregulation%2520and%2520sleep%2520regulation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%252C%2520India%252C%2520Sect.%2520B%26date%3D2003%26volume%3D69%26spage%3D507%26epage%3D524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Riedel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorward, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, P. I.</span><span> </span><span class="NLM_article-title">Central adrenoceptors modify hypothalamic thermoregulatory patterns of autonomic activity in conscious rabbits</span> <span class="citation_source-journal">Auton. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2F0165-1838%2881%2990085-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADyaL3MXktFymt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1981&pages=525-533&author=W.+Riedelauthor=P.+K.+Dorwardauthor=P.+I.+Korner&title=Central+adrenoceptors+modify+hypothalamic+thermoregulatory+patterns+of+autonomic+activity+in+conscious+rabbits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Central adrenoceptors modify hypothalamic thermoregulatory patterns of autonomic activity in conscious rabbits</span></div><div class="casAuthors">Riedel, Walter; Dorward, Patricia K.; Korner, P. I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Autonomic Nervous System</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2-4</span>),
    <span class="NLM_cas:pages">525-33</span>CODEN:
                <span class="NLM_cas:coden">JASYDS</span>;
        ISSN:<span class="NLM_cas:issn">0165-1838</span>.
    </div><div class="casAbstract">In conscious rabbits with indwelling intracisternal (i.c.) catheters i.c. injection of noradrenaline bitartrate (I bitartrate)  [51-40-1] (20-2000 ng) elicited dose-related cutaneous vasoconstriction of the ear skin vessels and redn. in renal sympathetic vasoconstrictor activity (integrated mass discharge).  There was shivering and a rise in the animals core temp., so that the injections of I mimicked the normal thermoregulatory pattern of cooling.  In 5 other rabbits with implanted hypothalamic thermodes the responses of the ear temp., renal sympathetic nerve activity and respiration rate to hypothalamic heating and cooling were studied.  The animals were studied: under control conditions, after i.c. administration of I, and 24 h after 6-hydroxydopamine (6-OHDA) when there is marked depletion of central nervous system noradrenergic transmitter stores.  After the drugs the temp.-response curves were displaced from control in approx. parallel fashion with little change in gain.  I elicited shifts that were directionally opposite to those produced by 6-OHDA, suggesting that the changes in thermoregulatory properties were specific effects of the transmitter.  Previous studies also suggest that the site of modulation of the thermoregulatory response is at bulbospinal levels, at least as far as the renal sympathetic response was concerned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6x9CxWaksNLVg90H21EOLACvtfcHk0lhMvq-wCxvjDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXktFymt7w%253D&md5=f8b4bcb441af78be24d9e27a9ea02ff1</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2F0165-1838%2881%2990085-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1838%252881%252990085-0%26sid%3Dliteratum%253Aachs%26aulast%3DRiedel%26aufirst%3DW.%26aulast%3DDorward%26aufirst%3DP.%2BK.%26aulast%3DKorner%26aufirst%3DP.%2BI.%26atitle%3DCentral%2520adrenoceptors%2520modify%2520hypothalamic%2520thermoregulatory%2520patterns%2520of%2520autonomic%2520activity%2520in%2520conscious%2520rabbits%26jtitle%3DAuton.%2520Neurosci.%26date%3D1981%26volume%3D3%26spage%3D525%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lahti, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyornila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hissa, R.</span><span> </span><span class="NLM_article-title">The influence of 6-OHDA on hypothermia produced by intrahypothalamically-injected carbachol in the pigeon</span> <span class="citation_source-journal">Experientia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1980&pages=1188&author=H.+Lahtiauthor=A.+Pyornilaauthor=R.+Hissa&title=The+influence+of+6-OHDA+on+hypothermia+produced+by+intrahypothalamically-injected+carbachol+in+the+pigeon"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLahti%26aufirst%3DH.%26aulast%3DPyornila%26aufirst%3DA.%26aulast%3DHissa%26aufirst%3DR.%26atitle%3DThe%2520influence%2520of%25206-OHDA%2520on%2520hypothermia%2520produced%2520by%2520intrahypothalamically-injected%2520carbachol%2520in%2520the%2520pigeon%26jtitle%3DExperientia%26date%3D1980%26volume%3D36%26spage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Michel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruhe, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oelke, M.</span><span> </span><span class="NLM_article-title">Tolerability of amine uptake inhibitors in urologic diseases</span> <span class="citation_source-journal">Curr. Drug Safety</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.2174%2F157488606775252601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVWmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=73-85&author=M.+C.+Michelauthor=H.+G.+Ruheauthor=A.+A.+de+Grootauthor=R.+Castroauthor=M.+Oelke&title=Tolerability+of+amine+uptake+inhibitors+in+urologic+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Tolerability of amine uptake inhibitors in urologic diseases</span></div><div class="casAuthors">Michel, Martin C.; Ruhe, Henricus G.; de Groot, Annemieke A.; Castro, Ramiro; Oelke, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Safety</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-85</span>CODEN:
                <span class="NLM_cas:coden">CDSUBQ</span>;
        ISSN:<span class="NLM_cas:issn">1574-8863</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Inhibitors of serotonin (5-HT) and/or noradrenaline (NA) reuptake have been developed for pharmacol. treatment of major depressive disorder.  Insights in the role of 5-HT and NA in the neurol. control of the lower urinary tract have also led to their application in common urol. conditions such as stress urinary incontinence (SUI), nocturnal enuresis and ejaculatory disorders.  The European approval of the 5-HT and NA reuptake inhibitor (SNRI) duloxetine for treatment of SUI underlines the importance of a new approach in SUI, but has also given rise to questions about the safety of antidepressants in urol.  This paper reviews the safety of 5-HT and NA reuptake inhibitors in their on- and off-label use in urol.  A systematic Medline search was performed for randomized controlled trials, meta-analyses and practice guidelines dealing with antidepressants in urol.  The safety profiles of the drugs in the urol. population were compared with data from psychiatric populations.  Tricyclic antidepressants are assocd. with serious cardiovascular side effects.  In addn., anticholinergic and antihistaminic side effects are common.  Although recently questions have been raised regarding the cardiovascular safety profile of venlafaxine, most selective 5-HT reuptake inhibitors and SNRI have not been assocd. with serious cardiovascular effects.  Their most common side effect is nausea.  However, nausea tends to be mild and, importantly, transient.  Patient counselling about side effects and up-titrating doses may be useful strategies for minimizing discomfort and withdrawals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOXIcQjLzWQ7Vg90H21EOLACvtfcHk0lhMvq-wCxvjDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVWmur8%253D&md5=be53d26f331c8a2051b7661498137779</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.2174%2F157488606775252601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157488606775252601%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DM.%2BC.%26aulast%3DRuhe%26aufirst%3DH.%2BG.%26aulast%3Dde%2BGroot%26aufirst%3DA.%2BA.%26aulast%3DCastro%26aufirst%3DR.%26aulast%3DOelke%26aufirst%3DM.%26atitle%3DTolerability%2520of%2520amine%2520uptake%2520inhibitors%2520in%2520urologic%2520diseases%26jtitle%3DCurr.%2520Drug%2520Safety%26date%3D2006%26volume%3D1%26spage%3D73%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Michel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oelke, M.</span><span> </span><span class="NLM_article-title">Duloxetine in the treatment of stress urinary incontinence</span> <span class="citation_source-journal">Women’s Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.2217%2F17455057.1.3.345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFeqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=345-348&author=M.+C.+Michelauthor=M.+Oelke&title=Duloxetine+in+the+treatment+of+stress+urinary+incontinence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Duloxetine in the treatment of stress urinary incontinence</span></div><div class="casAuthors">Michel, Martin C.; Oelke, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Women's Health</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-358</span>CODEN:
                <span class="NLM_cas:coden">WHOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1745-5057</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  This manuscript reviews the pharmacodynamics and pharmacokinetics of duloxetine and its efficacy and safety in women with stress urinary incontinence.  Duloxetine is a selective inhibitor of neuronal serotonin and norepinephrine uptake which increases urethral striated muscle activity and bladder capacity.  Duloxetine is readily absorbed and extensively metabolized; cytochrome P 450 1A2 (CYP1A2) inhibiting drugs can markedly increase duloxetine exposure.  The clin. efficacy of duloxetine has consistently been demonstrated in several randomized, double-blind studies in women with moderate-to-severe stress urinary incontinence, but the addnl. benefit relative to placebo was moderate.  Duloxetine treatment is frequently assocd. with adverse events such as nausea, dry mouth, fatigue, insomnia and constipation, but serious adverse events are rare.  Therefore, duloxetine appears suitable for the treatment of stress urinary incontinence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6COtI0VzGTbVg90H21EOLACvtfcHk0lhMvq-wCxvjDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFeqs7g%253D&md5=9861a3efce1324f9e9d8f4ccead279d0</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.2217%2F17455057.1.3.345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F17455057.1.3.345%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DM.%2BC.%26aulast%3DOelke%26aufirst%3DM.%26atitle%3DDuloxetine%2520in%2520the%2520treatment%2520of%2520stress%2520urinary%2520incontinence%26jtitle%3DWomen%25E2%2580%2599s%2520Health%26date%3D2005%26volume%3D1%26spage%3D345%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Osborne, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. M.</span><span> </span><span class="NLM_article-title">Duloxetine in the treatment of stress urinary incontinence</span> <span class="citation_source-journal">J. Pharm. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVyrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2005&pages=337-340&author=K.+L.+Osborneauthor=S.+M.+Davis&title=Duloxetine+in+the+treatment+of+stress+urinary+incontinence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Duloxetine in the treatment of stress urinary incontinence</span></div><div class="casAuthors">Osborne, Kristie L.; Davis, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy Technology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">337-340</span>CODEN:
                <span class="NLM_cas:coden">JPTEEB</span>;
        ISSN:<span class="NLM_cas:issn">8755-1225</span>.
    
            (<span class="NLM_cas:orgname">Harvey Whitney Books Co.</span>)
        </div><div class="casAbstract">Objective: To review the available literature regarding the use of duloxetine in the treatment of stress urinary incontinence.  Data Sources: Clin. trials were obtained through a PubMed search (1966-Dec. 2004) with the key words duloxetine, urinary incontinence, and stress.  Data Synthesis: This article analyzes 5 clin. studies comparing duloxetine with placebo.  The randomized, double-blind, multicenter trials were performed in the US and throughout the world and had strict inclusion criteria to enroll only patients with confirmed stress urinary incontinence.  All trials showed a statistically significant decrease in incontinence episode frequency of 50-60% for duloxetine compared with a placebo response of 27-40%.  Conclusions: Duloxetine appears to be an effective treatment for stress urinary incontinence.  Addnl. trials comparing duloxetine with pelvic floor muscle training would better define duloxetine's place in therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzCMGuu2R43LVg90H21EOLACvtfcHk0lhMvq-wCxvjDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVyrug%253D%253D&md5=1311c4425b432731dc632f437380de9c</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOsborne%26aufirst%3DK.%2BL.%26aulast%3DDavis%26aufirst%3DS.%2BM.%26atitle%3DDuloxetine%2520in%2520the%2520treatment%2520of%2520stress%2520urinary%2520incontinence%26jtitle%3DJ.%2520Pharm.%2520Technol.%26date%3D2005%26volume%3D21%26spage%3D337%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">McCormack, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, G. M.</span><span> </span><span class="NLM_article-title">Duloxetine: in stress urinary incontinence</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">2567</span><span class="NLM_x">–</span> <span class="NLM_lpage">2573</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=2567-2573&author=P.+L.+McCormackauthor=G.+M.+Keating&title=Duloxetine%3A+in+stress+urinary+incontinence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCormack%26aufirst%3DP.%2BL.%26aulast%3DKeating%26aufirst%3DG.%2BM.%26atitle%3DDuloxetine%253A%2520in%2520stress%2520urinary%2520incontinence%26jtitle%3DDrugs%26date%3D2004%26volume%3D64%26spage%3D2567%26epage%3D2573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Preskorn, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, R.</span><span> </span><span class="NLM_article-title">Other Antidepressants</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktVGntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2004&pages=263-324&author=S.+H.+Preskornauthor=R.+Ross&title=Other+Antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Other antidepressants</span></div><div class="casAuthors">Preskorn, S. H.; Ross, R.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">Antidepressants</span>),
    <span class="NLM_cas:pages">263-324</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  This chapter reviews the following antidepressants, which do not belong to one of the major classes described in the three preceding chapters: bupropion, mirtazapine and mianserin, nefazodone and trazodone, reboxetine, venlafaxine, duloxetine, milnacipran, and tianeptine.  Unlike the selective serotonin reuptake inhibitors (SSRIs), many of these antidepressants have an ascending rather than a flat dose-response curve.  The chapter provides a brief review of the chem., pharmacol., metab., safety and adverse effects, clin. use, and therapeutic indications of each antidepressant.  Bupropion is a weak dual uptake inhibitor of both dopamine and norepinephrine (NE).  Information concerning its pharmacodynamic and pharmacokinetic properties is limited, primarily because of the age of the drug (clin. trials begun in the mid-1970s).  Bupropion's most serious side effect is dose-dependent seizures, so that the highest recommended doses are 450 and 400 mg/day for the immediate release (IR) and sustained release (SR) formulations, resp.  Other adverse effects include restlessness, activation, tremors, insomnia, and nausea.  Bupropion was found to be an effective antidepressant in several double-blind studies that generally used doses higher than the max. recommended dose of 450 mg/day.  Despite fairly modest evidence of antidepressant efficacy, bupropion may be useful in a no. of clin. situations, including for patients with prominent psychomotor retardation, Parkinson's disease, or attention-deficit/hyperactivity disorder; for patients who have failed to respond to other antidepressants; and for patients who cannot tolerate sexual side effects of other antidepressants.  Bupropion has also been approved as an aid in smoking cessation.  Mirtazapine and its forerunner mianserin, are tetracyclic compds. with a unique mechanism of action.  Mirtazapine is an α2-antagonist that increases noradrenergic and serotonergic neurotransmission, the primary mechanism thought to underlie its antidepressant activity.  Mirtazapine does not cause many of the side effects assocd. with the SSRIs (e.g., nausea, loose stools, disturbed sleep pathol., sexual dysfunction) and causes minimal anticholinergic effects, no quinidine-like effects, and no effects on blood pressure.  Sedation can be a problem, esp. early in treatment, although this may be an advantage for patients with prominent insomnia, anxiety, or agitation.  Mirtazapine can cause increased appetite and wt. gain, transient neutropenia, and transient mild elevations of liver function tests.  Three cases of agranulocytosis were reported out of 3,000 patients in the mirtazapine clin. trial program, an incidence too low to draw any conclusion about cause and effect.  Although postmarketing experience has not found an unusual no. of cases of agranulocytosis, the package insert in the United States contains a warning that a white blood cell count should be done if a patient taking mirtazapine develops signs of fever or infection.  Because of its unique mechanism of action, mirtazapine may be efficacious for patients who have not benefited from other types of antidepressants.  Nefazodone and trazodone have chem. related structures that incorporate 5-HT2A receptor blockade plus weak 5-HT uptake blockade and possibly NE uptake blockade.  Trazodone is widely used as a nonhabit-forming sleep aid rather than as an antidepressant.  The antihistaminergic properties of trazodone are partly responsible for its popularity as a sleep aid, but can cause significant problems with daytime sedation when it is used as an antidepressant; however, it may be useful for treating agitation in geriatric patients.  Nefazodone, a more potent serotonin re-uptake inhibitor (SRI) than trazodone, was designed with the goal of producing a better antidepressant than trazodone, although it is a much weaker SRI than the SSRIs or venlafaxine.  Because it substantially inhibits CYP 3A3/4, nefazodone can elevate levels of coprescribed drugs metabolized via CYP 3A/3/4.  Nefazodone produces less activation and sexual dysfunction than the SSRIs and venlafaxine; it does not cause blood pressure elevation or disturb sleep physiol.; it improves subjective sleep quality.  The incidence and severity of the following adverse effects increase in a dose-dependent fashion as a function of the starting dose of nefazodone: dizziness/lightheadedness, confusion, sedation, gastrointestinal side effects.  Nefazodone appears to have efficacy in patients with clin. depression and prominent anxiety.  Although there appears to be greater interpatient variability in response to nefazodone than to many of the other newer antidepressants, nefazodone can be a useful option for patients who are unable to tolerate the adverse effects of the SSRIs.  Reboxetine is a selective NE reuptake pump inhibitor.  Its most common adverse effects are insomnia, sweating, constipation, dry mouth, and urinary hesitancy.  Most of the published trials of reboxetine have been active rather than placebo-controlled and results were not published in full with rigorous peer review, compromising the ability to make an assessment of efficacy.  Sufficient evidence of the efficacy of reboxetine in major depression has not been presented to receive approval for marketing in the United States, but reboxetine is available in several other countries.  Venlafaxine, a phenylethylamine, first inhibits the neuronal uptake pump for serotonin (SE) and then at higher concns. inhibits the uptake pump for NE.  Unlike tertiary amine tricyclic antidepressants (TCAs), which also inhibit the SE and NE uptake pumps, venlafaxine has low affinity for most other neural receptors and does not inhibit sodium fast channels, making it relatively safe in overdose.  Its adverse effects change qual. as the dose increases because of progressively greater blockade of NE uptake with increasing doses.  At low doses, the adverse-effect profile is similar to an SSRI with nausea, loose stools, sexual dysfunction, while venlafaxine at higher doses can produce generally mild increases in blood pressure, diaphoresis, tachycardia, tremors, and anxiety.  A disadvantage of venlafaxine relative to the SSRIs is the potential for dose-dependent blood pressure elevation, most likely due to the NE uptake inhibition caused by higher doses; however, this adverse effect is infrequently obsd. at doses below 225 mg/day.  Venlafaxine and the SSRIs have similar advantages over the TCAs and monoamine oxidase inhibitors.  Venlafaxine also has a no. of potential advantages over the SSRIs, including an ascending dose-antidepressant response curve, with possible greater overall efficacy at higher doses, evidence of more rapid onset of antidepressant action, evidence of superior efficacy in hospitalized patients with major depressive disorder compared with placebo or fluoxetine, and minimal effects on CYP enzymes in contrast to fluoxetine, fluvoxamine, paroxetine, and the non-SSRI, bupropion.  Duloxetine is a SE-NE re-uptake pump inhibitor, which is pending approval in the United States and other countries in late 2003.  It will be the third member of this pharmacol. class, which also contains venlafaxine and milnacipran (sibutramine, the fourth member of this class, is marketed for obesity rather than major depression).  Only a limited no. of articles have been published on this compd. but more should be expected shortly after its market introduction.  The manufacturer is initially seeking indications for both major depression and urinary incontinence.  Due to its inhibition of the SE and NE uptake pumps, duloxetine will undoubtedly carry a warning against use in combination with monoamine oxidase inhibitors.  It is also a moderate inhibitor of CYP 2D6, so that modest dose redns. and careful monitoring will be needed when prescribing duloxetine in combination with drugs that are preferentially metabolized by CYP 2D6, particularly those with narrow therapeutic indexes.  The most common side effects identified in clin. trials to date appear to be nausea, dry mouth, dizziness, constipation, insomnia, asthenia, and hypertension, consistent with its mechanisms of action.  Clin. trials to date have demonstrated rates of response and remission in patients with major depression that are comparable to other marketed antidepressants reviewed in this book.  Although milnacipran is marketed in France, Japan, and a few other countries, its development in the United States was discontinued.  It is an SE and NE reuptake inhibitor in the same class as venlafaxine, duloxetine, and the anti-obesity drug, sibutramine.  Milnacipran would be predicted to be susceptible to the same pharmacodynamic drug-drug interactions as other drugs in this class, but would not be expected to be involved in any CYP enzyme-mediated drug-drug interactions.  Milnacipran at doses of 50-200 mg/day has a favorable adverse-effect profile when compared with tertiary amine TCAs, including a lower incidence of abnormal liver function tests.  At doses of 50 or 100 mg twice a day but not 100 mg once a day, it caused a lower incidence of nausea and anxiety but a higher incidence of headache, dry mouth, and dysuria than did fluoxetine, 20 mg/day, or fluvoxamine, 100 mg twice a day.  As with other drugs in this class, dysuria is the most common troublesome and dose-dependent adverse effect (occurring in up to 7% of patients).  High-dose milnacipran has been reported to cause blood pressure elevation.  Like reboxetine, most of the published trials of milnacipran have been active rather than placebo-controlled and results were not published in full with rigorous peer review, compromising the ability to make an assessment of efficacy; however, findings to date suggest that milnacipran produces a superior antidepressant response compared with placebo at doses of 50 and 100 mg twice a day.  Tianeptine is marketed in France but few other countries around the world and there is little knowledge of this drug in the United States and other English-speaking countries.  However, a surprising amt. of research, particularly preclin., has been done with tianeptine, in part because of its apparent novel mechanism of action: Tianeptine, in contrast to most other antidepressants, increases SE uptake into neurons rather than blocking it.  However, its side-effect profile is similar to that of other newer antidepressants, with low abuse potential and a low risk of adverse effects on the cardiovascular system, the cholinergic systems, sleep/arousal, cognition, psychomotor functioning, and wt.  The most common adverse effects include nausea, constipation, abdominal pain, headache, dizziness, and altered dreaming.  Hepatotoxicity has been reported but is rare.  Like reboxetine and milnacipran, most of the published trials of tianeptine have been active rather than placebo-controlled and results were not published in full with rigorous peer review, compromising the ability to assess efficacy; however, trials to date do suggest efficacy in patients with major depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwEp5f1kPkH7Vg90H21EOLACvtfcHk0ljWeoyAOhoPYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktVGntbc%253D&md5=dd7cffe17e6ec1a58c507a02251641b5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPreskorn%26aufirst%3DS.%2BH.%26aulast%3DRoss%26aufirst%3DR.%26atitle%3DOther%2520Antidepressants%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2004%26volume%3D157%26spage%3D263%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Carminati, G. G.i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deriaz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertschy, G.</span><span> </span><span class="NLM_article-title">Low dose vanlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms</span> <span class="citation_source-journal">Prog. Neuropsychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">312</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2Fj.pnpbp.2005.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=16307837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVWks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2006&pages=312-315&author=G.+G.i.+Carminatiauthor=N.+Deriazauthor=G.+Bertschy&title=Low+dose+vanlafaxine+in+three+adolescents+and+young+adults+with+autistic+disorder+improves+self-injurious+behavior+and+attention+deficit%2Fhyperactivity+disorders+%28ADHD%29-like+symptoms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms</span></div><div class="casAuthors">Carminati, Giuliana Galli; Deriaz, Nicolas; Bertschy, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">312-315</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In our clin. practice, we have had good experiences with venlafaxine in the treatment of self-injurious behavior (SIB) and attention deficit/hyperactivity disorders (ADHD)-like symptoms in patients with pervasive developmental disorders (PDD), and we report here three cases of possible therapeutic response: (A) a 17-yr-old boy with autism and severe behavioral symptoms, including aggression toward self or property, SIB and hyperactivity, who appeared to respond to low-dose venlafaxine (18.75 mg/day); (B) a 23-yr-old woman with autism hyperactivity who appeared to respond to low-dose venlafaxine (18.75 mg/day); (C) a 17-yr-old girl with autism hyperactivity who appeared to respond to low-dose venlafaxine (18.75 mg/day).  Follow-ups occurred resp. 18, 36 and 6 mo after treatment initiation, making it possible to observe the stability of the clin. improvement in these cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosMh_ruuM69LVg90H21EOLACvtfcHk0ljWeoyAOhoPYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVWks74%253D&md5=c01183c070884a6452cd7e6e786ab6d2</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2005.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2005.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DCarminati%26aufirst%3DG.%2BG.i.%26aulast%3DDeriaz%26aufirst%3DN.%26aulast%3DBertschy%26aufirst%3DG.%26atitle%3DLow%2520dose%2520vanlafaxine%2520in%2520three%2520adolescents%2520and%2520young%2520adults%2520with%2520autistic%2520disorder%2520improves%2520self-injurious%2520behavior%2520and%2520attention%2520deficit%252Fhyperactivity%2520disorders%2520%2528ADHD%2529-like%2520symptoms%26jtitle%3DProg.%2520Neuropsychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2006%26volume%3D30%26spage%3D312%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Arnold, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crofford, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlreich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Detke, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyengar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. J.</span><span> </span><span class="NLM_article-title">A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2974</span><span class="NLM_x">–</span> <span class="NLM_lpage">2984</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1002%2Fart.20485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=15457467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2cXoslGgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=2974-2984&author=L.+M.+Arnoldauthor=Y.+Luauthor=L.+J.+Croffordauthor=M.+Wohlreichauthor=M.+J.+Detkeauthor=S.+Iyengarauthor=D.+J.+Goldstein&title=A+double-blind%2C+multicenter+trial+comparing+duloxetine+with+placebo+in+the+treatment+of+fibromyalgia+patients+with+or+without+major+depressive+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder</span></div><div class="casAuthors">Arnold, Lesley M.; Lu, Yili; Crofford, Leslie J.; Wohlreich, Madelaine; Detke, Michael J.; Iyengar, Smriti; Goldstein, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2974-2984</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The aim was to assess the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in subjects with primary fibromyalgia, with or without current major depressive disorder.  This study was a randomized, double-blind, placebo-controlled trial conducted in 18 outpatient research centers in the US.  A total of 207 subjects meeting the American College of Rheumatol. criteria for primary fibromyalgia were enrolled (89% female, 87% white, mean age 49 yr, 38% with current major depressive disorder).  After single-blind placebo treatment for 1 wk, subjects were randomly assigned to receive duloxetine 60 mg twice a day (n = 104) or placebo (n = 103) for 12 wk.  Co-primary outcome measures were the Fibromyalgia Impact Questionnaire (FIQ) total score (score range 0-80, with 0 indicating no impact) and FIQ pain score (score range 0-10).  Secondary outcome measures included mean tender point pain threshold, no. of tender points, FIQ fatigue, tiredness on awakening, and stiffness scores, Clin. Global Impression of Severity (CGI-Severity) scale, Patient Global Impression of Improvement (PGI-Improvement) scale, Brief Pain Inventory (short form), Medical Outcomes Study Short Form 36, Quality of Life in Depression Scale, and Sheehan Disability Scale.  Compared with placebo-treated subjects, duloxetine-treated subjects improved significantly more (P = 0.027) on the FIQ total score, with a treatment difference of -5.53 (95% confidence interval -10.43, -0.63), but not significantly more on the FIQ pain score (P = 0.130).  Compared with placebo-treated subjects, duloxetine-treated subjects had significantly greater redns. in Brief Pain Inventory av. pain severity score (P = 0.008), Brief Pain Inventory av. interference from pain score (P = 0.004), no. of tender points (P = 0.002), and FIQ stiffness score (P = 0.048), and had significantly greater improvement in mean tender point pain threshold (P = 0.002), CGI-Severity (P = 0.048), PGI-Improvement (P = 0.033), and several quality-of-life measures.  Duloxetine treatment improved fibromyalgia symptoms and pain severity regardless of baseline status of major depressive disorder.  Compared with placebo-treated female subjects (n = 92), duloxetine-treated female subjects (n = 92) demonstrated significantly greater improvement on most efficacy measures, while duloxetine-treated male subjects (n = 12) failed to improve significantly on any efficacy measure.  The treatment effect on significant pain redn. in female subjects was independent of the effect on mood or anxiety.  Duloxetine was safely administered and well tolerated.  In this randomized, controlled, 12-wk trial (with a 1-wk placebo lead-in phase), duloxetine was an effective and safe treatment for many of the symptoms assocd. with fibromyalgia in subjects with or without major depressive disorder, particularly for women, who had significant improvement across most outcome measures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdrZHNfd9FP7Vg90H21EOLACvtfcHk0ljWeoyAOhoPYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXoslGgsbo%253D&md5=7ce74fa526755954bdd06000ea2e1e52</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1002%2Fart.20485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.20485%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DL.%2BM.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DCrofford%26aufirst%3DL.%2BJ.%26aulast%3DWohlreich%26aufirst%3DM.%26aulast%3DDetke%26aufirst%3DM.%2BJ.%26aulast%3DIyengar%26aufirst%3DS.%26aulast%3DGoldstein%26aufirst%3DD.%2BJ.%26atitle%3DA%2520double-blind%252C%2520multicenter%2520trial%2520comparing%2520duloxetine%2520with%2520placebo%2520in%2520the%2520treatment%2520of%2520fibromyalgia%2520patients%2520with%2520or%2520without%2520major%2520depressive%2520disorder%26jtitle%3DArthritis%2520Rheum.%26date%3D2004%26volume%3D50%26spage%3D2974%26epage%3D2984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Arnold, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchett, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Souza, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyengar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernicke, J. F.</span><span> </span><span class="NLM_article-title">A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2005&pages=5-15&author=L.+M.+Arnoldauthor=A.+Rosenauthor=Y.+L.+Pritchettauthor=D.+N.+D%E2%80%99Souzaauthor=D.+J.+Goldsteinauthor=S.+Iyengarauthor=J.+F.+Wernicke&title=A+randomized%2C+double-blind%2C+placebo-controlled+trial+of+duloxetine+in+the+treatment+of+women+with+fibromyalgia+with+or+without+major+depressive+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DL.%2BM.%26aulast%3DRosen%26aufirst%3DA.%26aulast%3DPritchett%26aufirst%3DY.%2BL.%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DD.%2BN.%26aulast%3DGoldstein%26aufirst%3DD.%2BJ.%26aulast%3DIyengar%26aufirst%3DS.%26aulast%3DWernicke%26aufirst%3DJ.%2BF.%26atitle%3DA%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%2520of%2520duloxetine%2520in%2520the%2520treatment%2520of%2520women%2520with%2520fibromyalgia%2520with%2520or%2520without%2520major%2520depressive%2520disorder%26jtitle%3DPain%26date%3D2005%26volume%3D119%26spage%3D5%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sayar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aksu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ak, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosun, M.</span><span> </span><span class="NLM_article-title">Venlafaxine treatment of fibromyalgia</span> <span class="citation_source-journal">Ann. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1561</span><span class="NLM_x">–</span> <span class="NLM_lpage">1565</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2003&pages=1561-1565&author=K.+Sayarauthor=G.+Aksuauthor=I.+Akauthor=M.+Tosun&title=Venlafaxine+treatment+of+fibromyalgia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSayar%26aufirst%3DK.%26aulast%3DAksu%26aufirst%3DG.%26aulast%3DAk%26aufirst%3DI.%26aulast%3DTosun%26aufirst%3DM.%26atitle%3DVenlafaxine%2520treatment%2520of%2520fibromyalgia%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2003%26volume%3D37%26spage%3D1561%26epage%3D1565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemrick-Luecke, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlkeld, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiligenstein, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehlert, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, K. W.</span><span> </span><span class="NLM_article-title">Atomoxetine increases extracellular levels of norepinephrine and dopamine in the prefrontal cortex of rat: a potential mechanism for efficacy in attention hyperactivity disorder</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=699-711&author=F.+P.+Bymasterauthor=J.+S.+Katnerauthor=D.+J.+Nelsonauthor=S.+K.+Hemrick-Lueckeauthor=P.+J.+Threlkeldauthor=J.+H.+Heiligensteinauthor=S.+M.+Morinauthor=D.+R.+Gehlertauthor=K.+W.+Perry&title=Atomoxetine+increases+extracellular+levels+of+norepinephrine+and+dopamine+in+the+prefrontal+cortex+of+rat%3A+a+potential+mechanism+for+efficacy+in+attention+hyperactivity+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DKatner%26aufirst%3DJ.%2BS.%26aulast%3DNelson%26aufirst%3DD.%2BJ.%26aulast%3DHemrick-Luecke%26aufirst%3DS.%2BK.%26aulast%3DThrelkeld%26aufirst%3DP.%2BJ.%26aulast%3DHeiligenstein%26aufirst%3DJ.%2BH.%26aulast%3DMorin%26aufirst%3DS.%2BM.%26aulast%3DGehlert%26aufirst%3DD.%2BR.%26aulast%3DPerry%26aufirst%3DK.%2BW.%26atitle%3DAtomoxetine%2520increases%2520extracellular%2520levels%2520of%2520norepinephrine%2520and%2520dopamine%2520in%2520the%2520prefrontal%2520cortex%2520of%2520rat%253A%2520a%2520potential%2520mechanism%2520for%2520efficacy%2520in%2520attention%2520hyperactivity%2520disorder%26jtitle%3DNeuropsychopharmacology%26date%3D2002%26volume%3D27%26spage%3D699%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Krell, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leuchter, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, M.</span><span> </span><span class="NLM_article-title">Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain</span> <span class="citation_source-journal">Psychosomatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=379-384&author=H.+V.+Krellauthor=A.+F.+Leuchterauthor=I.+A.+Cookauthor=M.+Abrams&title=Evaluation+of+reboxetine%2C+a+noradrenergic+antidepressant%2C+for+the+treatment+of+fibromyalgia+and+chronic+low+back+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrell%26aufirst%3DH.%2BV.%26aulast%3DLeuchter%26aufirst%3DA.%2BF.%26aulast%3DCook%26aufirst%3DI.%2BA.%26aulast%3DAbrams%26aufirst%3DM.%26atitle%3DEvaluation%2520of%2520reboxetine%252C%2520a%2520noradrenergic%2520antidepressant%252C%2520for%2520the%2520treatment%2520of%2520fibromyalgia%2520and%2520chronic%2520low%2520back%2520pain%26jtitle%3DPsychosomatics%26date%3D2005%26volume%3D46%26spage%3D379%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Berigan, T.</span><span> </span><span class="NLM_article-title">Use of atomoxetine adjunctively in fybromyalgia syndrome</span> <span class="citation_source-journal">Can. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">500</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=15362262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A280%3ADC%252BD2cvlsValsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2004&pages=499-500&author=T.+Berigan&title=Use+of+atomoxetine+adjunctively+in+fybromyalgia+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">The use of atomoxetine adjunctively in fibromyalgia syndrome</span></div><div class="casAuthors">Berigan Tim</div><div class="citationInfo"><span class="NLM_cas:title">Canadian journal of psychiatry. Revue canadienne de psychiatrie</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">499-500</span>
        ISSN:<span class="NLM_cas:issn">0706-7437</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTesu-fHiMb9besJRIHUP1ofW6udTcc2eaVLKs_46RObrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cvlsValsg%253D%253D&md5=531650ac7fbf1bbf281ea5dd4cb062b5</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerigan%26aufirst%3DT.%26atitle%3DUse%2520of%2520atomoxetine%2520adjunctively%2520in%2520fybromyalgia%2520syndrome%26jtitle%3DCan.%2520J.%2520Psychiatry%26date%3D2004%26volume%3D49%26spage%3D499%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Yardley, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husbands, G. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, Gary, Butch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bicksler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muth, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sielecki, A. R.</span><span> </span><span class="NLM_article-title">2-Phenyl-2-(1-hydroxylcycloalkyl)ethylamine derivatives: synthesis and antidepressant activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2899</span><span class="NLM_x">–</span> <span class="NLM_lpage">2905</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00172a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=2899-2905&author=J.+P.+Yardleyauthor=G.+E.+M.+Husbandsauthor=J.+Stack%2C+Gary%2C+Butchauthor=J.+Bickslerauthor=J.+A.+Moyerauthor=E.+A.+Muthauthor=T.+Andreeauthor=H.+Fletcherauthor=M.+N.+G.+Jamesauthor=A.+R.+Sielecki&title=2-Phenyl-2-%281-hydroxylcycloalkyl%29ethylamine+derivatives%3A+synthesis+and+antidepressant+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm00172a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00172a035%26sid%3Dliteratum%253Aachs%26aulast%3DYardley%26aufirst%3DJ.%2BP.%26aulast%3DHusbands%26aufirst%3DG.%2BE.%2BM.%26aulast%3DStack%252C%2BGary%252C%2BButch%26aufirst%3DJ.%26aulast%3DBicksler%26aufirst%3DJ.%26aulast%3DMoyer%26aufirst%3DJ.%2BA.%26aulast%3DMuth%26aufirst%3DE.%2BA.%26aulast%3DAndree%26aufirst%3DT.%26aulast%3DFletcher%26aufirst%3DH.%26aulast%3DJames%26aufirst%3DM.%2BN.%2BG.%26aulast%3DSielecki%26aufirst%3DA.%2BR.%26atitle%3D2-Phenyl-2-%25281-hydroxylcycloalkyl%2529ethylamine%2520derivatives%253A%2520synthesis%2520and%2520antidepressant%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D2899%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Mason, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deecher, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richmond, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahaney, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trybulski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneker, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span> </span><span class="NLM_article-title">Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1124%2Fjpet.107.125716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=17673606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynsbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2007&pages=720-729&author=J.+N.+Masonauthor=D.+C.+Deecherauthor=R.+L.+Richmondauthor=G.+Stackauthor=P.+E.+Mahaneyauthor=E.+J.+Trybulskiauthor=R.+C.+Winnekerauthor=R.+D.+Blakely&title=Desvenlafaxine+succinate+identifies+novel+antagonist+binding+determinants+in+the+human+norepinephrine+transporter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter</span></div><div class="casAuthors">Mason, John N.; Deecher, Darlene C.; Richmond, Rhonda L.; Stack, Gary; Mahaney, Paige E.; Trybulski, Eugene; Winneker, Richard C.; Blakely, Randy D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">720-729</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Desvenlafaxine succinate (DVS) is a recently introduced antagonist of the human norepinephrine and serotonin transporters (hNET and hSERT, resp.), currently in clin. development for use in the treatment of major depressive disorder and vasomotor symptoms assocd. with menopause.  Initial evaluation of the pharmacol. properties of DVS revealed significantly reduced potency for the hNET expressed in membranes compared with whole cells when competing for [3H]nisoxetine (NIS) binding.  Using hNET in transfected human embryonic kidney-293 cells, this difference in potency for DVS at sites labeled by [3H]NIS was found to distinguish DVS, the DVS analog rac-1-[1-(3-chloro-phenyl)-2-(4-methylpiperazin-1-yl)-ethyl]cyclohexanol (WY-46824), methylphenidate, and the cocaine analog 3β-(4-iodophenyl)tropane-2β-carboxylic acid Me ester (RTI-55) from other hNET antagonists, such as NIS, mazindol, tricyclic antidepressants, and cocaine.  These differences seem not to arise from prepn.-specific perturbations of ligand intrinsic affinity or antagonist-sp. surface trafficking but rather from protein conformational alterations that perturb the relationships between distinct hNET binding sites.  In an initial search for mol. features that differentially define antagonist binding determinants, we document that Val148 in hNET transmembrane domain 3 selectively disrupts NIS binding but not that of DVS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooe8l03U5I17Vg90H21EOLACvtfcHk0lgaMxKM36jZgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynsbzM&md5=5e4e4e39e1fbf412fb6dd7af67fc33a1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.125716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.125716%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%2BN.%26aulast%3DDeecher%26aufirst%3DD.%2BC.%26aulast%3DRichmond%26aufirst%3DR.%2BL.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DMahaney%26aufirst%3DP.%2BE.%26aulast%3DTrybulski%26aufirst%3DE.%2BJ.%26aulast%3DWinneker%26aufirst%3DR.%2BC.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26atitle%3DDesvenlafaxine%2520succinate%2520identifies%2520novel%2520antagonist%2520binding%2520determinants%2520in%2520the%2520human%2520norepinephrine%2520transporter%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D323%26spage%3D720%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Reith, M. E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meisler, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sershen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lajtha, A.</span><span> </span><span class="NLM_article-title">Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1123</span><span class="NLM_x">–</span> <span class="NLM_lpage">1129</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1986&pages=1123-1129&author=M.+E.+A.+Reithauthor=B.+E.+Meislerauthor=H.+Sershenauthor=A.+Lajtha&title=Structural+requirements+for+cocaine+congeners+to+interact+with+dopamine+and+serotonin+uptake+sites+in+mouse+brain+and+to+induce+stereotyped+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReith%26aufirst%3DM.%2BE.%2BA.%26aulast%3DMeisler%26aufirst%3DB.%2BE.%26aulast%3DSershen%26aufirst%3DH.%26aulast%3DLajtha%26aufirst%3DA.%26atitle%3DStructural%2520requirements%2520for%2520cocaine%2520congeners%2520to%2520interact%2520with%2520dopamine%2520and%2520serotonin%2520uptake%2520sites%2520in%2520mouse%2520brain%2520and%2520to%2520induce%2520stereotyped%2520behavior%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1986%26volume%3D35%26spage%3D1123%26epage%3D1129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Madras, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahey, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canfield, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spealman, R. D.</span><span> </span><span class="NLM_article-title">Effects of cocaine and related drugs in nonhuman primates. I. [<sup>3</sup>H]Cocaine binding sites in caudate-putamen</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=2529364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADyaL1MXmtV2jur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1989&pages=131-141&author=B.+K.+Madrasauthor=M.+A.+Faheyauthor=J.+Borgmanauthor=D.+R.+Canfieldauthor=R.+D.+Spealman&title=Effects+of+cocaine+and+related+drugs+in+nonhuman+primates.+I.+%5B3H%5DCocaine+binding+sites+in+caudate-putamen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of cocaine and related drugs in nonhuman primates.  I.  [3H]Cocaine binding sites in caudate-putamen</span></div><div class="casAuthors">Madras, Bertha K.; Fahey, Michele A.; Bergman, Jack; Canfield, Don R.; Spealman, Roger D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-41</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Specific binding sites for [3H]cocaine were identified in caudate-putamen membranes prepd. from nonhuman primate brains (Macaca fascicularis and Saimiri sciureus).  Satn. of the sites was detd. in competition studies using a fixed concn. of [3H]cocaine (2.7 nM) and increasing concns. of unlabeled cocaine (1 pM-100 μM).  Computer resoln. of the shallow displacement curve (nH, 0.58) revealed that a 2-component binding model [Kd1, 19.2 nM, max. binding1 (Bmax1), 28.3 pmol/g of tissue; Kd2, 1120 nM, Bmax2, 431 pmol/g of tissue] was statistically preferred over a 1-component model (K50, 283 nM, Bmax, 471 pmol/g of tissue).  Binding of [3H]cocaine was NaCl-dependent, with specific binding reduced by 72% when NaCl (100 mM) was omitted from the incubation medium.  [3H]cocaine was displaced stereoselectively by the enantiomers of cocaine and by the diastereoisomers of cocaine and its phenyltropane analog.  Cocaine congeners displaced specifically bound [3H]cocaine with IC50 values ranging from 17 nM to >100 μM in the following rank order of potency: WIN 35,428 > WIN 35,065-2 > (-)-cocaine > WIN 35,981 > (-)-norcocaine > WIN 35,140 > (+)-cocaine, (+)-pseudococaine > 3α-tropanyl-1H-indolecarboxylic acid ester > 1αH-tropan-3-yl-3,5-dichlorobenzoate > benzoylecgonine, benzoylnorecgonine, and (-)-pseudococaine.  Several monoamine uptake inhibitors structurally unrelated to cocaine also displaced [3H]cocaine with IC50 values ranging from 1.6 nM to 50 μM.  The rank order of potency was: (±)-trans-3-(3',4'-dichlorophenyl)-N-methyl-1-indanamine > mazindol > nomifensine > methylphenidate, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl-4-(3-phenylpropyl)piperazine, N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine > (-)-cocaine > 1-amino-4-phenylbicyclo-[2,2,2]-octane > bupropion, nisoxetine > desipramine, talsupram > citalopram.  Other drugs, including the dopamine releasing agent (+)-amphetamine and the dopamine receptor agonists (-)-apomorphine, (+)-4-propyl-9-hydroxy-naphthoxazine, quinpirole, and SKF 38393 were weak displacers of [3H]cocaine.  Monoamine neurotransmitters were also relatively weak, but dopamine was considered more potent than either norepinephrine or serotonin.  The affinities of the cocaine congeners and other monoamine uptake inhibitors at [3H]cocaine binding sites correspond closely with their reported potencies for inhibiting uptake of dopamine (r, 0.93), but not norepinephrine or serotonin (r, 0.54 and 0.38, resp.).  The results are consistent with the view that [3H]cocaine binding sites in monkey caudate-putamen are assocd. with elements of the dopamine uptake system and mediate the inhibitory effects of cocaine on dopamine transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaAo6KhEy2t7Vg90H21EOLACvtfcHk0lgIfssXddwUhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXmtV2jur4%253D&md5=fa81bb26f5fbd9c460d2477d96980b6b</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMadras%26aufirst%3DB.%2BK.%26aulast%3DFahey%26aufirst%3DM.%2BA.%26aulast%3DBorgman%26aufirst%3DJ.%26aulast%3DCanfield%26aufirst%3DD.%2BR.%26aulast%3DSpealman%26aufirst%3DR.%2BD.%26atitle%3DEffects%2520of%2520cocaine%2520and%2520related%2520drugs%2520in%2520nonhuman%2520primates.%2520I.%2520%255B3H%255DCocaine%2520binding%2520sites%2520in%2520caudate-putamen%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1989%26volume%3D251%26spage%3D131%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Steru, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chermat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thierry, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, P.</span><span> </span><span class="NLM_article-title">The tail suspension test: a new method for screening antidepressants in mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1985&pages=367-370&author=L.+Steruauthor=R.+Chermatauthor=B.+Thierryauthor=P.+Simon&title=The+tail+suspension+test%3A+a+new+method+for+screening+antidepressants+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSteru%26aufirst%3DL.%26aulast%3DChermat%26aufirst%3DR.%26aulast%3DThierry%26aufirst%3DB.%26aulast%3DSimon%26aufirst%3DP.%26atitle%3DThe%2520tail%2520suspension%2520test%253A%2520a%2520new%2520method%2520for%2520screening%2520antidepressants%2520in%2520mice%26jtitle%3DPsychopharmacology%26date%3D1985%26volume%3D85%26spage%3D367%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Porsolt, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chermat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenegre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avril, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janvier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steru, L.</span><span> </span><span class="NLM_article-title">Use of the automated tail suspension test for the primary screening of psychotropic agents</span> <span class="citation_source-journal">Arch. Int. Pharmacodyn. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=2889430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADyaL2sXlsVKksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=1987&pages=11-30&author=R.+D.+Porsoltauthor=R.+Chermatauthor=A.+Lenegreauthor=I.+Avrilauthor=S.+Janvierauthor=L.+Steru&title=Use+of+the+automated+tail+suspension+test+for+the+primary+screening+of+psychotropic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Use of the automated tail suspension test for the primary screening of psychotropic agents</span></div><div class="casAuthors">Porsolt, R. D.; Chermat, R.; Lenegre, A.; Avril, I.; Janvier, S.; Steru, L.</div><div class="citationInfo"><span class="NLM_cas:title">Archives Internationales de Pharmacodynamie et de Therapie</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-30</span>CODEN:
                <span class="NLM_cas:coden">AIPTAK</span>;
        ISSN:<span class="NLM_cas:issn">0003-9780</span>.
    </div><div class="casAbstract">An animal model for screening psychotropic agents is described.  Mice, when suspended by the tail, will alternate between active attempts to escape and immobility.  A specially developed computerized device (ITEMATIC-TST) automatically measures the duration of immobility of 6 mice at one time and at the same time provides a measure of the energy expended by each animal, the power of the movements.  Use of these 2 parameters enables activity profiles to be generated which can distinguish different classes of psychotropic activity.  Immobility is decreased by antidepressants and psychostimulants, but increased by neuroleptics and minor tranquilizers.  Minor tranquilizers can be distinguished from neuroleptics in that they decrease the power of the movements, whereas neuroleptics are without effect on this parameter.  The present expts. examd. whether the activity profiles generated in this procedure could indeed be useful for primary psychotropic screening.  The results largely confirm the usefulness of this model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1DQphbIM5yLVg90H21EOLACvtfcHk0lgIfssXddwUhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlsVKksrk%253D&md5=266f283122e69a86186d304aa0f940cc</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPorsolt%26aufirst%3DR.%2BD.%26aulast%3DChermat%26aufirst%3DR.%26aulast%3DLenegre%26aufirst%3DA.%26aulast%3DAvril%26aufirst%3DI.%26aulast%3DJanvier%26aufirst%3DS.%26aulast%3DSteru%26aufirst%3DL.%26atitle%3DUse%2520of%2520the%2520automated%2520tail%2520suspension%2520test%2520for%2520the%2520primary%2520screening%2520of%2520psychotropic%2520agents%26jtitle%3DArch.%2520Int.%2520Pharmacodyn.%2520Ther.%26date%3D1987%26volume%3D288%26spage%3D11%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Teste, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinjard, P.</span><span> </span><span class="NLM_article-title">Electrotherapy in mice: dopaminergic and noradrenergic effects in the tail suspension test</span> <span class="citation_source-journal">Fundam. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=2341112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A280%3ADyaK3c3ls1SqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1990&pages=39-47&author=J.+F.+Testeauthor=I.+Martinauthor=P.+Rinjard&title=Electrotherapy+in+mice%3A+dopaminergic+and+noradrenergic+effects+in+the+tail+suspension+test"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Electrotherapy in mice: dopaminergic and noradrenergic effects in the Tail Suspension Test</span></div><div class="casAuthors">Teste J F; Martin I; Rinjard P</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & clinical pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-47</span>
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    </div><div class="casAbstract">The Tail Suspension Test (TST) is a psychotropic screening test which is used principally to detect antidepressant activity.  Electrotherapy (ECT) is used to treat depressions which are resistant to the usual antidepressant drugs and has proved to have a profile in the TST approaching that of antidepressants after treating mice at the rate of 2 shocks per day for 5 days.  The results of a single treatment were not statistically different from those of the control group, whereas single daily treatment for 5 days showed a reduction in immobility which did not differ significantly from the control group.  The reduction in immobility, induced by 5 days of ECT treatment twice daily, was antagonized by sulpiride and prazosin but not by yohimbine, methysergide, metergoline and DL propranolol.  The results suggest that electrotherapy leads to an increase in noradrenergic and dopaminergic activities expressed by a reduction in immobility in the TST.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAv6SAeOkkbIHWj6b1v8uTfW6udTcc2eYBQigkyNVhz7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c3ls1SqtA%253D%253D&md5=ad81c4945c61ae070b06d6a749758024</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTeste%26aufirst%3DJ.%2BF.%26aulast%3DMartin%26aufirst%3DI.%26aulast%3DRinjard%26aufirst%3DP.%26atitle%3DElectrotherapy%2520in%2520mice%253A%2520dopaminergic%2520and%2520noradrenergic%2520effects%2520in%2520the%2520tail%2520suspension%2520test%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D1990%26volume%3D4%26spage%3D39%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cryan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mombereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassout, A.</span><span> </span><span class="NLM_article-title">The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2Fj.neubiorev.2005.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=15890404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFWlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2005&pages=571-625&author=J.+F.+Cryanauthor=C.+Mombereauauthor=A.+Vassout&title=The+tail+suspension+test+as+a+model+for+assessing+antidepressant+activity%3A+review+of+pharmacological+and+genetic+studies+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13dR"><div class="casContent"><span class="casTitleNuber">13d</span><div class="casTitle"><span class="NLM_cas:atitle">The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice</span></div><div class="casAuthors">Cryan, John F.; Mombereau, Cedric; Vassout, Annick</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience and Biobehavioral Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">571-625</span>CODEN:
                <span class="NLM_cas:coden">NBREDE</span>;
        ISSN:<span class="NLM_cas:issn">0149-7634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Since its introduction almost 20 years ago, the tail suspension test has become one of the most widely used models for assessing antidepressant-like activity in mice.  The test is based on the fact that animals subjected to the short-term, inescapable stress of being suspended by their tail, will develop an immobile posture.  Various antidepressant medications reverse the immobility and promote the occurrence of escape-related behavior.  This review focuses on the utility this test as part of a research program aimed at understanding the mechanism of action of antidepressants.  We discuss the inherent difficulties in modeling depression in rodents.  We describe how the tail suspension differs from the closely related forced swim test.  Further, we address some key issues assocd. with using the TST as a model of antidepressant action.  We discuss issues regarding whether it satisfies criteria to be a valid model for assessing depression-related behavioral traits.  We elaborate on the tests' ease of use, strain differences obsd. in the test and gender effects in the test.  We focus on the utility of the test for genetic anal.  Furthermore, we discuss the concept of whether immobility maybe a behavioral trait relevant to depression.  All of the available pharmacol. data using the test in genetically modified mice is collated.  Special attention is given to selective breeding programs such as the Rouen 'depressed' mice which have been bred for high and low immobility in the tail suspension test.  We provide an extensive pooling of the pharmacol. studies published to date using the test.  Finally, we provide novel pharmacol. validation of an automated system (Bioseb) for assessing immobility.  Taken together, we conclude that the tail suspension test is a useful test for assessing the behavioral effects of antidepressant compds. and other pharmacol. and genetic manipulations relevant to depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPJ-qSeXwP-LVg90H21EOLACvtfcHk0li1v-_j5jG6gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFWlurk%253D&md5=e76fb149061f03dbe30fa94202d87b37</span></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2005.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2005.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DCryan%26aufirst%3DJ.%2BF.%26aulast%3DMombereau%26aufirst%3DC.%26aulast%3DVassout%26aufirst%3DA.%26atitle%3DThe%2520tail%2520suspension%2520test%2520as%2520a%2520model%2520for%2520assessing%2520antidepressant%2520activity%253A%2520review%2520of%2520pharmacological%2520and%2520genetic%2520studies%2520in%2520mice%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2005%26volume%3D29%26spage%3D571%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Ripoll, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dailly, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hascoet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourin, M.</span><span> </span><span class="NLM_article-title">Antidepressant-like effects in various mice strains in the tail suspension test</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2FS0166-4328%2803%2900034-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=12900045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFyisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2003&pages=193-200&author=N.+Ripollauthor=J.+P.+Davidauthor=E.+Daillyauthor=M.+Hascoetauthor=M.+Bourin&title=Antidepressant-like+effects+in+various+mice+strains+in+the+tail+suspension+test"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like effects in various mice strains in the tail suspension test</span></div><div class="casAuthors">Ripoll, Nadege; David, Denis Joseph Paul; Dailly, Eric; Hascoet, Martine; Bourin, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">193-200</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Several studies have reported rodent strain differences in the response to antidepressants in animal models of depression.  The aim of the present study was to investigate the potential contribution of genetic factors to antidepressant response in an animal model of depression: the tail suspension test (TST).  For this study 4 mice strains (Swiss and NMRI, 2 outbred strains and DBA/2 and C57BL/6J Rj, 2 inbred strains) were submitted to the TST after acute administration of 5 antidepressants: the tricyclic antidepressants (TCAs) imipramine and desipramine, the selective serotonin (5-HT) reuptake inhibitors (SSRIs) paroxetine and citalopram and the dopamine reuptake inhibitor bupropion.  The C57BL/6J Rj strain had a longer baseline immobility time in comparison to the other strains.  All antidepressants studied in this work decreased immobility time in the Swiss and C57BL/6J Rj strains.  However, the Swiss strain displayed greater sensitivity to citalopram (from 2 mg/kg) and C57BL/6J Rj to paroxetine (from 0.5 mg/kg).  This latter presented a greater size-effect with citalopram than with other strains and reached > 60% from 8 mg/kg.  Moreover the size-effect of desipramine, paroxetine, and bupropion in Swiss mice was greater than in the other strains in the TST.  The NMRI and DBA/2 mice only responded to 5-HT reuptake inhibitors, both selective (paroxetine, citalopram) or non-selective (imipramine).  The NMRI strain was more sensitive to imipramine and presented a size-effect (43% at 8 mg/kg) superior to those of other strains.  DBA/2 strain was more sensitive to citalopram than paroxetine and imipramine.  The authors' results suggest that response to an antidepressant treatment is under control of genetic factors and that the strain of mouse is an important parameter to consider.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRT0MS5Wb4lLVg90H21EOLACvtfcHk0li1v-_j5jG6gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFyisrg%253D&md5=20e317b1c83b188a0c438f20d68ba750</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0166-4328%2803%2900034-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-4328%252803%252900034-2%26sid%3Dliteratum%253Aachs%26aulast%3DRipoll%26aufirst%3DN.%26aulast%3DDavid%26aufirst%3DJ.%2BP.%26aulast%3DDailly%26aufirst%3DE.%26aulast%3DHascoet%26aufirst%3DM.%26aulast%3DBourin%26aufirst%3DM.%26atitle%3DAntidepressant-like%2520effects%2520in%2520various%2520mice%2520strains%2520in%2520the%2520tail%2520suspension%2520test%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2003%26volume%3D143%26spage%3D193%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Siegmund, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadmus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, G.</span><span> </span><span class="NLM_article-title">A method for evaluating both non-narcotic and narcotic analgesics</span> <span class="citation_source-journal">Proc. Soc. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1957&pages=279-731&author=E.+Siegmundauthor=R.+Cadmusauthor=G.+Lu&title=A+method+for+evaluating+both+non-narcotic+and+narcotic+analgesics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiegmund%26aufirst%3DE.%26aulast%3DCadmus%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DG.%26atitle%3DA%2520method%2520for%2520evaluating%2520both%2520non-narcotic%2520and%2520narcotic%2520analgesics%26jtitle%3DProc.%2520Soc.%2520Exp.%2520Biol.%2520Med.%26date%3D1957%26volume%3D95%26spage%3D279%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhart, G. F.</span><span> </span><span class="NLM_article-title">Spinal serotonin receptors mediate descending facilitation of a nociceptive reflex from the nuclei reticualris gigantocellularis and gigantocellularis pars alpha in the rat</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">550</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2F0006-8993%2891%2990402-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=1888999" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=550&publication_year=1991&pages=35-48&author=M.+Zhouauthor=G.+F.+Gebhart&title=Spinal+serotonin+receptors+mediate+descending+facilitation+of+a+nociceptive+reflex+from+the+nuclei+reticualris+gigantocellularis+and+gigantocellularis+pars+alpha+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2891%2990402-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252891%252990402-H%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DGebhart%26aufirst%3DG.%2BF.%26atitle%3DSpinal%2520serotonin%2520receptors%2520mediate%2520descending%2520facilitation%2520of%2520a%2520nociceptive%2520reflex%2520from%2520the%2520nuclei%2520reticualris%2520gigantocellularis%2520and%2520gigantocellularis%2520pars%2520alpha%2520in%2520the%2520rat%26jtitle%3DBrain%2520Res.%26date%3D1991%26volume%3D550%26spage%3D35%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Holden, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proudfit, H. K.</span><span> </span><span class="NLM_article-title">Microinjection of morphine in the A7 catecholamine cell group produces opposing effects on nociception that are mediated by alpha1- and alpha2-adrenoceptors</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">990</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1999&pages=979-990&author=J.+E.+Holdenauthor=E.+J.+Schwartzauthor=H.+K.+Proudfit&title=Microinjection+of+morphine+in+the+A7+catecholamine+cell+group+produces+opposing+effects+on+nociception+that+are+mediated+by+alpha1-+and+alpha2-adrenoceptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolden%26aufirst%3DJ.%2BE.%26aulast%3DSchwartz%26aufirst%3DE.%2BJ.%26aulast%3DProudfit%26aufirst%3DH.%2BK.%26atitle%3DMicroinjection%2520of%2520morphine%2520in%2520the%2520A7%2520catecholamine%2520cell%2520group%2520produces%2520opposing%2520effects%2520on%2520nociception%2520that%2520are%2520mediated%2520by%2520alpha1-%2520and%2520alpha2-adrenoceptors%26jtitle%3DNeuroscience%26date%3D1999%26volume%3D91%26spage%3D979%26epage%3D990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gebhart, G.</span><span> </span><span class="NLM_article-title">Modulatory Effects of Descending Systems on Spinal Dorsal Horn Neurons</span>. In  <span class="citation_source-book">Spinal Afferent Processing</span>; <span class="NLM_contrib-group">Yaksh, T. L.</span>, Ed.; <span class="NLM_publisher-name">Plenum</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1986</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">391</span>− <span class="NLM_lpage">416</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&pages=391-416&author=G.+Gebhart&title=Spinal+Afferent+Processing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGebhart%26aufirst%3DG.%26atitle%3DModulatory%2520Effects%2520of%2520Descending%2520Systems%2520on%2520Spinal%2520Dorsal%2520Horn%2520Neurons%26btitle%3DSpinal%2520Afferent%2520Processing%26aulast%3DYaksh%26aufirst%3DT.%2BL.%26pub%3DPlenum%26date%3D1986%26spage%3D391%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fields, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinricher, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, P.</span><span> </span><span class="NLM_article-title">Neurotransmitters in nociceptive modulatory circuits</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1146%2Fannurev.ne.14.030191.001251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=1674413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADyaK3MXlt1Ohs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1991&pages=219-245&author=H.+L.+Fieldsauthor=M.+M.+Heinricherauthor=P.+Mason&title=Neurotransmitters+in+nociceptive+modulatory+circuits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotransmitters in nociceptive modulatory circuits</span></div><div class="casAuthors">Fields, Howard L.; Heinricher, Mary M.; Mason, Peggy</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">219-45</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    </div><div class="casAbstract">A review, with 169 refs.  The roles of enkephalin, excitatory amino acids, norepinephrine, neurotensin, and serotonin within the rostral ventromedial medulla (RVM) and in the dorsal horn region in the modulation of pain are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlF1JpMq9hU7Vg90H21EOLACvtfcHk0lg53djp5fXPoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlt1Ohs7c%253D&md5=3715cea898264507bbe171b2bbd31c90</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1146%2Fannurev.ne.14.030191.001251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.ne.14.030191.001251%26sid%3Dliteratum%253Aachs%26aulast%3DFields%26aufirst%3DH.%2BL.%26aulast%3DHeinricher%26aufirst%3DM.%2BM.%26aulast%3DMason%26aufirst%3DP.%26atitle%3DNeurotransmitters%2520in%2520nociceptive%2520modulatory%2520circuits%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1991%26volume%3D14%26spage%3D219%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Fields, H. L.; Basbaum, A.</span><span> </span><span class="NLM_article-title">Central Nervous System Mechanisms of Pain Modulation</span>. In  <span class="citation_source-book">Textbook of Pain</span>; <span class="NLM_contrib-group">Wall, P. D.; Melzack, R.</span>, Eds.; <span class="NLM_publisher-name">Churchill Livingstone</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">1999</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">309</span>− <span class="NLM_lpage">329</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=309-329&author=H.+L.+Fields&author=A.+Basbaumauthor=P.+D.+Wall&author=R.+Melzack&title=Textbook+of+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFields%26aufirst%3DH.%2BL.%26atitle%3DCentral%2520Nervous%2520System%2520Mechanisms%2520of%2520Pain%2520Modulation%26btitle%3DTextbook%2520of%2520Pain%26aulast%3DWall%26aufirst%3DP.%2BD.%26pub%3DChurchill%2520Livingstone%26date%3D1999%26spage%3D309%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">Descending control of pain</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2FS0301-0082%2802%2900009-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=12034378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVarsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2002&pages=355-474&author=M.+J.+Millan&title=Descending+control+of+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Descending control of pain</span></div><div class="casAuthors">Millan, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">355-474</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Upon receipt in the dorsal horn (DH) of the spinal cord, nociceptive (pain-signalling) information from the viscera, skin and other organs is subject to extensive processing by a diversity of mechanisms, certain of which enhance, and certain of which inhibit, its transfer to higher centers.  In this regard, a network of descending pathways projecting from cerebral structures to the DH plays a complex and crucial role.  Specific centrifugal pathways either suppress (descending inhibition) or potentiate (descending facilitation) passage of nociceptive messages to the brain.  Engagement of descending inhibition by the opioid analgesic, morphine, fulfils an important role in its pain-relieving properties, while induction of analgesia by the adrenergic agonist, clonidine, reflects actions at α2-adrenoceptors (α2-ARs) in the DH normally recruited by descending pathways.  However, opioids and adrenergic agents exploit but a tiny fraction of the vast panoply of mechanisms now known to be involved in the induction and/or expression of descending controls.  For example, no drug interfering with descending facilitation is currently available for clin. use.  The present review focuses on: (1) the organization of descending pathways and their pathophysiol. significance; (2) the role of individual transmitters and specific receptor types in the modulation and expression of mechanisms of descending inhibition and facilitation and (3) the advantages and limitations of established and innovative analgesic strategies which act by manipulation of descending controls.  Knowledge of descending pathways has increased exponentially in recent years, so this is an opportune moment to survey their operation and therapeutic relevance to the improved management of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgzpGfk_Zv97Vg90H21EOLACvtfcHk0lg53djp5fXPoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVarsr0%253D&md5=9826f6eb6f47fb3e9d663adf496f5456</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2802%2900009-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252802%252900009-6%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DDescending%2520control%2520of%2520pain%26jtitle%3DProg.%2520Neurobiol.%26date%3D2002%26volume%3D66%26spage%3D355%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Leventhal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, K. E.</span><span> </span><span class="NLM_article-title">Differential and synergistic effects of selective norepinephrine and serotonin reuptake inhibitors in rodent models of pain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">1178</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1124%2Fjpet.106.109728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=17142646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1Wgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=1178-1186&author=L.+Leventhalauthor=V.+Smithauthor=G.+Hornbyauthor=T.+H.+Andreeauthor=M.+R.+Brandtauthor=K.+E.+Rogers&title=Differential+and+synergistic+effects+of+selective+norepinephrine+and+serotonin+reuptake+inhibitors+in+rodent+models+of+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Differential and synergistic effects of selective norepinephrine and serotonin reuptake inhibitors in rodent models of pain</span></div><div class="casAuthors">Leventhal, Liza; Smith, Valerie; Hornby, Geoffrey; Andree, Terrance H.; Brandt, Michael R.; Rogers, Kathryn E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1178-1185</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">There is increasing recognition that norepinephrine (NE) and serotonin (5-HT) reuptake inhibitors (NRIs and SRIs) are efficacious in treating some types of pain.  To date, studies have not systematically evaluated the relative activity at the NE and/or 5-HT transporter required for maximal efficacy in rodent pain models.  Known selective NE and 5-HT reuptake inhibitors reboxetine, desipramine, fluoxetine, and paroxetine were evaluated in both in vitro and in vivo assays.  Using the spinal nerve ligation model of neuropathic pain, the compds. differentially reversed tactile allodynia.  Evaluation of a broader spectrum of reuptake inhibitors in the para-phenylquinone (PPQ)-induced abdominal constriction model, a model of acute visceral pain, demonstrated that both the SRIs and the NRIs significantly blocked abdominal constrictions.  However, the magnitude of this effect was greater following treatment with compds. having greater affinity for NRI compared with SRI affinity.  In addn., isobolog. analyses indicated significant synergistic effects for all combinations of desipramine and fluoxetine in the PPQ model of visceral pain.  Collectively, the present results support the hypothesis that compds. with greater NRI activity should be more effective for the treatment of pain than compds. having only SRI activity, and this hypothesis is also supported by clin. data.  These studies also suggest that the potency and effectiveness of NRIs might be enhanced by the presence of 5-HT activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqnBpxtWsSO7Vg90H21EOLACvtfcHk0lg53djp5fXPoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1Wgtbc%253D&md5=dd017f412b5f784c2d6492596d8371b5</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.109728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.109728%26sid%3Dliteratum%253Aachs%26aulast%3DLeventhal%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DV.%26aulast%3DHornby%26aufirst%3DG.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DBrandt%26aufirst%3DM.%2BR.%26aulast%3DRogers%26aufirst%3DK.%2BE.%26atitle%3DDifferential%2520and%2520synergistic%2520effects%2520of%2520selective%2520norepinephrine%2520and%2520serotonin%2520reuptake%2520inhibitors%2520in%2520rodent%2520models%2520of%2520pain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D1178%26epage%3D1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Berendsen, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weekers, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kloosterboer, H. J.</span><span> </span><span class="NLM_article-title">Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">419</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2FS0014-2999%2801%2900966-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=11348629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtlChtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2001&pages=47-54&author=H.+H.+Berendsenauthor=A.+H.+Weekersauthor=H.+J.+Kloosterboer&title=Effect+of+tibolone+and+raloxifene+on+the+tail+temperature+of+oestrogen-deficient+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats</span></div><div class="casAuthors">Berendsen, H. H. G.; Weekers, A. H. J.; Kloosterboer, H. J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-54</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Estradiol, clonidine, tibolone and raloxifene were tested for their effects on the tail temp. of estrogen deficient rats, a potential new model that can be used to test compds. that may be of use in the treatment of hot flushes in humans.  Rats underwent ovariectomies or sham operations and their tail temp. and phys. activity were measured telemetrically.  Estrogen depletion affected tail temp. in the rats' active, but not their resting phase.  During the transition from the resting to the active phase, tail temp. in normal rats dropped by about 6, but only by approx. 1 after ovariectomy.  Treatment of the ovariectomized rats with estrogen, clonidine or tibolone dose-dependently restored the drop in tail temp.  However, raloxifene did not change the tail temp. of ovariectomized rats.  Thus, tibolone and raloxifene have different effects on the temp. regulation in the tail.  This method of measuring tail temp. free of stress in ovariectomized rats may serve as a useful procedure for selecting compds. that are of potential use in the treatment of hot flushes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKjW2gIyOPH7Vg90H21EOLACvtfcHk0lhmzyK035avxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtlChtLY%253D&md5=b83ee7386c42053956d0a0471c0dba5a</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2801%2900966-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252801%252900966-9%26sid%3Dliteratum%253Aachs%26aulast%3DBerendsen%26aufirst%3DH.%2BH.%26aulast%3DWeekers%26aufirst%3DA.%2BH.%26aulast%3DKloosterboer%26aufirst%3DH.%2BJ.%26atitle%3DEffect%2520of%2520tibolone%2520and%2520raloxifene%2520on%2520the%2520tail%2520temperature%2520of%2520oestrogen-deficient%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D419%26spage%3D47%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sipe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leventhal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burroughs, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosmi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deecher, D. C.</span><span> </span><span class="NLM_article-title">Serotonin 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1028</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2Fj.brainres.2004.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=15527744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsFSrtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1028&publication_year=2004&pages=191-202&author=K.+Sipeauthor=L.+Leventhalauthor=K.+Burroughsauthor=S.+Cosmiauthor=G.+H.+Johnstonauthor=D.+C.+Deecher&title=Serotonin+2A+receptors+modulate+tail-skin+temperature+in+two+rodent+models+of+estrogen+deficiency-related+thermoregulatory+dysfunction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction</span></div><div class="casAuthors">Sipe, Kimberly; Leventhal, Liza; Burroughs, Kevin; Cosmi, Scott; Johnston, Grace H.; Deecher, Darlene C.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1028</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">191-202</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Menopause-assocd. thermoregulatory dysfunction, including hot flushes and night sweats, is effectively treated by hormonal therapies that include estrogens.  Evidence suggests that estrogen regulates serotonin 2A (5-HT2A) receptor expression and that 5-HT2A receptors are involved in thermoregulation.  Therefore, the role of 5-HT2A receptors in thermoregulation was assessed in two rat models of ovariectomy-induced thermoregulatory dysfunction.  The first model is based on measurement of the tail-skin temp. (TST) increase following naloxone-induced withdrawal in morphine-dependent ovariectomized (OVX) rats (MD model), while the second model relies on telemetric assessment of diurnal TST changes in ovariectomized rats (telemetry model).  Treatment with a 5-HT2A/2C receptor agonist, (-)-2,5-dimethoxy-4-iodoamphetamine hydrochloride (DOI), prevented the naloxone-induced TST increase in the MD model and restored normal active-phase TST in the telemetry model.  The selective 5-HT2A receptor antagonist, MDL-100907, had no effect on the naloxone-induced flush when administered alone in the MD model, but it decreased DOI's ability to abate the flush.  In the telemetry model, MDL-100907 attenuated the DOI-induced decrease in active-phase TST.  Interestingly, MDL-100907 increased TST in both models when given alone, with the TST increase occurring prior to the naloxone-induced flush in the MD model.  To evaluate the role of central nervous system (CNS) 5-HT2A receptors in TST regulation, DOI was administered in combination with a known peripheral 5-HT2A/2C receptor antagonist, xylamidine, in the MD model.  Xylamidine had no effect on DOI's ability to abate the naloxone-induced flush.  These results indicate that activation of central 5-HT2A receptors restores temp. regulation in two rodent models of ovariectomy-induced thermoregulatory dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLGpyDIO6zFrVg90H21EOLACvtfcHk0lhmzyK035avxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsFSrtbs%253D&md5=c02dd86937455c1da8b0ed27917aab8c</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2004.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2004.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DSipe%26aufirst%3DK.%26aulast%3DLeventhal%26aufirst%3DL.%26aulast%3DBurroughs%26aufirst%3DK.%26aulast%3DCosmi%26aufirst%3DS.%26aulast%3DJohnston%26aufirst%3DG.%2BH.%26aulast%3DDeecher%26aufirst%3DD.%2BC.%26atitle%3DSerotonin%25202A%2520receptors%2520modulate%2520tail-skin%2520temperature%2520in%2520two%2520rodent%2520models%2520of%2520estrogen%2520deficiency-related%2520thermoregulatory%2520dysfunction%26jtitle%3DBrain%2520Res.%26date%3D2004%26volume%3D1028%26spage%3D191%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Deecher, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfinito, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leventhal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosmi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchenthaler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneker, R.</span><span> </span><span class="NLM_article-title">Alleviation of thermoregulatory dysfunction with the new serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized rodent models</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">1376</span><span class="NLM_x">–</span> <span class="NLM_lpage">1383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2007&pages=1376-1383&author=D.+C.+Deecherauthor=P.+Alfinitoauthor=L.+Leventhalauthor=G.+H.+Johnstonauthor=S.+Cosmiauthor=I.+Merchenthalerauthor=R.+Winneker&title=Alleviation+of+thermoregulatory+dysfunction+with+the+new+serotonin+and+norepinephrine+reuptake+inhibitor+desvenlafaxine+succinate+in+ovariectomized+rodent+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeecher%26aufirst%3DD.%2BC.%26aulast%3DAlfinito%26aufirst%3DP.%26aulast%3DLeventhal%26aufirst%3DL.%26aulast%3DJohnston%26aufirst%3DG.%2BH.%26aulast%3DCosmi%26aufirst%3DS.%26aulast%3DMerchenthaler%26aufirst%3DI.%26aulast%3DWinneker%26aufirst%3DR.%26atitle%3DAlleviation%2520of%2520thermoregulatory%2520dysfunction%2520with%2520the%2520new%2520serotonin%2520and%2520norepinephrine%2520reuptake%2520inhibitor%2520desvenlafaxine%2520succinate%2520in%2520ovariectomized%2520rodent%2520models%26jtitle%3DEndocrinology%26date%3D2007%26volume%3D148%26spage%3D1376%26epage%3D1383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maswood, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfinito, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosmi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leventhal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deecher, D. C.</span><span> </span><span class="NLM_article-title">Evalulation of the selective serotonin reuptake inhibitor, fluoxetine, in ovariectomized (OVX) rat models of temperature regulation</span> <span class="citation_source-journal">Neuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2006&pages=330-338&author=N.+Maswoodauthor=P.+D.+Alfinitoauthor=S.+Cosmiauthor=L.+Leventhalauthor=G.+H.+Johnstonauthor=D.+C.+Deecher&title=Evalulation+of+the+selective+serotonin+reuptake+inhibitor%2C+fluoxetine%2C+in+ovariectomized+%28OVX%29+rat+models+of+temperature+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaswood%26aufirst%3DN.%26aulast%3DAlfinito%26aufirst%3DP.%2BD.%26aulast%3DCosmi%26aufirst%3DS.%26aulast%3DLeventhal%26aufirst%3DL.%26aulast%3DJohnston%26aufirst%3DG.%2BH.%26aulast%3DDeecher%26aufirst%3DD.%2BC.%26atitle%3DEvalulation%2520of%2520the%2520selective%2520serotonin%2520reuptake%2520inhibitor%252C%2520fluoxetine%252C%2520in%2520ovariectomized%2520%2528OVX%2529%2520rat%2520models%2520of%2520temperature%2520regulation%26jtitle%3DNeuroendocrinology%26date%3D2006%26volume%3D85%26spage%3D330%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Pawlyk, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosmi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfinito, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maswood, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deecher, D. C.</span><span> </span><span class="NLM_article-title">Effects of the 5-HT2A antagonist mirtazapine in rat models of thermoregulation</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1123</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1016%2Fj.brainres.2006.09.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=17067560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eksrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1123&publication_year=2006&pages=135-144&author=A.+C.+Pawlykauthor=S.+Cosmiauthor=P.+D.+Alfinitoauthor=N.+Maswoodauthor=D.+C.+Deecher&title=Effects+of+the+5-HT2A+antagonist+mirtazapine+in+rat+models+of+thermoregulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the 5-HT2A antagonist mirtazapine in rat models of thermoregulation</span></div><div class="casAuthors">Pawlyk, Aaron C.; Cosmi, Scott; Alfinito, Peter D.; Maswood, Navin; Deecher, Darlene C.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1123</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">135-144</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Thermoregulation is a complex intercommunicative function requiring coordination between core body temp. (CBT), the central nervous system, and peripheral vasculature.  In menopausal women, dysregulation of thermoregulatory mechanisms leads to hot flushes and night sweats.  A previous study in ovariectomized (OVX) rats has suggested that mirtazapine can alleviate thermoregulatory dysfunction by blocking 5-HT2A receptor signaling.  This is in opposition to other work in which 5-HT2A receptor blockade appeared to exacerbate thermoregulatory dysfunction in OVX rats.  Thus, the goals of the present study were to reexamine the effects of mirtazapine on temp. regulation in OVX rat models and explore further the role of 5-HT2A receptor blockade.  Mirtazapine exhibited potent functional antagonism (EC50 = 0.62 nM) at the cloned human 5-HT2A receptor.  In the morphine-dependent model of thermoregulatory dysfunction, mirtazapine (10 mg/kg, i.p.) induced an increase in tail-skin temp. (TST) prior to naloxone administration.  In the telemetry model, mirtazapine (0.3-3 mg/kg, i.p.) caused an increase in TST.  However, at the highest dose tested (10 mg/kg, i.p.), mirtazapine induced a small but significant decrease in TST followed by an increase in TST.  To examine this finding further, mirtazapine's effect on CBT was detd.  Administration of mirtazapine (1-3 mg/kg, i.p.) resulted in a slight decrease in CBT but at the 10 mg/kg dose a dramatic decrease (- 3.6°) in CBT was obsd.  These data support the concept that 5-HT2A receptors play a role in temp. regulation but that functional blockade of these receptors by mirtazapine is not a likely mechanism for restoring thermoregulatory processes in OVX rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUCakZiyPqdbVg90H21EOLACvtfcHk0lhmzyK035avxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eksrzE&md5=3ded0feab3044de87f60d3e5e8f7cb3f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2006.09.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2006.09.050%26sid%3Dliteratum%253Aachs%26aulast%3DPawlyk%26aufirst%3DA.%2BC.%26aulast%3DCosmi%26aufirst%3DS.%26aulast%3DAlfinito%26aufirst%3DP.%2BD.%26aulast%3DMaswood%26aufirst%3DN.%26aulast%3DDeecher%26aufirst%3DD.%2BC.%26atitle%3DEffects%2520of%2520the%25205-HT2A%2520antagonist%2520mirtazapine%2520in%2520rat%2520models%2520of%2520thermoregulation%26jtitle%3DBrain%2520Res.%26date%3D2006%26volume%3D1123%26spage%3D135%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Pacholczyk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, S. G.</span><span> </span><span class="NLM_article-title">Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm8002262&amp;key=10.1038%2F350350a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=2008212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADyaK3MXlsFaiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1991&pages=350-354&author=T.+Pacholczykauthor=R.+D.+Blakelyauthor=S.+G.+Amara&title=Expression+cloning+of+a+cocaine-+and+antidepressant-sensitive+human+noradrenaline+transporter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter</span></div><div class="casAuthors">Pacholczyk, Tadeusz; Blakely, Randy D.; Amara, Susan G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">6316</span>),
    <span class="NLM_cas:pages">350-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">At most synapses, chem. signalling is terminated by a rapid reaccumulation of neurotransmitter into presynaptic terminals.  Uptake systems for the biogenic amines are the initial site of action for therapeutic antidepressants and drugs such as cocaine and the amphetamines.  A cDNA clone encoding a human noradrenaline transporter was isolated.  The cDNA sequence predicts a protein of 617 amino acids, with 12-13 highly hydrophobic regions compatible with membrane-spanning domains.  Expression of the cDNA clone in transfected HeLa cells indicates that noradrenaline transport activity is sodium-dependent and sensitive to selective noradrenaline transport inhibitors.  Transporter RNA is localized to the brainstem and the adrenal gland.  The predicted protein sequence demonstrates significant amino-acid identity with the Na+/γ-aminobutyric acid transporter, thus identifying a new gene family for neurotransmitter transporter proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8wD9ty6pC27Vg90H21EOLACvtfcHk0lgLQ4oKInLAGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsFaiurg%253D&md5=1362c3278dbb943e28a0b6e3819652df</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2F350350a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F350350a0%26sid%3Dliteratum%253Aachs%26aulast%3DPacholczyk%26aufirst%3DT.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26aulast%3DAmara%26aufirst%3DS.%2BG.%26atitle%3DExpression%2520cloning%2520of%2520a%2520cocaine-%2520and%2520antidepressant-sensitive%2520human%2520noradrenaline%2520transporter%26jtitle%3DNature%26date%3D1991%26volume%3D350%26spage%3D350%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Ramamoorthy, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamoorthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papapetropoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catravas, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leibach, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganapathy, V.</span><span> </span><span class="NLM_article-title">Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in choriocarcinoma cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">17189</span><span class="NLM_x">–</span> <span class="NLM_lpage">17195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=17189-17195&author=J.+D.+Ramamoorthyauthor=S.+Ramamoorthyauthor=A.+Papapetropoulosauthor=J.+D.+Catravasauthor=F.+H.+Leibachauthor=V.+Ganapathy&title=Cyclic+AMP-independent+up-regulation+of+the+human+serotonin+transporter+by+staurosporine+in+choriocarcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamamoorthy%26aufirst%3DJ.%2BD.%26aulast%3DRamamoorthy%26aufirst%3DS.%26aulast%3DPapapetropoulos%26aufirst%3DA.%26aulast%3DCatravas%26aufirst%3DJ.%2BD.%26aulast%3DLeibach%26aufirst%3DF.%2BH.%26aulast%3DGanapathy%26aufirst%3DV.%26atitle%3DCyclic%2520AMP-independent%2520up-regulation%2520of%2520the%2520human%2520serotonin%2520transporter%2520by%2520staurosporine%2520in%2520choriocarcinoma%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D17189%26epage%3D17195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Pristupa, Z. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niznik, H. B.</span><span> </span><span class="NLM_article-title">Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [<sup>3</sup>H]WIN 35,428 and [<sup>3</sup>H]GBR 12,935 binding</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm8002262&amp;key=8302271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm8002262&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=125-35&author=Z.+B.+Pristupaauthor=J.+M.+Wilsonauthor=B.+J.+Hoffmanauthor=S.+J.+Kishauthor=H.+B.+Niznik&title=Pharmacological+heterogeneity+of+the+cloned+and+native+human+dopamine+transporter%3A+disassociation+of+%5B3H%5DWIN+35%2C428+and+%5B3H%5DGBR+12%2C935+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding</span></div><div class="casAuthors">Pristupa, Zdenek B.; Wilson, Julie M.; Hoffman, Beth J.; Kish, Stephen J.; Niznik, Hyman B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-35</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Controversy exists as to whether the functional state of the dopamine (DA) transporter is identical to sites mediating the specific binding of selective DA transporter radioligands.  Therefore, the authors compared the pharmacol. profile of numerous dopamine transport substrates and inhibitors on [3H]DA uptake with the binding of [3H]WIN 35,428 and [3H]GBR 12,935 to COS-7 cells transiently expressing the cloned human DA transporter.  [3H]DA uptake and [3H]WIN 35,428 binding was specific, saturable, and to a single class of binding sites with an estd. Km/Vmax of ∼2 μM and 6 pmol/min/105 cells for DA uptake and Kd/Bmax values of ∼10 nM and 113 fmol/105 cells for [3H]WIN 35,428.  [3H]DA uptake was inhibited in a concn.-dependent and uniphasic manner by dopaminergic agents with an appropriate rank order of potency for the DA transporter.  Although most uptake blockers inhibited [3H]WIN 35,428 binding in a uniphasic manner, WIN 35,428, Lu 19,005, D-amphetamine, and DA clearly displayed the presence of both high and low affinity components.  Comparison of the Ki values for the inhibition of [3H]DA uptake with [3H]WIN 35,428 binding reveals that, for uptake blockers and D-amphetamine, it is the high affinity component that shares pharmacol. identity with effects on DA uptake (r = 0.9985), whereas for DA it is the low affinity site.  In striking contrast, however, [3H]GBR 12,935 binding to COS-7 cells could not be made to exhibit a pharmacol. profile indicative of the DA transporter and suggests that the site regulating functional [3H]DA uptake may not be identical with sites labeled by [3H]GBR 12,935 in these cells.  Moreover, these sites appear unrelated to those previously described in native membranes as "piperazine acceptor" or P 450 proteins.  Comparison of Ki values and rank order of potency for the inhibition of [3H]WIN 35,428 or [3H]GBR 12,935 binding to human caudate membranes reveals pharmacol. homol., but not identity, with that of the cloned DA uptake process.  Taken together, these data suggest that 1) [3H]WIN 35,428 recognizes two sites of the DA transporter, of which only one appears to represent the functional state of the protein, and 2) [3H]WIN 35,428 and [3H]GBR 12,935 do not appear to bind the same functional form/state of the DA transporter.  Whether the nonidentity of binding sites is a manifestation of some post-translational regulatory event (e.g., phosphorylation/accessory binding protein) or caused by the existence of multiple mol. forms of the DA transporter is currently unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU2Vc8HuOAsLVg90H21EOLACvtfcHk0lgLQ4oKInLAGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFemu7c%253D&md5=a6ce271aad17d6f7f282bd716bbd1ddf</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPristupa%26aufirst%3DZ.%2BB.%26aulast%3DWilson%26aufirst%3DJ.%2BM.%26aulast%3DHoffman%26aufirst%3DB.%2BJ.%26aulast%3DKish%26aufirst%3DS.%2BJ.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26atitle%3DPharmacological%2520heterogeneity%2520of%2520the%2520cloned%2520and%2520native%2520human%2520dopamine%2520transporter%253A%2520disassociation%2520of%2520%255B3H%255DWIN%252035%252C428%2520and%2520%255B3H%255DGBR%252012%252C935%2520binding%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D45%26spage%3D125%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i87"><a href="/doi/suppl/10.1021/jm8002262">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_61214"></div></div></div></div></div><hr /></hr><p class="last">Crystallographic information in cif format, elemental analysis and purity results for all compounds tested in biological assays, raw data from rat telemetry studies, and data and procedures for pharmacokinetic studies. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm8002262/suppl_file/jm8002262-file002.pdf">jm8002262-file002.pdf (176.94 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm8002262/suppl_file/jm8002262-file004.cif">jm8002262-file004.cif (18.77 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm8002262&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm8002262%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-13%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm8002262" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                199KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994dcd6afbd197","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
